Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3026725	s-e2	nmol/l (nmol/l)	6865	9972	2.79%
3026725	s-e2	— (—)	2218	2742	100.00%	Distribution not available
3026725	s-estradioli	nmol/l____ (nmol/l)	23	25	0.00%
3026725	s-estradioli	nmol/l (nmol/l)	19	20	0.00%
3026725	s-estradioli	— (—)	12	12	100.00%	Distribution not available
3026725	s-e2	nmol/l____ (nmol/l)	6	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Noninflammatory disorders of female genital tract

1123

1407

4.15

312.46

1.6

1.4

0.50

0.32

nmol/l

5.09

940

997

Malignant neoplasm of breast, HER2-negative, including Hilmo

1259

1954

4.31

307.65

1.4

1.3

0.28

0.42

nmol/l

6.84

810

1488

Disorders of other endocrine glands

1558

3663

4.40

307.65

1.8

1.4

0.32

0.42

nmol/l

2.92

1214

2843

L02BG Aromatase inhibitors

888

1349

6.87

307.65

1.7

1.3

0.31

0.35

nmol/l

0.50

544

946

Hypopituitarism

433

368

13.45

307.65

2.0

1.4

0.24

0.37

nmol/l

3.33

304

284

Female infertility

1764

1234

9.52

307.65

1.7

1.4

0.64

0.33

nmol/l

13.37

1543

858

L02BA Anti-estrogens

646

1094

6.37

307.65

1.6

1.3

0.29

0.37

nmol/l

1.64

466

761

Amenorrhoea

621

515

14.56

307.65

2.0

1.4

0.22

0.36

nmol/l

3.88

511

375

Malignant neoplasm of breast

1220

1879

4.37

307.65

1.4

1.3

0.27

0.41

nmol/l

6.94

778

1430

Malignant neoplasm of breast, ER-positive, including Hilmo

1064

1328

6.29

307.65

1.4

1.3

0.25

0.38

nmol/l

5.28

674

976

Medicines for HER+ breast cancer

1249

1867

6.62

307.65

1.6

1.3

0.33

0.38

nmol/l

1.10

830

1354

Medical treatment for female infertility

1770

3420

5.96

307.65

1.8

1.3

0.71

0.38

nmol/l

15.93

1565

2640

Exclusions for E4_PCOS_BROAD

872

1381

6.93

307.65

1.9

1.4

0.27

0.42

nmol/l

5.28

630

1076

Malignant neoplasm of breast, HER-positive

1060

1324

6.30

307.65

1.4

1.3

0.25

0.37

nmol/l

5.21

670

972

Female infertility, cervical, vaginal, other or unspecified origin

1694

1210

10.00

307.65

1.7

1.4

0.67

0.33

nmol/l

15.93

1495

837

Malignant neoplasm of breast, including Hilmo

1259

1954

4.31

307.65

1.4

1.3

0.28

0.42

nmol/l

6.84

810

1488

Female infertility, associated with anovulation

626

715

10.18

307.65

2.1

1.3

0.55

0.37

nmol/l

1.76

547

525

Malignant neoplasm of breast, HER2-negative

1215

1875

4.36

307.65

1.4

1.3

0.27

0.41

nmol/l

7.09

773

1426

Malignant neoplasm

1746

3929

2.66

264.24

1.5

1.4

0.29

0.41

nmol/l

9.07

1215

3093

Malignant neoplasm

1745

3934

2.65

263.12

1.5

1.4

0.29

0.41

nmol/l

9.33

1214

3099

Personal history of malignant neoplasm

397

586

7.44

259.82

1.5

1.4

0.26

0.35

nmol/l

2.07

309

420

Malignant neoplasm, wide definition

1808

4152

2.59

259.33

1.5

1.4

0.29

0.42

nmol/l

9.11

1276

3288

Solid cancers

1682

3761

2.68

258.18

1.5

1.4

0.29

0.42

nmol/l

8.51

1160

2955

Malignant neoplasm, including Hilmo

1807

4174

2.57

256.53

1.5

1.4

0.29

0.42

nmol/l

9.33

1276

3307

Solid cancers, including Hilmo

1752

3989

2.61

256.17

1.5

1.4

0.29

0.42

nmol/l

8.65

1228

3152

Hypogonadotropic hypogonadism

195

109

20.97

247.65

2.1

1.6

0.13

0.25

nmol/l

1.32

139

Testicular dysfunction

167

23.04

225.28

2.0

1.3

0.13

0.12

nmol/l

0.60

130

Polycystic ovarian syndrome, broad definition

727

2090

3.86

218.07

2.0

1.4

0.54

0.50

nmol/l

0.21

643

1726

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

864

2757

3.24

212.73

1.8

1.4

0.30

0.42

nmol/l

5.27

630

2092

Endometriosis

779

1247

3.75

202.83

1.5

1.4

0.53

0.33

nmol/l

5.88

645

864

Ovarian dysfunction

539

1349

4.51

198.04

1.8

1.4

0.43

0.53

nmol/l

0.92

463

1128

Testicular hypofunction

147

21.92

194.14

2.0

1.4

0.13

0.12

nmol/l

0.70

114

Benign neoplasm: Pituitary gland, craniopharyngeal duct

273

383

8.01

188.20

2.0

1.5

0.31

0.39

nmol/l

1.28

195

311

Irregular menses

1586

5372

2.29

184.23

1.7

1.4

0.32

0.47

nmol/l

12.67

1311

4179

Exclusions for E4_PCOS_CONSORTIUM

1850

5464

2.16

181.25

1.7

1.4

0.34

0.45

nmol/l

5.80

1404

4330

Gender identity disorders

188

183

14.49

178.98

2.4

1.7

0.26

0.35

nmol/l

0.98

168

155

Any event in cancer register

1855

5142

2.14

176.25

1.5

1.4

0.32

0.45

nmol/l

8.94

1328

4151

Hypothyroidism, levothyroxine purchases

826

1527

3.14

163.01

1.7

1.5

0.44

0.51

nmol/l

0.72

682

1281

Hypothyroidism and >3 levothyroxin purchases

826

1527

3.14

163.01

1.7

1.5

0.44

0.51

nmol/l

0.72

682

1281

Hypothyroidism (congenital or acquired)

825

1527

3.13

162.13

1.7

1.5

0.44

0.51

nmol/l

0.71

681

1281

Endometriosis of ovary

422

933

4.43

160.73

1.5

1.4

0.61

0.33

nmol/l

5.26

356

627

Pain and other conditions associated with female genital organs and menstrual cycle

560

1345

3.60

155.44

1.4

0.42

0.32

nmol/l

1.51

468

958

Endometriosis of pelvic peritoneum

438

993

4.18

152.71

1.5

1.4

0.52

0.33

nmol/l

4.12

363

676

Hyperfunction of pituitary gland

271

491

6.18

145.85

1.7

1.3

0.31

0.47

nmol/l

2.46

204

397

Polycystic ovarian syndrome, consortium definition

1858

5466

1.99

144.09

1.7

1.4

0.35

0.47

nmol/l

5.77

1533

4236

Ovarian cyst

704

1308

3.16

142.70

1.5

1.4

0.46

0.32

nmol/l

2.55

570

913

Genitourinary diseases

790

1340

3.00

142.15

1.6

1.5

0.36

0.25

nmol/l

2.61

637

981

Hypothyroidism, other/unspecified

1742

5827

2.00

141.64

1.6

1.4

0.44

0.41

nmol/l

0.40

1373

4576

Disorders of the thyroid gland

1792

5969

1.98

141.36

1.6

1.4

0.42

0.41

nmol/l

0.26

1415

4683

Procreative management

819

2569

2.70

139.51

1.7

1.5

0.55

0.28

nmol/l

5.87

685

1872

Behavioural syndromes associated with physiological disturbances and physical factors

1760

6152

1.96

137.74

1.6

1.5

0.36

0.41

nmol/l

1.63

1367

4780

Hypothyreosis and Thyroxine purchase for inclusion criteria

1778

6030

1.96

137.37

1.6

1.4

0.43

0.41

nmol/l

0.39

1400

4720

Excessive, frequent and irregular menstruation

763

1402

2.97

137.27

1.5

1.4

0.40

0.32

nmol/l

2.20

627

995

Endocrine, nutritional and metabolic diseases

1668

4170

2.05

136.64

1.7

1.4

0.38

0.42

nmol/l

0.55

1341

3284

Unspecified/other endometriosis

332

732

4.70

136.04

1.5

1.3

0.56

0.35

nmol/l

3.13

281

532

Neoplasms

1666

4442

2.00

128.68

1.6

1.5

0.38

0.45

nmol/l

1.58

1316

3671

Complications associated with artificial fertilization

136

132

12.26

126.47

2.1

1.3

1.68

0.40

nmol/l

4.97

131

103

Recurrent or chronic depression

822

2259

2.58

123.45

1.6

1.5

0.39

0.44

nmol/l

0.60

614

1782

Depression

1755

6341

1.87

119.73

1.6

1.5

0.38

0.41

nmol/l

0.53

1357

4938

Neurotic, stress-related and somatoform disorders

1698

6285

1.89

118.78

1.6

1.5

0.36

0.41

nmol/l

1.49

1326

4871

Benign neoplasm of other and unspecified endocrine glands

318

773

4.29

118.22

1.9

1.4

0.32

0.37

nmol/l

0.68

226

584

Anxiety disorders

1702

6290

1.88

118.00

1.6

1.5

0.36

0.41

nmol/l

1.50

1329

4872

Other menopausal disorders

495

834

3.39

111.26

1.4

0.36

0.33

nmol/l

0.31

381

546

Hyperprolactinaemia

214

404

6.04

110.89

1.6

1.3

0.30

0.48

nmol/l

2.53

167

334

Mood disorders

1788

6366

1.82

109.74

1.6

1.5

0.37

0.41

nmol/l

0.75

1379

4956

Anxiety disorders, excluding more controls

1476

4939

1.93

109.71

1.6

1.4

0.37

0.43

nmol/l

1.36

1142

3819

Mood [affective] disorders

1784

6366

1.82

109.37

1.6

1.5

0.37

0.41

nmol/l

0.74

1375

4956

Endometriosis diagnosis and infertility diagnosis occurring together

484

1657

3.14

108.15

1.6

1.5

0.66

0.47

nmol/l

2.73

425

1308

Anxiety (asthma-related co-morbidities)

1369

5470

1.94

105.02

1.6

1.5

0.39

0.42

nmol/l

0.52

1086

4265

Polycystic ovarian syndrome

357

1049

3.77

104.02

1.9

1.4

0.51

0.57

nmol/l

0.32

322

885

Sleep disorders

1602

6091

1.83

102.84

1.5

0.37

0.42

nmol/l

1.05

1250

4728

Female infertility, tubal origin

187

329

6.12

102.80

1.7

1.3

0.67

0.39

nmol/l

2.07

172

218

All anxiety disorders

1429

5963

1.89

102.74

1.6

1.5

0.39

0.42

nmol/l

0.53

1141

4660

Primary ovarian failure

157

248

7.67

98.94

1.9

1.3

0.24

0.51

nmol/l

3.18

124

208

Hypothyroidism, strict autoimmune

1376

4809

1.90

98.09

1.5

1.4

0.46

0.42

nmol/l

0.47

1093

3802

Insomnia

1608

6375

1.78

93.21

1.5

0.36

0.41

nmol/l

1.47

1256

4955

Polyp of the female genital tract

490

948

2.99

91.22

1.5

1.4

0.46

0.33

nmol/l

2.99

387

625

Mood disorders, excluding more controls

1518

4978

1.81

90.89

1.5

1.4

0.36

0.42

nmol/l

1.37

1162

3851

Other antidepressants

1585

4565

1.79

88.38

1.5

0.34

0.43

nmol/l

2.80

1182

3635

Uterine polyps

458

911

3.00

86.76

1.5

1.4

0.46

0.33

nmol/l

2.54

356

600

Used for control exclusion in common control thyroid runs

1744

5161

1.72

84.74

1.6

1.4

0.38

0.40

nmol/l

0.48

1370

4083

Dysplasia of cervi uteri

453

1161

2.81

80.67

1.5

1.3

0.47

0.34

nmol/l

2.06

371

799

Endometriosis of rectovaginal septum and vagina

174

358

5.07

79.83

1.7

1.4

0.53

0.41

nmol/l

1.03

142

255

Depression medications

706

1557

2.33

78.30

1.5

0.40

0.51

nmol/l

1.21

528

1301

Oligomenorrhoea

128

215

6.39

73.86

1.8

1.4

0.26

0.40

nmol/l

1.64

107

162

Ovarian hyperstimulation (induction)

129

228

6.67

72.45

2.1

1.3

1.74

0.36

nmol/l

5.25

124

186

Headache

1214

5410

1.75

69.09

1.5

0.34

0.44

nmol/l

5.26

941

4280

Use of cabergoline

128

8.44

64.71

1.8

1.5

0.33

0.37

nmol/l

0.21

106

Other anxiety disorders

1094

5382

1.76

63.30

1.6

1.5

0.38

0.44

nmol/l

1.01

902

4265

Hypothyroidism, strict autoimmune, 3 medication purchases required

1420

5874

1.64

61.72

1.5

1.4

0.45

0.41

nmol/l

0.46

1127

4594

Habitual aborter

103

168

6.77

61.70

1.7

1.3

0.72

0.40

nmol/l

1.22

133

KRA_PSY_EATING, excluding more controls

370

1478

2.62

60.06

1.8

1.5

0.26

0.51

nmol/l

10.55

294

1250

Depression or dysthymia

836

2408

1.91

58.79

1.5

0.34

0.42

nmol/l

1.49

624

1892

Any reimbursement code in KELA

1247

3718

1.70

58.23

1.6

1.5

0.37

0.47

nmol/l

3.01

968

3061

Menorrhagia

474

1128

2.38

57.57

1.4

0.39

0.34

nmol/l

0.75

375

763

Panhypopituitarism

9.17

57.15

2.5

1.5

0.25

0.29

nmol/l

0.34

Medical observation and evaluation for suspected diseases and conditions

1046

3042

1.78

57.11

1.6

1.4

0.34

0.42

nmol/l

1.43

801

2392

Sleep disorders (combined)

1629

5459

1.57

56.48

1.5

0.38

0.43

nmol/l

1.10

1252

4282

Hypertrophy of breast in women and men

466

2141

2.24

55.26

1.4

0.31

0.41

nmol/l

1.27

354

1609

General symptoms and signs

1695

5536

1.55

54.31

1.6

1.5

0.30

0.44

nmol/l

11.87

1289

4380

Anorexia (incl.atypical)

243

849

3.04

52.39

1.9

1.5

0.26

0.51

nmol/l

5.22

193

708

Adrenocortical insufficiency

107

211

5.39

52.02

1.9

1.3

0.34

0.47

nmol/l

0.73

172

Adenomyosis (Endometriosis of uterus)

204

640

3.26

51.75

1.5

1.4

0.45

0.36

nmol/l

0.73

165

420

Thyrotropin deficiency

101

8.36

50.31

1.8

1.4

0.46

0.40

nmol/l

0.24

Any gastric operation

1392

4450

1.58

49.44

1.6

1.5

0.42

nmol/l

0.02

1088

3569

GASTRO-related operations

1392

4450

1.58

49.44

1.6

1.5

0.42

nmol/l

0.02

1088

3569

Selective serotonin reuptake inhibitors

1382

4579

1.58

49.32

1.5

0.35

0.43

nmol/l

1.90

1032

3642

Dentofacial anomalies [including malocclusion]

1315

6638

1.57

48.52

1.5

0.43

0.41

nmol/l

0.35

1029

5176

Other disorders of adrenal gland

125

299

4.41

48.00

1.8

1.3

0.32

0.44

nmol/l

0.93

234

Liquid cancers, including Hilmo

313

1138

2.45

45.91

1.7

1.4

0.25

0.33

nmol/l

1.55

243

845

Eating disorder

374

1708

2.30

45.82

1.8

1.6

0.26

0.48

nmol/l

10.03

298

1437

Eating disorders

383

1800

2.21

43.44

1.8

1.5

0.26

0.48

nmol/l

8.34

302

1507

Migraine

1107

5494

1.59

43.19

1.5

0.38

0.44

nmol/l

1.17

868

4387

Pain in joint

891

3266

1.69

43.11

1.5

0.32

0.42

nmol/l

2.98

681

2601

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

162

496

3.32

42.88

1.7

1.4

0.25

0.30

nmol/l

0.95

130

384

Anaemias

463

1449

2.08

42.60

1.6

1.5

0.39

0.52

nmol/l

2.42

377

1219

Triptan medication for migraine, single purchase ok

1360

6130

1.52

42.52

1.5

0.45

0.39

nmol/l

0.82

1049

4769

Migraine, single triptan purchase ok & required. ICD-code if available is included

1360

6130

1.52

42.52

1.5

0.45

0.39

nmol/l

0.82

1049

4769

Benign neoplasms

1570

5822

1.48

41.73

1.6

1.5

0.39

0.41

nmol/l

0.34

1245

4632

Endometriosis of intestine

129

6.29

41.50

1.6

1.3

0.55

0.37

nmol/l

0.86

104

Any mental disorder

1483

4997

1.50

41.16

1.6

1.4

0.37

0.42

nmol/l

0.95

1123

3865

Psychiatric diseases

1273

4183

1.53

39.81

1.5

1.4

0.38

0.42

nmol/l

0.75

970

3229

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1469

6455

1.47

39.18

1.5

0.37

0.39

nmol/l

0.37

1135

5016

Endometriosis ASRM stages 3,4

502

2705

1.90

38.34

1.5

0.60

0.46

nmol/l

1.88

420

2105

Primary amenorrhea

133

6.61

37.21

2.3

1.6

0.20

0.40

nmol/l

2.74

115

Liquid cancers

240

940

2.44

35.61

1.7

1.4

0.28

0.34

nmol/l

0.84

189

695

Cystitis

1347

5497

1.47

35.35

1.5

0.39

0.42

nmol/l

0.46

1055

4292

Nonorganic sleeping disorders, excluding more controls

431

2274

1.93

35.03

1.8

1.4

0.39

0.45

nmol/l

0.42

349

1808

Hypertrichosis

122

365

3.69

34.96

1.6

1.5

0.34

0.50

nmol/l

0.88

104

311

Diabetes insipidus

10.00

34.92

2.6

1.4

0.24

0.32

nmol/l

0.62

Other noninflammatory disorders of vulva and perineum

160

555

2.95

34.47

1.5

1.4

0.36

nmol/l

0.02

130

381

Benzodiazepine use

1444

6852

1.43

33.99

1.5

0.35

0.41

nmol/l

1.58

1099

5369

Disorders of adult personality and behaviour

631

3763

1.71

33.97

1.8

1.5

0.35

0.42

nmol/l

1.06

506

3000

Hirsutism in women

113

329

3.82

33.88

1.5

0.35

0.50

nmol/l

0.75

282

Other diseases of blood and blood-forming organs, wide

283

1296

2.22

33.76

1.6

1.4

0.24

0.35

nmol/l

3.31

193

970

First line medication for Crohn's disease

1646

6339

1.41

33.53

1.6

1.5

0.33

0.42

nmol/l

6.35

1236

5042

Primary_lymphoid and hematopoietic malignant neoplasms

213

870

2.48

33.01

1.7

1.4

0.28

0.29

nmol/l

0.11

173

641

Opioids

1540

5687

1.41

31.41

1.6

1.5

0.39

0.43

nmol/l

0.72

1185

4516

Agranulocytosis

172

653

2.69

31.29

1.6

1.4

0.24

0.37

nmol/l

2.50

111

495

Postmenopausal atrophic vaginitis

271

647

2.31

31.13

1.3

1.4

0.22

0.30

nmol/l

1.61

182

396

Episodal and paroxysmal disorders

1620

5932

1.39

31.11

1.5

0.36

0.42

nmol/l

1.69

1235

4713

Triptan medication for migraine, min. 3 purchases

1219

6362

1.45

30.73

1.5

0.44

0.42

nmol/l

0.26

955

5014

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

766

4804

1.58

30.54

1.5

1.4

0.36

0.39

nmol/l

0.78

579

3647

Deep endometriosis

238

1076

2.29

29.87

1.6

1.4

0.54

0.46

nmol/l

0.84

200

875

Supervision of high-risk pregnancy

556

1951

1.75

29.84

1.4

1.5

0.48

0.32

nmol/l

2.50

453

1446

Malignant neoplasm of ovary, including Hilmo

240

3.85

29.68

3.1

1.4

0.18

0.35

nmol/l

3.41

189

Complications of procedures, not elsewhere classified

1099

6109

1.46

29.57

1.5

0.34

0.41

nmol/l

2.57

837

4720

Pregnancy examination and test

505

1789

1.80

29.56

1.6

1.5

0.58

0.33

nmol/l

5.30

428

1355

Acromegaly and pituitary gigantism

12.04

29.23

2.2

1.3

0.37

0.33

nmol/l

0.08

Ovarian dysfunction, other/unspecified

7.98

29.16

1.5

1.4

0.27

0.48

nmol/l

1.45

Rare circulating lymphoid malignancy, including Hilmo

5.79

29.00

2.0

1.4

0.23

0.38

nmol/l

1.29

Malignant neoplasm of breast, ER-negative, including Hilmo

218

889

2.32

28.92

1.2

1.3

0.36

0.40

nmol/l

0.42

155

658

Endometriosis ASRM stages 1,2

445

2528

1.80

28.88

1.5

0.51

0.46

nmol/l

0.52

368

1976

Neurological diseases

1384

4954

1.41

28.68

1.6

1.5

0.37

0.44

nmol/l

1.35

1071

3949

Abdominal and pelvic pain

1317

4674

1.42

28.55

1.4

1.5

0.40

0.39

nmol/l

0.22

1001

3662

Premenstrual syndrome

103

5.74

28.54

1.4

0.46

0.41

nmol/l

0.20

Complications of medical and surgical care

957

5846

1.48

28.31

1.5

0.34

0.40

nmol/l

2.05

729

4484

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

705

4498

1.58

28.27

1.5

1.4

0.36

0.39

nmol/l

0.62

535

3411

Family history of malignant neoplasm

255

1210

2.16

28.22

1.5

0.34

0.45

nmol/l

1.82

191

939

Drug-induced neutropenia

115

372

3.18

28.17

1.5

1.4

0.26

0.33

nmol/l

0.84

274

Malaise and fatigue

643

3146

1.62

28.03

1.6

1.5

0.28

0.43

nmol/l

8.46

470

2432

Corticotropin deficiency

7.51

27.47

1.7

1.5

0.35

0.30

nmol/l

0.21

Persons encountering health services in other circumstances, wide

1514

5676

1.38

27.45

1.6

1.4

0.36

0.41

nmol/l

1.22

1167

4395

Other eating disorders

200

877

2.40

27.34

1.8

1.6

0.25

0.51

nmol/l

7.88

160

735

Acute upper respiratory infections

1428

6226

1.38

27.11

1.5

0.34

0.41

nmol/l

2.77

1064

4871

Hodgkin lymphoma, hilmo

189

4.18

27.08

1.8

1.5

0.37

0.38

nmol/l

0.05

151

Other abnormal uterine and vaginal bleeding

251

838

2.18

27.04

1.3

1.4

0.34

0.33

nmol/l

0.15

192

553

Symptoms and signs involving the digestive system and abdomen

1307

4674

1.41

26.86

1.5

0.41

0.39

nmol/l

0.27

990

3662

Caries of enamel

1361

6469

1.38

26.51

1.5

0.44

0.37

nmol/l

1.39

1040

5028

Postmenopausal bleeding

247

587

2.22

25.93

1.4

0.26

0.28

nmol/l

0.21

163

346

Fever of other and unknown origin

753

4301

1.53

25.80

1.6

1.5

0.29

0.43

nmol/l

9.27

564

3373

General examination and investigation of persons without complaint and reported diagnosis

877

3042

1.51

25.73

1.6

1.4

0.36

0.42

nmol/l

0.85

673

2392

Parasetamol

1151

4099

1.43

25.60

1.5

0.42

0.40

nmol/l

0.20

903

3290

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

173

699

2.42

25.58

1.7

1.3

0.18

0.27

nmol/l

3.11

105

506

Intestinal infectious diseases, including avohilmo, including avohilmo

1533

6328

1.36

25.54

1.5

0.38

0.39

nmol/l

0.18

1174

4911

Impotence

5.41

25.45

2.5

1.5

0.14

0.12

nmol/l

0.94

Persons encountering health services in circumstances related to reproduction

709

3078

1.56

25.30

1.6

1.5

0.31

0.26

nmol/l

1.29

547

2249

Chronic diseases of tonsils and adenoids

1208

5470

1.40

25.21

1.5

0.39

0.40

nmol/l

0.12

961

4265

Acute upper respiratory infections of multiple and unspecified sites

1158

6082

1.40

24.35

1.5

0.34

0.42

nmol/l

2.89

890

4764

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1415

6645

1.35

23.79

1.5

0.32

0.42

nmol/l

4.75

1083

5198

Acute lymphocytic leukaemia

7.24

23.77

1.8

1.5

0.27

0.46

nmol/l

0.98

Acute lymphocytic leukaemia, helper endpoint

7.24

23.77

1.8

1.4

0.27

0.46

nmol/l

0.98

Acute lymphocytic leukaemia, including Hilmo

7.24

23.77

1.8

1.5

0.27

0.46

nmol/l

0.98

Diseases of male genital organs

282

702

2.03

23.62

1.7

1.6

0.13

0.14

nmol/l

0.41

203

531

Other reaction to severe stress, and adjustment disorders

718

4814

1.51

23.41

1.6

1.5

0.35

0.45

nmol/l

3.10

571

3811

Examination and observation for other reasons

801

3039

1.50

23.25

1.5

1.4

0.44

0.42

nmol/l

0.15

609

2390

Codeine

1390

5574

1.35

23.01

1.6

1.5

0.38

0.43

nmol/l

1.35

1064

4426

Use of hypnotics and sedatives

1366

5785

1.36

23.00

1.5

1.4

0.33

0.42

nmol/l

4.06

1029

4479

Other noninflammatory disorders of uterus, except cervix

190

559

2.29

22.87

1.4

0.30

0.29

nmol/l

0.13

148

341

Postprocedural endocrine and metabolic disorders, not elsewhere classified

239

1200

2.03

22.75

1.7

1.4

0.35

0.41

nmol/l

0.88

185

918

Secondary and unspecified malignant neoplasm of lymph nodes

286

3.20

22.68

1.7

1.4

0.29

nmol/l

0.04

234

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1430

5676

1.34

22.51

1.6

1.4

0.34

0.41

nmol/l

2.05

1119

4395

Disorders of conjunctiva

1248

7153

1.36

22.43

1.6

1.5

0.42

0.40

nmol/l

0.35

990

5566

Other metabolic disorders

247

1268

1.99

22.06

1.7

1.4

0.34

0.41

nmol/l

1.04

191

968

Conjunctivitis

1189

7065

1.36

21.86

1.6

1.5

0.43

0.40

nmol/l

0.37

952

5496

Other abnormal products of conception

906

4192

1.44

21.69

1.5

0.53

0.44

nmol/l

1.69

746

3336

Nonorganic sleeping disorders

431

2627

1.67

21.58

1.8

1.5

0.39

0.43

nmol/l

0.26

349

2073

Mycoses, including avohilmo

1279

7271

1.35

21.54

1.6

1.5

0.38

0.40

nmol/l

0.48

1001

5677

Secondary uncertain malignant neoplasm

107

386

2.80

21.51

1.7

1.4

0.27

0.30

nmol/l

0.40

306

333

3.08

21.44

1.5

0.43

0.55

nmol/l

0.41

279

285

1550

1.87

21.39

1.8

1.5

0.41

0.45

nmol/l

0.28

223

1201

Lymphoid leukaemia

165

3.90

21.38

1.9

1.5

0.23

0.31

nmol/l

0.91

125

Routine general health check-up of defined subpopulation

234

3.48

21.30

2.1

1.4

0.34

0.39

nmol/l

0.23

177

Malignant neoplasm of breast, HER-negative

176

771

2.21

21.20

1.2

1.3

0.34

0.40

nmol/l

0.66

121

561

Other diseases of urinary system

1358

5718

1.34

21.11

1.5

0.41

nmol/l

0.06

1059

4466

Other endocrine disorders

105

364

2.85

21.04

1.9

1.4

0.30

0.37

nmol/l

0.72

291

Complications of surgical and medical care, not elsewhere classified

1301

6502

1.34

21.01

1.5

0.35

0.41

nmol/l

2.02

987

5052

Conjunctivitis (acute, non atopic), including avohilmo

1325

5996

1.34

20.97

1.5

0.40

0.38

nmol/l

0.26

1032

4639

Autoimmune diseases

1531

5925

1.32

20.81

1.6

1.5

0.40

0.39

nmol/l

0.17

1210

4640

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

595

1920

1.57

20.78

1.5

0.36

0.44

nmol/l

1.04

463

1559

Other nutritional deficiencies

1039

6938

1.38

20.72

1.5

0.39

0.42

nmol/l

0.51

832

5406

malignant neoplasm of female genital organs, including Hilmo

156

655

2.29

20.43

2.3

1.3

0.24

0.42

nmol/l

3.60

105

486

Other disorders of lacrimal gland

469

2964

1.60

20.10

1.4

1.5

0.30

0.40

nmol/l

2.57

330

2220

Malignant neoplasm of ovary

182

3.66

20.10

3.8

1.4

0.18

0.36

nmol/l

2.75

146

Persons encountering health services in other circumstances

603

3985

1.51

20.05

1.5

0.31

0.44

nmol/l

4.15

466

3108

Drug-induced adrenocortical insufficiency

109

4.65

19.93

1.7

1.4

0.39

0.33

nmol/l

0.34

Hypothyroidism, drug reimbursement

242

876

1.96

19.59

1.5

1.4

0.36

0.54

nmol/l

2.95

181

749

Endocrine disorders, other/unspecified

119

4.43

19.56

1.8

1.3

0.36

0.41

nmol/l

0.21

Irritable bowel syndrome

448

2837

1.60

19.14

1.6

1.5

0.37

0.43

nmol/l

1.27

357

2193

Codeine or tramadol medication

1535

6459

1.30

18.86

1.5

0.37

0.41

nmol/l

1.09

1174

5091

Primary adrenocortical insufficiency

5.61

18.79

1.8

1.4

0.33

0.36

nmol/l

0.11

Other noninflammatory disorders of vagina

105

405

2.64

18.69

1.8

1.3

0.40

0.38

nmol/l

0.15

277

Spontaneous abortion

919

4466

1.39

18.58

1.5

0.52

0.42

nmol/l

1.63

730

3518

Sleep apnoea, including avohilmo

1194

5431

1.33

18.51

1.5

0.31

0.40

nmol/l

3.47

868

4168

Cushing syndrome

5.77

18.38

3.1

1.4

0.27

0.45

nmol/l

1.04

Symptoms and signs involving the circulatory and respiratory systems

1518

5898

1.30

18.31

1.5

0.38

0.42

nmol/l

0.94

1150

4709

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1040

6022

1.35

18.04

1.5

0.45

0.44

nmol/l

0.17

821

4713

Other soft tissue disorders, not elsewhere classified

1339

5846

1.31

17.85

1.5

0.38

0.42

nmol/l

0.59

1015

4673

Special screening examination for infectious and parasitic diseases

531

2567

1.53

17.69

1.6

1.5

0.40

0.46

nmol/l

1.19

448

2075

Dental caries

301

1658

1.73

17.51

1.6

1.5

0.36

0.42

nmol/l

0.34

240

1289

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1038

7104

1.34

17.43

1.5

0.38

0.41

nmol/l

0.42

846

5549

Other special examinations and investigations of persons without complaint or reported diagnosis

840

3043

1.41

17.38

1.5

1.4

0.38

0.42

nmol/l

0.46

650

2392

Asthma (mode)

1072

4195

1.35

17.38

1.6

1.4

0.41

nmol/l

0.00

806

3307

Personality disorders, excluding more controls

468

3058

1.54

17.31

1.6

1.4

0.38

0.47

nmol/l

0.95

368

2455

Generalized anxiety disorder

399

2526

1.60

17.20

1.4

1.5

0.37

0.45

nmol/l

1.36

329

2053

Symptoms and signs concerning food and fluid intake

131

581

2.28

17.11

1.7

1.5

0.25

0.40

nmol/l

2.68

102

454

Sleep apnoea

1039

4892

1.34

17.07

1.5

1.4

0.30

0.38

nmol/l

2.13

744

3693

Hyperkinetic disorders, excluding more controls

346

1978

1.66

17.03

1.7

1.5

0.34

0.49

nmol/l

3.16

292

1663

Other headache syndromes

638

4440

1.44

17.02

1.5

0.32

0.43

nmol/l

4.10

470

3483

Neurological diseases, wide definition

596

2021

1.49

16.87

1.6

1.5

0.43

0.46

nmol/l

0.22

456

1631

Pain, not elsewhere classified

394

2497

1.59

16.81

1.6

1.5

0.37

0.47

nmol/l

1.41

300

1957

Other symptoms and signs involving the digestive system and abdomen

226

1235

1.85

16.72

1.7

1.5

0.34

0.38

nmol/l

0.42

181

938

Antihypertensive medication - note that there are other indications

1269

5102

1.31

16.55

1.6

1.5

0.37

0.45

nmol/l

2.47

1002

4143

Dermatitis and eczema

1467

6829

1.28

16.36

1.5

0.36

0.40

nmol/l

1.21

1116

5350

Pain (limb, back, neck, head abdominally)

896

3281

1.37

16.30

1.5

0.38

0.42

nmol/l

0.35

676

2609

Diabetes, insulin treatment (Kela reimbursement)

670

5594

0.71

16.28

1.5

0.25

0.38

nmol/l

7.57

482

4243

Other other unspecified disorders of the circulatory system

151

3.61

16.07

1.4

0.23

0.28

nmol/l

0.31

108

Certain infectious and parasitic diseases

1369

5351

1.29

15.80

1.6

1.5

0.36

0.42

nmol/l

1.89

1048

4236

Caries of dentine

260

1450

1.74

15.76

1.5

0.29

0.42

nmol/l

2.92

209

1129

Any operation in hilmo

4.39

15.73

1.7

1.2

0.35

0.41

nmol/l

0.20

Asthma

1069

4172

1.33

15.60

1.6

1.4

0.41

nmol/l

0.01

805

3293

Certain infectious and parasitic diseases, including avohilmo

943

3508

1.35

15.54

1.5

0.40

0.42

nmol/l

0.19

721

2754

Polyuria

190

1008

1.90

15.40

1.6

1.4

0.24

0.33

nmol/l

1.72

151

760

Asthma, excluding more controls

1062

4131

1.33

15.36

1.6

1.4

0.42

nmol/l

0.02

802

3260

Bronchitis

1456

6928

1.27

15.18

1.5

0.34

0.41

nmol/l

2.65

1119

5423

Hyperhidrosis

332

2.66

15.05

1.6

1.5

0.31

0.50

nmol/l

2.08

277

Nausea and vomiting

332

2025

1.61

14.96

1.5

1.6

0.37

0.38

nmol/l

0.04

254

1579

malignant neoplasm of female genital organs

124

557

2.20

14.92

2.6

1.3

0.24

0.42

nmol/l

2.66

410

Disorders of lacrimal system

519

3524

1.46

14.75

1.4

1.5

0.31

0.39

nmol/l

2.27

374

2638

Disorders of puberty

139

3.65

14.43

2.1

1.4

0.36

nmol/l

0.00

111

Carcinoma in situ of breast, intraductal

102

440

2.36

14.41

1.3

1.4

0.51

0.31

nmol/l

1.03

298

Soft tissue disorders

1445

5887

1.26

14.37

1.5

0.36

0.42

nmol/l

1.33

1084

4705

Coxibs

329

1059

1.64

14.28

1.7

1.6

0.31

0.39

nmol/l

1.35

263

875

Non-selective monoamine reuptake inhibitors

313

1874

1.61

14.19

1.5

1.4

0.32

0.37

nmol/l

0.57

223

1399

Temporomandibular joint disorders, including avohilmo

874

6420

1.33

14.09

1.5

0.43

nmol/l

0.00

693

5093

Symptoms and signs involving the nervous and musculoskeletal systems

660

4794

1.38

14.05

1.5

0.33

0.39

nmol/l

1.06

495

3664

Intestinal infectious diseases

1235

7241

1.27

14.05

1.6

1.5

0.37

0.40

nmol/l

0.70

961

5667

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

659

5364

0.73

14.03

1.5

1.4

0.25

0.38

nmol/l

7.63

472

4068

Other obstetric conditions, not elsewhere classified

1000

4852

1.32

13.96

1.5

0.58

0.43

nmol/l

2.63

832

3936

Other complications of surgical and medical care, not elsewhere classified

144

722

2.03

13.95

1.6

1.5

0.34

0.38

nmol/l

0.10

105

556

Other diseases of upper respiratory tract

1345

5563

1.26

13.65

1.5

0.40

nmol/l

0.03

1028

4335

Allergic conjunctivitis

924

6820

1.31

13.63

1.6

1.5

0.43

0.41

nmol/l

0.12

741

5296

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

984

4772

1.32

13.62

1.5

0.58

0.44

nmol/l

2.52

821

3884

Other symptoms and signs involving the nervous and musculoskeletal systems

525

3705

1.43

13.34

1.5

0.35

0.41

nmol/l

0.73

387

2839

Other dorsopathies, not elsewhere classified

1419

5909

1.25

13.27

1.5

0.37

0.42

nmol/l

0.98

1102

4678

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

885

6495

1.31

13.19

1.6

1.5

0.43

0.41

nmol/l

0.15

715

5042

Asthma, including avohilmo

1546

6907

1.24

13.09

1.5

0.39

0.40

nmol/l

0.18

1185

5423

Isolated growth hormone deficiency

5.56

12.98

2.6

1.5

0.22

0.44

nmol/l

0.99

Cervical polyps

104

473

2.23

12.98

1.4

0.51

0.32

nmol/l

1.49

297

Inflammatory diseases of female pelvic organs

1141

6163

1.27

12.93

1.5

0.47

0.43

nmol/l

0.59

908

4831

Inflammatory diseases of prostate (prostatitis)

221

2.82

12.91

1.6

1.5

0.11

0.12

nmol/l

0.49

162

Hypo-osmolality and hyponatraemia

117

553

2.11

12.90

1.7

1.5

0.22

0.28

nmol/l

0.71

387

Acetic acid derivatives and related substances

314

1010

1.62

12.90

1.6

0.43

0.40

nmol/l

0.23

256

831

Other disorders of fluid, electrolyte and acid-base balance

224

1239

1.71

12.86

1.7

1.4

0.25

0.31

nmol/l

0.89

164

876

Disorders of puberty, all

203

3.02

12.85

2.1

1.6

0.36

0.32

nmol/l

0.18

164

Panic disorder

326

2119

1.56

12.76

1.6

1.5

0.30

0.45

nmol/l

4.43

258

1721

Other sleep disorders

150

789

1.93

12.66

1.6

1.5

0.38

0.39

nmol/l

0.03

123

628

Obesity and other hyperalimentation

943

6885

1.29

12.66

1.5

0.39

0.42

nmol/l

0.42

754

5360

Congenital malformations, deformations and chromosomal abnormalities

943

6947

1.29

12.63

1.5

0.38

0.41

nmol/l

0.47

762

5448

Factors influencing health status and contact with health services

256

763

1.69

12.49

1.6

1.4

0.27

nmol/l

0.01

191

580

Asthma (only as main-diagnosis)

966

4172

1.30

12.45

1.5

1.4

0.42

0.41

nmol/l

0.04

729

3293

Chronic periodontitis, including avohilmo

725

6132

0.75

12.41

1.4

1.5

0.34

0.39

nmol/l

0.60

513

4718

Obesity

938

6877

1.29

12.35

1.5

0.39

0.42

nmol/l

0.42

750

5354

Periodontitis

730

6141

0.75

12.13

1.4

1.5

0.34

0.39

nmol/l

0.59

515

4730

Torsion of ovary, ovarian pedicle and fallopian tube

130

3.41

12.02

1.3

0.45

0.36

nmol/l

0.41

Other diseases of intestines

1492

6792

1.23

11.90

1.5

0.36

0.41

nmol/l

1.26

1160

5346

Asthma (only as main-diagnosis), excluding more controls

961

4131

1.29

11.82

1.5

1.4

0.42

nmol/l

0.02

727

3260

Malignant neoplasm of endocrine gland, including Hilmo

454

2.19

11.76

1.8

1.4

0.33

0.41

nmol/l

0.57

369

Autism spe, excluding more controls

258

2.65

11.72

1.8

1.4

0.29

0.44

nmol/l

1.24

218

Dorsalgia

1372

5896

1.24

11.68

1.5

0.36

0.42

nmol/l

1.43

1050

4668

Other functional intestinal disorders

500

3248

1.41

11.67

1.6

1.5

0.36

0.39

nmol/l

0.23

388

2445

Other joint disorders

1371

5799

1.24

11.66

1.5

0.35

0.43

nmol/l

2.61

1063

4619

Dorsopathies

1437

5931

1.23

11.58

1.6

1.5

0.36

0.42

nmol/l

1.08

1111

4692

Disorders of skin appendages

766

5850

1.31

11.42

1.5

0.39

0.41

nmol/l

0.28

620

4568

Contraceptive management

523

2629

1.40

11.41

1.5

0.36

0.28

nmol/l

1.01

390

1922

Symptoms and signs involving the skin and subcutaneous tissue

902

6672

1.28

11.35

1.4

1.5

0.40

nmol/l

0.04

687

5165

Pain associated with micturition

146

792

1.87

11.26

1.4

1.5

0.31

0.38

nmol/l

0.69

116

608

Abnormalities of heart beat

439

3002

1.43

11.25

1.5

0.31

0.41

nmol/l

2.61

338

2357

Emotional disorders starting during childhood or adolecense, excluding more controls

118

580

2.02

11.23

1.5

0.29

0.46

nmol/l

2.78

495

Follow-up examination after treatment for conditions other than malignant neoplasms

587

2870

1.37

11.19

1.5

1.4

0.37

0.44

nmol/l

1.34

465

2257

Female genital prolapse

246

835

1.65

11.17

1.4

0.36

0.33

nmol/l

0.29

185

536

Oxycodone

274

1497

1.57

11.15

1.5

1.4

0.20

0.34

nmol/l

4.91

189

1077

Disease of hard tissues of teeth, NOS

536

2015

1.40

11.14

1.4

1.5

0.36

0.40

nmol/l

0.48

399

1562

Other specific joint derangements/joint disorders

1151

5758

1.25

11.13

1.5

0.33

0.43

nmol/l

4.80

882

4588

Dental pulpitis, including avohilmo

1324

6915

1.23

11.09

1.4

1.5

0.41

0.40

nmol/l

0.14

1038

5404

Urinary track infection

1166

4682

1.26

11.08

1.5

0.45

0.44

nmol/l

0.14

913

3679

Cerebral cysts

107

527

2.08

11.07

1.4

1.5

0.30

0.42

nmol/l

1.42

431

Other extrapyramidal and movement disorders in other diseases

242

1517

1.61

11.02

1.4

0.32

0.37

nmol/l

0.58

192

1127

Abnormal findings in secretions and smears from cervix uteri vagina vulva

992

5794

1.27

11.00

1.5

0.46

0.45

nmol/l

0.18

788

4548

Fenamates

192

760

1.74

10.96

1.5

0.32

0.45

nmol/l

1.84

153

615

Chronic rhinitis, nasopharyngitis and pharyngitis

439

3119

1.42

10.87

1.5

0.35

0.38

nmol/l

0.56

351

2372

Male infertility

149

3.06

10.79

1.9

1.5

0.13

nmol/l

0.14

105

Monoamine oxidase A inhibitors

115

585

1.99

10.76

1.4

0.37

nmol/l

0.02

445

Psychotic depression

419

2.18

10.73

1.5

0.43

0.48

nmol/l

0.20

345

Obesity related asthma

389

2711

1.44

10.73

1.6

1.4

0.34

0.37

nmol/l

0.27

288

2027

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

585

4210

1.35

10.58

1.5

0.29

0.37

nmol/l

3.47

444

3216

Gastrointestinal diseases

1004

3988

1.27

10.51

1.5

0.41

0.43

nmol/l

0.32

791

3170

Atopic dermatitis

1004

6396

1.26

10.46

1.6

1.5

0.40

0.42

nmol/l

0.35

802

5038

Persons encountering health services for examination and investigation

788

3043

1.30

10.32

1.5

1.4

0.35

0.42

nmol/l

1.40

611

2392

Restless leg syndrome

171

999

1.73

10.31

1.5

1.4

0.37

0.39

nmol/l

0.14

141

749

Somatoform disorder

244

1562

1.58

10.27

1.5

1.4

0.30

0.45

nmol/l

4.00

180

1215

Other maternal disorders predominantly related to pregnancy

1037

5204

1.25

10.26

1.4

1.5

0.49

0.40

nmol/l

1.39

822

4017

Post-traumatic stress disorder

232

1477

1.60

10.16

1.6

1.5

0.36

0.47

nmol/l

1.68

188

1223

1430

5991

1.21

10.10

1.5

0.34

0.42

nmol/l

3.56

1073

4686

Candidiasis, including avohilmo

461

3361

1.38

9.89

1.7

1.5

0.45

0.42

nmol/l

0.20

360

2628

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

548

3576

1.35

9.85

1.6

0.33

0.45

nmol/l

3.90

448

2985

Tonsillectomy and adenotomy

1099

6215

1.24

9.81

1.5

0.43

0.42

nmol/l

0.13

898

4917

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1162

7397

1.23

9.81

1.6

1.5

0.40

nmol/l

0.01

894

5794

Disorders of pituitary gland, other and/or unspecified

9.05

9.80

2.5

1.2

0.31

0.18

nmol/l

0.71

Implicit viral Sepsis, including avohilmo

278

1850

1.51

9.63

1.5

0.29

0.37

nmol/l

1.62

207

1401

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

543

3532

1.34

9.61

1.6

1.4

0.28

0.35

nmol/l

2.23

402

2589

Sexual dysfunction

113

3.29

9.56

2.3

1.5

0.18

0.44

nmol/l

2.70

Other CVD

113

596

1.91

9.51

1.4

0.24

0.28

nmol/l

0.34

436

Osteoporosis

154

819

1.74

9.43

1.9

1.4

0.23

0.28

nmol/l

0.46

545

Disorders of parathyroid gland

133

734

1.80

9.34

1.5

1.3

0.31

nmol/l

0.02

514

Cardiovascular diseases

1226

5351

1.22

9.34

1.6

1.5

0.43

nmol/l

0.04

961

4342

Other congenital malformations

163

971

1.71

9.28

1.6

1.5

0.51

0.42

nmol/l

0.29

132

765

Dysphagia

204

1282

1.60

9.26

1.4

0.44

0.33

nmol/l

0.61

148

958

Secondary polycythaemia

3.45

9.24

1.7

1.5

0.20

0.27

nmol/l

0.68

Wide developmental disorders, excluding more controls

326

2.24

9.19

1.8

1.5

0.28

0.45

nmol/l

1.63

275

Mycoses

318

2202

1.45

9.18

1.5

0.42

0.40

nmol/l

0.11

235

1690

Cluster headache, wide

335

2.23

9.15

1.6

1.4

0.25

0.43

nmol/l

2.43

278

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

486

1.99

9.14

1.6

1.4

0.19

0.25

nmol/l

1.42

345

Myalgia

357

2531

1.42

9.09

1.5

0.34

0.43

nmol/l

1.66

259

2000

Diseases of the eye and adnexa

1239

5118

1.22

9.09

1.5

0.41

nmol/l

0.03

957

4080

Abnormal weight loss

449

2.03

8.99

1.7

1.5

0.27

0.33

nmol/l

0.82

346

Malignant neoplasm of endocrine gland

416

2.07

8.97

1.8

1.4

0.33

0.41

nmol/l

0.55

339

Non-Hodgkin lymphoma, all, including Hilmo

331

2.19

8.87

1.7

1.4

0.26

nmol/l

0.05

251

Tramadol

905

4372

1.25

8.74

1.6

1.4

0.31

0.42

nmol/l

3.44

680

3385

Other pulmonary diagnosis

1034

4211

1.23

8.71

1.5

1.4

0.42

0.41

nmol/l

0.12

787

3323

ILD differential diagnosis

1030

4195

1.23

8.67

1.5

1.4

0.42

0.41

nmol/l

0.12

783

3307

Certain disorders involving the immune mechanism

198

1258

1.59

8.66

1.7

1.4

0.28

0.35

nmol/l

0.71

156

939

Extrapyramidal and movement disorders

304

2110

1.45

8.66

1.4

0.32

0.35

nmol/l

0.45

243

1548

Weight loss

102

539

1.91

8.65

1.6

1.5

0.25

0.34

nmol/l

1.58

420

Excluding asthma or asthma-COPD overlap

1033

4211

1.23

8.63

1.5

1.4

0.42

0.41

nmol/l

0.11

788

3323

Obsessive-compulsive disorder

166

1016

1.67

8.60

1.6

1.5

0.43

0.48

nmol/l

0.26

134

849

Cluster headache, strict

331

2.20

8.60

1.6

1.4

0.25

0.43

nmol/l

2.32

276

COPD differential diagnosis

1029

4197

1.23

8.56

1.5

1.4

0.42

0.41

nmol/l

0.12

782

3309

Fibromyalgia

179

1118

1.63

8.52

1.4

0.32

0.43

nmol/l

1.50

122

883

Maternal care for known or suspected fetal abnormality and damage

453

2865

1.36

8.42

1.6

1.5

0.60

0.45

nmol/l

1.54

391

2299

Diseases of the skin and subcutaneous tissue

1248

5207

1.21

8.38

1.5

0.38

0.42

nmol/l

0.56

962

4081

Brain meningioma, including Hilmo

178

2.62

8.36

1.4

1.3

0.22

0.36

nmol/l

1.91

140

Bacterial infection, other or unspecified

406

2513

1.37

8.18

1.5

1.4

0.25

0.37

nmol/l

4.23

290

1863

Abnormalities of breathing

1233

5888

1.20

8.15

1.5

0.33

0.42

nmol/l

3.69

919

4702

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

470

3503

1.33

8.13

1.4

0.40

0.48

nmol/l

1.46

363

2816

Personality disorders

468

3535

1.33

8.10

1.6

1.5

0.38

0.42

nmol/l

0.33

368

2821

L01XE Protein kinase inhibitors

164

2.66

8.06

1.5

1.4

0.20

0.29

nmol/l

0.87

120

Antenatal screening

491

2067

1.34

8.05

1.4

1.5

0.49

0.32

nmol/l

1.87

393

1541

Thyroiditis, ILD-related definition

190

1220

1.58

8.05

1.6

1.5

0.42

0.44

nmol/l

0.12

148

954

Type 2 diabetes, wide definition

400

3407

0.74

8.00

1.5

1.4

0.22

0.34

nmol/l

6.87

277

2483

Pain in limb

1092

5747

1.21

8.00

1.4

1.5

0.37

0.42

nmol/l

1.26

826

4598

Melanocytic naevi

436

3264

1.34

7.99

1.5

0.42

0.43

nmol/l

0.09

343

2532

Oedema, not elsewhere classified

282

1916

1.44

7.95

1.5

1.4

0.33

0.42

nmol/l

1.52

213

1458

Postviral fatigue syndrome

134

2.97

7.93

1.5

0.26

0.36

nmol/l

1.47

113

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

113

636

1.80

7.90

1.6

1.5

0.26

0.41

nmol/l

2.40

496

Brain meningioma

172

2.59

7.86

1.4

1.3

0.23

0.36

nmol/l

1.72

135

Other/unspecified dorsalgia

444

3297

1.34

7.85

1.5

0.34

0.40

nmol/l

1.28

327

2539

Chromosomal abnormalities, not elsewhere classified

234

2.39

7.84

2.0

1.4

0.31

0.39

nmol/l

0.77

186

Primary hyperparathyroidism

437

1.96

7.84

1.6

1.4

0.36

0.29

nmol/l

0.46

302

Diarrhoea and gastroenteritis of presumed infectious origin

905

6614

1.23

7.84

1.6

1.5

0.36

0.41

nmol/l

1.47

702

5209

Disorders of tooth development and eruption

254

1409

1.48

7.83

1.6

1.5

0.52

0.46

nmol/l

0.20

211

1121

Short stature, not elsewhere classified

176

2.56

7.83

1.9

1.5

0.25

0.36

nmol/l

1.01

144

Acne, including avohilmo

571

3594

1.30

7.82

1.6

0.35

0.47

nmol/l

2.93

475

3019

Hernia of abdominal wall, postoperative

155

945

1.64

7.81

1.5

1.4

0.31

0.38

nmol/l

0.64

108

716

Deviated nasal septum

259

1779

1.46

7.80

1.5

1.4

0.24

0.34

nmol/l

3.44

196

1338

COPD/asthma/ILD related infections

1330

5612

1.19

7.79

1.5

0.36

0.42

nmol/l

1.80

991

4424

COPD/asthma related infections

1330

5612

1.19

7.79

1.5

0.36

0.42

nmol/l

1.80

991

4424

Abnormal results of function studies

109

610

1.81

7.77

1.7

1.5

0.27

0.38

nmol/l

1.19

474

Hyperparathyroidism

107

588

1.81

7.73

1.5

1.4

0.33

0.29

nmol/l

0.30

408

Dissociative [conversion] disorders

492

1.92

7.71

1.5

0.52

0.47

nmol/l

0.08

409

Other diseases of hard tissues of teeth

514

2019

1.32

7.71

1.4

1.5

0.34

0.40

nmol/l

0.92

387

1566

Lower back pain or/and sciatica

1346

7089

1.18

7.63

1.5

0.36

0.41

nmol/l

1.07

1005

5580

Disorders of mineral metabolism

449

1.94

7.62

1.3

1.5

0.33

0.31

nmol/l

0.08

339

Disturbances of skin sensation

417

3127

1.34

7.60

1.4

1.5

0.36

0.43

nmol/l

0.78

322

2441

Hyperkinetic disorders

349

2487

1.39

7.60

1.7

1.6

0.34

0.43

nmol/l

1.52

294

2081

Malignant melanoma, including Hilmo

105

584

1.81

7.59

1.4

0.27

0.32

nmol/l

0.60

436

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

175

2.54

7.58

1.3

1.4

0.34

nmol/l

0.01

141

Disturbance of activity and attention

335

2378

1.39

7.52

1.7

1.6

0.34

0.44

nmol/l

1.45

281

1995

Persons with potential health hazards related to communicable diseases

696

5538

1.25

7.46

1.5

0.33

0.45

nmol/l

5.49

516

4474

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

290

2.16

7.41

2.0

1.5

0.22

0.35

nmol/l

2.17

239

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

160

2.62

7.41

1.3

1.4

0.70

0.36

nmol/l

0.79

120

Benign neoplasm: Cerebral meninges

426

1.94

7.38

1.4

0.25

0.29

nmol/l

0.37

304

Sleep disorders, other/unspecified

387

2.01

7.35

1.9

1.5

0.58

0.40

nmol/l

0.28

311

Covid-19 confirmed case

367

2707

1.36

7.35

1.6

1.5

0.30

0.40

nmol/l

3.38

276

2102

Personal history of other diseases and conditions

237

1625

1.47

7.25

1.5

0.42

0.47

nmol/l

0.24

195

1312

Visual disturbances

523

4071

1.29

7.23

1.6

1.5

0.37

0.39

nmol/l

0.22

386

3115

Other and unspecified drugs and medicaments

104

589

1.79

7.17

1.7

1.5

0.26

0.39

nmol/l

1.98

457

Bacterial infection, other or unspecified, including avohilmo

466

2920

1.31

7.13

1.5

1.4

0.25

0.37

nmol/l

5.10

335

2194

Visual disturbances and blindness

547

4285

1.28

7.13

1.6

1.5

0.37

0.39

nmol/l

0.29

407

3284

Disorders of ocular muscles, binocular movement, accommodation and refraction

691

5523

1.25

7.10

1.5

0.35

0.40

nmol/l

0.84

522

4320

Congenital malformations and deformations of the musculoskeletal system

161

1022

1.59

7.07

1.6

1.5

0.31

0.42

nmol/l

1.70

135

815

Contact with and exposure to communicable diseases

620

4926

1.26

7.07

1.4

1.5

0.34

0.46

nmol/l

4.96

453

3996

Abnormal findings on diagnostic imaging of central nervous system

406

1.96

7.06

1.4

0.31

0.38

nmol/l

0.47

322

Paracetamol or NSAID medication

216

721

1.52

7.06

1.4

1.6

0.35

0.36

nmol/l

0.12

168

604

Other disorders of male genital organs

3.06

7.05

1.8

1.4

0.13

0.12

nmol/l

0.09

Low back pain

1025

5781

1.20

6.98

1.4

1.5

0.38

0.42

nmol/l

0.72

770

4574

Autism spe

327

2.08

6.95

1.8

1.6

0.29

0.37

nmol/l

0.89

272

Benign neoplasm of meninges

464

1.87

6.93

1.4

0.24

0.29

nmol/l

0.44

331

Excessive attrition of teeth

856

7004

1.21

6.90

1.5

0.45

0.40

nmol/l

0.47

660

5471

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

194

1290

1.51

6.88

1.6

1.5

0.33

0.43

nmol/l

1.34

162

1019

Malignant melanoma

495

1.83

6.80

1.4

0.28

0.30

nmol/l

0.20

379

Malignant neoplasm of thyroid gland, including Hilmo

404

1.93

6.78

1.7

1.4

0.34

0.39

nmol/l

0.31

333

Specific personality disorders

409

3115

1.32

6.78

1.6

1.5

0.38

0.43

nmol/l

0.44

325

2504

Postprocedural disorders of nervous system

149

947

1.60

6.74

1.4

1.5

0.37

0.46

nmol/l

0.89

123

765

Other symptoms and signs involving cognitive functions and awareness

322

2090

1.37

6.72

1.5

1.4

0.26

0.34

nmol/l

2.03

244

1530

Hyperplasia of prostate

109

347

1.77

6.72

1.6

1.4

0.13

0.12

nmol/l

0.64

267

Oter anti-inflammatory and antirheumatic agents, non-steroids

127

413

1.70

6.66

1.9

1.4

0.28

0.46

nmol/l

1.58

318

Varicose veins

278

2895

0.72

6.58

1.4

0.43

0.32

nmol/l

0.56

190

2052

Constipation

917

5168

1.20

6.57

1.5

1.4

0.34

0.37

nmol/l

0.36

679

3908

Disorders of thyroid, IBD co-morbidities

310

1545

1.38

6.55

1.5

0.41

0.48

nmol/l

1.02

243

1248

Implicit viral Sepsis

169

1108

1.53

6.54

1.4

1.5

0.24

0.35

nmol/l

2.37

125

856

Migraine without aura

441

3414

1.30

6.52

1.4

1.5

0.38

0.46

nmol/l

0.72

352

2747

Asthma, hospital admissions , main diagnosis only

1015

7444

1.19

6.49

1.5

0.41

0.40

nmol/l

0.14

767

5840

Malignant neoplasm of brain, including Hilmo

215

2.26

6.44

2.1

1.5

0.23

0.34

nmol/l

1.75

180

Other disorders starting during childhood or adolecense, excluding more controls

538

1.77

6.44

1.7

1.4

0.24

0.48

nmol/l

4.35

449

Disorders of refraction and accommodation

429

3298

1.30

6.44

1.5

0.35

0.40

nmol/l

0.78

335

2574

Viral Sepsis

169

1112

1.53

6.44

1.4

1.5

0.24

0.35

nmol/l

2.35

125

858

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

900

7156

0.83

6.40

1.5

0.34

0.40

nmol/l

1.70

673

5571

Mouth breathing

336

2502

1.35

6.39

1.5

0.30

0.34

nmol/l

0.52

250

1845

Bipolar affective disorders

300

2203

1.37

6.38

1.6

1.5

0.36

0.45

nmol/l

1.32

247

1759

Haemorrhoids and perianal venous thrombosis

280

2016

1.38

6.35

1.4

1.5

0.39

0.38

nmol/l

0.03

207

1504

Phobic anxiety disorders

267

1925

1.40

6.30

1.6

1.5

0.37

0.43

nmol/l

0.50

208

1559

Migraine with aura

486

3824

1.28

6.29

1.5

0.40

0.46

nmol/l

0.69

400

3086

Other general symptoms and signs

477

1.81

6.24

1.7

1.4

0.26

0.47

nmol/l

3.99

378

Enlarged lymph nodes

169

1121

1.52

6.23

1.5

0.24

0.44

nmol/l

6.23

139

862

Gestational diabetes (for exclusion)

942

5448

1.20

6.23

1.5

0.54

0.44

nmol/l

1.44

778

4353

Candidiasis

188

1278

1.48

6.19

1.5

0.48

0.45

nmol/l

0.14

137

1016

Social phobias

179

1208

1.50

6.15

1.6

1.5

0.32

0.44

nmol/l

1.11

140

990

Migraine without aura and triptan purchases

379

2903

1.32

6.13

1.4

1.5

0.39

0.43

nmol/l

0.28

300

2321

Iron deficiency

539

1.78

6.13

1.5

0.53

0.49

nmol/l

0.14

457

Autism

343

1.98

6.12

1.8

1.6

0.29

0.37

nmol/l

0.92

283

Abrasion of teeth

413

3197

1.30

6.07

1.5

1.4

0.35

0.40

nmol/l

0.62

304

2377

Polyneuropathies and other disorders of the peripheral nervous system

132

833

1.59

6.07

1.8

1.4

0.27

0.28

nmol/l

0.17

100

608

Bulimia nervosa (incl. atypical)

105

634

1.70

5.98

1.5

0.26

0.55

nmol/l

5.35

537

All pneumoniae

956

7332

0.84

5.98

1.5

0.34

0.40

nmol/l

1.84

714

5732

Pneumonias (Asthma/COPD co-morbidities)

947

7304

0.84

5.96

1.5

0.34

0.40

nmol/l

1.74

706

5708

Malignant neoplasm of mesothelium and soft tissue

2.87

5.95

1.4

0.18

0.34

nmol/l

1.65

Hard cardiovascular diseases

466

3495

0.79

5.94

1.4

0.24

0.31

nmol/l

2.65

326

2502

Benign neoplasm of ovary

161

1069

1.52

5.94

1.8

1.4

0.46

0.37

nmol/l

0.51

111

755

Exposure to unspecified factor

1251

7337

1.16

5.90

1.5

0.34

0.40

nmol/l

1.72

940

5768

Dermatophytosis, including avohilmo

751

6105

1.21

5.89

1.5

0.33

0.39

nmol/l

1.44

576

4746

Sciatica+with lumbago

587

4202

1.24

5.88

1.5

1.4

0.35

0.40

nmol/l

0.53

420

3241

Any death

178

1815

0.68

5.84

1.3

1.4

0.17

0.26

nmol/l

4.11

116

1254

Spermatocele

113

2.67

5.82

1.4

1.5

0.12

nmol/l

0.11

Other diseases of blood and blood-forming organs

306

1.98

5.79

1.6

1.5

0.25

0.31

nmol/l

0.51

234

Anogenital herpesviral [herpes simplex] infection, including avohilmo

260

1902

1.39

5.79

1.5

0.43

0.47

nmol/l

0.35

209

1548

Diseases of oral cavity, salivary glands and jaws

498

2019

1.27

5.79

1.4

1.5

0.35

0.40

nmol/l

0.62

389

1566

Benign paroxysmal vertigo

243

1752

1.39

5.78

1.3

1.4

0.31

0.36

nmol/l

0.82

179

1270

Migraine with aura and triptan purchases

356

2728

1.32

5.77

1.5

0.44

nmol/l

0.01

293

2195

572

4594

1.24

5.77

1.5

0.36

0.39

nmol/l

0.33

426

3586

Hypertrophy of breast

281

2079

1.36

5.77

1.3

1.4

0.44

0.42

nmol/l

0.13

208

1567

Other and unspecified polyneuropathies, also in other diseases

110

674

1.64

5.73

1.6

1.5

0.28

nmol/l

0.00

491

Pneumonia, organism unspecified

787

6449

0.83

5.73

1.5

0.34

0.39

nmol/l

1.28

587

4993

Persistent mood disorders

221

1572

1.42

5.72

1.4

1.5

0.32

0.42

nmol/l

1.19

180

1223

Other inflammation of eyelid, including avohilmo

688

5685

1.22

5.72

1.6

1.5

0.42

nmol/l

0.02

550

4469

Diseases of the respiratory system

831

3468

1.20

5.71

1.5

1.4

0.42

nmol/l

0.03

616

2744

Redundant prepuce, phimosis and paraphimosis

567

1.69

5.67

1.5

1.7

0.14

0.15

nmol/l

0.26

418

Anankastic personality disorder

424

1.83

5.67

1.8

1.4

0.25

0.45

nmol/l

3.16

356

Maternal care related to the fetus and amniotic cavity and possible delivery problems

845

4153

1.20

5.63

1.5

0.47

0.39

nmol/l

1.23

658

3225

Other congenital malformations, including avohilmo

213

1515

1.42

5.56

1.6

1.5

0.47

0.41

nmol/l

0.25

178

1192

ILD medications: prednisolone, methylprednisolone, prednisone

1364

6596

1.15

5.56

1.5

0.33

0.42

nmol/l

5.15

1044

5175

Other septicaemia, including avohilmo

253

1732

1.37

5.55

1.6

1.4

0.24

0.34

nmol/l

3.01

194

1265

Other septicaemia

244

1669

1.38

5.54

1.5

1.4

0.24

0.34

nmol/l

2.89

186

1222

Crossbite

121

706

1.60

5.52

1.5

0.26

0.29

nmol/l

0.48

560

Other diseases of lip and oral mucosa

438

3460

1.27

5.52

1.4

1.5

0.39

nmol/l

0.02

330

2588

Outcome of delivery

376

1777

1.31

5.51

1.5

0.53

0.33

nmol/l

2.21

329

1331

Emotional disorders and disorders of social functioning with onset specific to childhood

126

793

1.59

5.51

1.5

1.6

0.28

0.39

nmol/l

1.99

104

659

Use of pramipexole

153

1023

1.50

5.48

1.5

1.4

0.32

0.31

nmol/l

0.08

110

729

ILD medications

1432

6743

1.15

5.47

1.5

0.34

0.41

nmol/l

3.45

1094

5305

Diseases of the musculoskeletal system and connective tissue

863

3636

1.19

5.43

1.5

0.41

0.46

nmol/l

0.53

666

2944

Implicit fungal Sepsis, including avohilmo

371

1.85

5.39

2.0

1.5

0.32

0.36

nmol/l

0.24

294

Haemorrhage from respiratory passages

217

1371

1.40

5.39

1.6

1.5

0.23

0.33

nmol/l

3.25

163

1027

Follow-up examination after treatment for malignant neoplasms

335

1.89

5.39

1.3

1.4

0.30

0.26

nmol/l

0.11

236

Cluster headache, wide,, including avohilmo

520

1.72

5.38

1.5

1.4

0.26

0.42

nmol/l

2.88

421

Oxicams

181

701

1.47

5.35

1.5

0.36

0.44

nmol/l

0.55

129

567

Infections with a predominantly sexual mode of transmission, including avohilmo

768

5903

1.20

5.33

1.5

0.38

0.45

nmol/l

1.77

640

4742

Erosion and ectropion of cervix uteri

2.82

5.33

1.6

1.5

0.32

0.33

nmol/l

0.03

Other disorders of optic [2nd] nerve and visual pathways

439

1.78

5.31

1.7

1.4

0.29

0.39

nmol/l

0.82

348

Propionic acid derivatives

303

1135

1.35

5.31

1.5

1.6

0.36

0.38

nmol/l

0.15

243

929

Obesity, other/unspecified

518

4195

1.24

5.30

1.5

0.44

0.42

nmol/l

0.15

423

3243

Malignant melanoma of skin, including Hilmo

468

1.74

5.29

1.4

0.25

0.31

nmol/l

0.83

362

Malignant neoplasm of urinary organs

181

2.22

5.27

1.4

0.21

0.26

nmol/l

0.39

138

Ehlers-Danlos syndrome, including avohilmo

197

2.23

5.26

1.6

1.5

0.30

0.42

nmol/l

1.44

168

Cluster headache, strict, including avohilmo

509

1.72

5.24

1.5

1.4

0.26

0.42

nmol/l

2.58

413

Arthropathies

1318

5805

1.15

5.21

1.6

1.5

0.36

0.43

nmol/l

2.36

1019

4622

Viral infections characterized by skin and mucous membrane lesions

449

3580

1.26

5.21

1.5

0.36

0.40

nmol/l

0.60

355

2746

Anomalies of dental arch relationship, including avohilmo

325

2253

1.31

5.19

1.5

0.42

0.40

nmol/l

0.07

236

1775

Sequelae with surgical and medical care as external cause

164

1126

1.46

5.18

1.4

0.33

0.36

nmol/l

0.29

125

841

Hypoparathyroidism

152

2.34

5.12

1.7

1.4

0.34

0.36

nmol/l

0.09

123

Ehlers-Danlos syndrome

154

2.39

5.12

1.6

1.5

0.29

0.41

nmol/l

1.19

133

Other diseases of liver

176

1228

1.44

5.12

1.5

1.4

0.23

0.34

nmol/l

3.08

128

898

Misadventures to patients during surgical and medical care

140

934

1.51

5.12

1.5

0.31

0.38

nmol/l

0.83

113

718

Cervicocranial syndrome

126

823

1.54

5.10

1.5

1.4

0.51

0.37

nmol/l

0.34

625

Polyarthropathies

566

4428

0.82

5.07

1.5

0.32

0.42

nmol/l

3.69

420

3456

Other disorders of penis

197

2.14

5.07

1.9

1.5

0.13

nmol/l

0.01

146

Non-follicular lymphoma

258

1.99

5.07

1.7

1.5

0.21

0.28

nmol/l

1.03

187

Hypokalaemia

573

1.65

5.07

1.6

1.4

0.31

0.35

nmol/l

0.32

431

Diseases of the ear and mastoid process

1492

6584

1.14

5.06

1.5

0.37

0.41

nmol/l

1.01

1149

5166

Other skin changes

164

1133

1.46

5.03

1.4

0.36

0.37

nmol/l

0.06

120

847

Cervical disc disorders

278

2098

1.33

4.99

1.5

1.4

0.28

0.35

nmol/l

1.68

211

1524

Disorders of calcium metabolism

309

1.90

4.98

1.3

1.5

0.39

0.30

nmol/l

0.50

229

Malignant neoplasm of other connective and soft tissue, including Hilmo

117

2.50

4.97

1.4

0.18

0.34

nmol/l

2.08

Cerebrovascular diseases

279

2550

0.76

4.95

1.4

0.26

0.30

nmol/l

0.49

211

1812

Viral and other specified intestinal infections, including avohilmo

475

3695

1.24

4.95

1.6

0.40

0.43

nmol/l

0.24

370

3010

Malignant neoplasm of kidney, except renal pelvis

167

2.23

4.93

1.4

0.18

0.27

nmol/l

1.06

129

Malignant neoplasm of urinary organs, including Hilmo

220

2.05

4.91

1.4

1.3

0.20

0.26

nmol/l

0.49

168

Diseases of liver

277

2096

1.33

4.90

1.4

0.22

0.34

nmol/l

5.36

199

1538

Injury of muscle and tendon at shoulder and upper arm level

208

1507

1.38

4.87

1.5

1.4

0.23

0.27

nmol/l

0.66

157

1066

Transplanted organ and tissue status

481

1.70

4.84

1.6

1.5

0.23

0.31

nmol/l

1.66

351

Voice disturbances

271

2051

1.33

4.81

1.4

0.37

0.39

nmol/l

0.17

206

1535

Asthma, hospital admission 2, infections

669

5466

1.20

4.81

1.5

0.37

0.38

nmol/l

0.08

501

4250

Asthma-related infections

669

5466

1.20

4.81

1.5

0.37

0.38

nmol/l

0.08

501

4250

Emotional disorders starting during childhood or adolescence

119

774

1.55

4.80

1.5

1.7

0.29

0.38

nmol/l

1.45

647

Septicaemia

279

1928

1.32

4.80

1.5

1.4

0.25

0.36

nmol/l

2.55

207

1422

Malignant neoplasm of thyroid gland

386

1.78

4.79

1.8

1.4

0.34

0.40

nmol/l

0.27

316

Abnormal findings on diagnostic imaging of other body structures

130

867

1.51

4.79

2.0

1.4

0.33

0.35

nmol/l

0.17

104

644

Viral warts, including avohilmo

305

2350

1.31

4.78

1.7

1.5

0.40

0.42

nmol/l

0.13

243

1842

Congenital malformations of breast

281

1.96

4.78

1.7

1.4

0.81

0.42

nmol/l

0.43

239

Implicit fungal Sepsis

170

2.20

4.77

1.4

0.30

0.34

nmol/l

0.21

135

Asthma (diagnoses ohter than nonallergic)

1055

7401

1.15

4.73

1.6

1.5

0.40

0.39

nmol/l

0.11

788

5814

Sequelae of external causes of morbidity and mortality

220

1618

1.37

4.73

1.5

0.32

0.38

nmol/l

0.81

168

1211

Wide developmental disorders

425

1.74

4.71

1.8

1.6

0.28

0.35

nmol/l

0.79

342

Atypical facial pain

389

1.77

4.70

1.6

1.4

0.29

0.37

nmol/l

0.50

294

Major coronary heart disease event

390

2932

0.79

4.68

1.4

0.23

0.28

nmol/l

1.10

261

2049

Radiculopathy

117

768

1.53

4.64

1.3

1.4

0.29

0.34

nmol/l

0.64

563

Postpartum care and examination

339

1660

1.29

4.60

1.3

1.5

0.51

0.34

nmol/l

2.22

271

1267

Acne

241

1802

1.34

4.58

1.6

0.38

0.44

nmol/l

0.52

203

1492

Scar conditions and fibrosis of skin

393

1.76

4.57

1.4

0.35

0.40

nmol/l

0.18

307

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

193

2.08

4.54

1.4

0.18

0.27

nmol/l

1.37

148

Oral lichen planus and hypothyroidism or thyroxine medication

2.70

4.53

1.2

1.5

0.17

0.27

nmol/l

1.98

Major coronary heart disease event excluding revascularizations

141

1344

0.69

4.50

1.2

1.5

0.19

0.22

nmol/l

0.49

912

Malignant neoplasm of skin, including Hilmo

273

1387

1.32

4.49

1.3

0.27

0.33

nmol/l

1.49

199

1021

Cerebral palsy and other paralytic syndromes

112

735

1.54

4.49

1.5

0.26

0.38

nmol/l

2.10

566

Chronic sinusitis

486

3982

1.22

4.44

1.6

1.4

0.33

0.40

nmol/l

1.53

371

3040

Immunodeficiencies

352

1.79

4.42

1.7

1.4

0.24

0.42

nmol/l

2.33

276

Other degenerative diseases of the nervous system

103

1146

0.65

4.42

1.4

0.38

0.43

nmol/l

0.24

894

Appendectomy

835

6836

1.17

4.42

1.6

1.5

0.46

0.41

nmol/l

0.79

665

5298

Influenza and pneumonia

1059

7468

0.87

4.42

1.5

0.34

0.40

nmol/l

2.04

799

5861

Gastro-oesophageal reflux disease

681

4853

1.19

4.41

1.5

1.4

0.34

0.37

nmol/l

0.49

521

3651

Benign neoplasm: Colon

282

2038

1.30

4.38

1.4

0.31

0.29

nmol/l

0.22

203

1418

Other complications of labour and delivery, not elsewhere classified

360

2544

1.27

4.37

1.6

1.5

0.62

0.45

nmol/l

2.75

327

2105

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

240

1.98

4.35

1.6

1.5

0.28

0.41

nmol/l

1.77

204

Enthesopathies of lower limb, excluding foot

247

1875

1.32

4.35

1.6

1.4

0.34

0.39

nmol/l

0.63

182

1416

Explicit Sepsis

348

2509

1.27

4.34

1.5

0.30

0.39

nmol/l

2.28

264

1920

Stroke, including SAH

192

1873

0.73

4.30

1.5

1.4

0.22

0.29

nmol/l

1.79

140

1324

Hypermobility syndrome

118

794

1.51

4.30

1.5

0.36

0.47

nmol/l

1.14

643

Abnormal findings on examination of blood, without diagnosis

325

2312

1.27

4.29

1.5

1.4

0.28

0.35

nmol/l

1.60

247

1743

Symptoms and signs involving speech and voice

310

2429

1.28

4.29

1.5

1.4

0.35

0.40

nmol/l

0.47

234

1818

Fungal Sepsis

185

2.08

4.26

1.4

0.29

0.33

nmol/l

0.23

146

Osteopathies and chondropathies

505

3813

1.21

4.25

1.7

1.5

0.26

0.38

nmol/l

6.09

378

2854

Melanocytic naevi of trunk

150

1057

1.43

4.24

1.4

1.5

0.50

0.43

nmol/l

0.33

117

826

Other noninfective disorders of lymphatic vessels and lymph nodes

220

1.98

4.23

1.4

0.25

0.36

nmol/l

1.01

174

Other epidermal thickening

255

1.91

4.23

1.5

1.4

0.24

0.40

nmol/l

2.29

201

Salpingitis and oophoritis

194

1428

1.37

4.23

1.6

1.4

0.46

0.36

nmol/l

0.71

147

1033

Explicit Sepsis, including avohilmo

357

2579

1.26

4.22

1.5

0.30

0.39

nmol/l

2.23

271

1969

Insulin medication

348

3611

0.80

4.20

1.3

1.5

0.36

0.37

nmol/l

0.08

257

2763

Postpartum haemorrhage

579

4014

1.20

4.13

1.4

1.5

0.53

0.41

nmol/l

1.52

489

3121

Renal tubulo-interstitial diseases

755

6433

0.86

4.13

1.5

0.34

0.40

nmol/l

1.81

557

5014

Supervision of normal pregnancy

437

2028

1.24

4.11

1.4

1.5

0.39

0.32

nmol/l

0.55

342

1507

Mixed and other personality disorders

121

825

1.48

4.11

1.5

0.37

0.42

nmol/l

0.30

657

Cervicobrachial syndrome

246

1883

1.31

4.11

1.4

1.5

0.40

nmol/l

0.01

189

1421

Disorders of vestibular function (Vertigo)

370

2898

1.25

4.09

1.4

0.29

0.38

nmol/l

2.76

265

2119

Anti-inflammatory and antirheumatic products, non-steroids

292

1135

1.30

4.06

1.5

1.6

0.33

0.38

nmol/l

0.62

231

929

Paralytic ileus and intestinal obstruction

153

1089

1.41

4.04

1.4

1.5

0.22

0.33

nmol/l

2.75

113

776

Malignant melanoma of skin

376

1.71

4.04

1.4

0.26

0.31

nmol/l

0.45

295

Ectopic pregnancy

265

2058

1.30

4.02

1.5

0.52

0.45

nmol/l

0.43

216

1581

Malignant neoplasm of eye, brain and central nervous system

176

2.07

4.01

2.0

1.5

0.23

0.33

nmol/l

1.04

147

Hypoplasia of dental enamel , including avohilmo

452

1.65

4.01

1.7

1.5

0.26

0.37

nmol/l

1.25

379

Erosion of teeth , including avohilmo

413

3377

1.23

3.99

1.5

0.33

0.43

nmol/l

2.42

308

2683

Other and unspecified dermatitis

571

4811

1.19

3.98

1.5

0.33

0.40

nmol/l

1.67

432

3682

Chronic lower respiratory diseases

1485

7001

1.12

3.97

1.5

0.40

nmol/l

0.08

1116

5515

Convulsions, not elsewhere classified

251

1912

1.30

3.96

1.6

1.5

0.32

0.43

nmol/l

2.25

196

1523

Other noninfective gastroenteritis and colitis

256

1979

1.30

3.96

1.5

0.28

0.39

nmol/l

3.47

183

1513

Noninfective enteritis and colitis

513

4280

1.20

3.94

1.5

0.33

0.39

nmol/l

1.50

393

3297

Unspecified mental disorder

490

4077

1.21

3.93

1.5

0.36

0.41

nmol/l

0.60

373

3172

Diabetic nephropathy, excluding more controls

630

0.54

3.93

1.5

1.6

0.26

0.38

nmol/l

0.98

478

Acne vulgaris

186

1378

1.36

3.93

1.6

0.39

0.45

nmol/l

0.36

157

1134

Disorders of breast

740

5607

1.17

3.92

1.5

1.4

0.44

nmol/l

0.01

551

4350

Premature rupture of membranes

540

3222

1.20

3.91

1.4

1.5

0.45

0.43

nmol/l

0.17

430

2579

Malignant neoplasm of skin

241

1243

1.31

3.91

1.3

0.27

0.32

nmol/l

1.01

174

915

Diseases of salivary glands

356

2871

1.25

3.91

1.4

1.5

0.34

0.41

nmol/l

1.30

265

2196

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

606

1.55

3.91

1.5

1.4

0.30

0.39

nmol/l

0.97

474

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

136

2.19

3.90

1.1

1.3

0.16

0.19

nmol/l

0.30

Continuous positive airway pressure

123

703

1.46

3.90

1.3

0.17

0.29

nmol/l

3.56

485

All kidney diseases

954

7282

0.88

3.90

1.5

0.34

0.40

nmol/l

1.83

704

5727

Provisional assignment of new diseases of uncertain etiology

627

5290

1.18

3.89

1.6

1.5

0.40

0.41

nmol/l

0.11

490

4148

Syncope and collapse

370

2495

1.24

3.88

1.4

1.5

0.35

0.43

nmol/l

1.16

272

1957

Cough

416

3181

1.22

3.87

1.5

0.32

0.37

nmol/l

0.60

295

2457

Congenital malformations of the musculoskeletal system, not elsewhere classified

201

2.01

3.87

1.5

0.27

0.39

nmol/l

1.63

173

Codes for special purposes

627

5293

1.18

3.86

1.6

1.5

0.40

0.41

nmol/l

0.11

490

4151

Thyrotoxicosis, other and/or unspecified

229

1754

1.31

3.84

1.6

1.4

0.42

0.43

nmol/l

0.12

175

1340

Other inflammation of eyelid

137

968

1.42

3.84

1.4

0.35

0.38

nmol/l

0.15

728

Hypermetropia

562

1.56

3.80

1.6

1.5

0.28

0.38

nmol/l

0.96

426

Osteoporosis with pathological fracture (FG)

166

2.06

3.80

1.9

1.4

0.12

0.21

nmol/l

2.12

102

External causes of morbidity and mortality

895

3901

1.15

3.80

1.5

0.40

0.46

nmol/l

1.03

687

3134

Epilepsy

276

2161

1.28

3.79

1.5

0.34

0.40

nmol/l

0.79

213

1685

Diseases of tongue

316

1.75

3.79

1.4

1.5

0.37

0.51

nmol/l

0.43

238

Cardiovascular diseases (excluding rheumatic etc)

1145

5802

1.13

3.78

1.5

0.44

0.43

nmol/l

0.11

881

4678

Symptoms and signs involving the urinary system

631

4049

1.18

3.78

1.6

1.5

0.34

0.37

nmol/l

0.26

499

3029

Percutaneous Coronary Intervention

371

2776

0.81

3.77

1.3

1.4

0.24

0.27

nmol/l

0.83

250

1935

Dermatographic urticaria

109

743

1.48

3.75

1.6

1.4

0.39

0.43

nmol/l

0.18

592

Acute sinusitis

727

5704

1.16

3.75

1.5

0.36

0.43

nmol/l

2.16

571

4493

Kela reimbursement Agammaglobulinemia (D80-84)

2.78

3.72

1.3

1.4

0.28

0.38

nmol/l

0.38

Other systemic involvement of connective tissue (FG)

254

1944

1.29

3.71

1.4

0.33

0.42

nmol/l

1.14

192

1470

Sulfonylureas

532

0.52

3.71

1.4

1.5

0.15

0.18

nmol/l

0.57

360

Molar incisor enamel hypoplasia

474

1.60

3.70

1.7

1.6

0.26

0.36

nmol/l

1.38

398

Spondylosis

399

2554

1.22

3.65

1.4

0.30

0.33

nmol/l

0.36

272

1857

Coronary revascularization (ANGIO or CABG)

374

2782

0.81

3.65

1.3

1.4

0.24

0.27

nmol/l

0.87

252

1939

Other systemic involvement of connective tissue

256

2004

1.28

3.65

1.4

1.5

0.33

0.41

nmol/l

1.03

193

1505

Congenital malformations of breast, including avohilmo

308

1.77

3.64

1.7

1.4

0.81

0.40

nmol/l

0.44

264

Benign neoplasm: Colon, unspecified

113

778

1.46

3.64

1.4

0.32

0.24

nmol/l

0.66

532

Lagophthalmos

3.57

3.63

1.3

1.5

0.14

0.26

nmol/l

—

Anisometropia and aniseikonia

219

1.90

3.62

1.6

1.5

0.32

0.37

nmol/l

0.21

169

Subjective visual disturbances

273

2158

1.27

3.61

1.5

0.34

0.40

nmol/l

0.69

209

1670

Other and unspecified anaemias

244

1782

1.29

3.59

1.7

1.4

0.27

0.34

nmol/l

1.34

194

1293

Other anaemias

247

1802

1.29

3.58

1.7

1.4

0.27

0.34

nmol/l

1.37

196

1308

Benign neoplasm: Pancreas

2.42

3.57

1.2

1.4

0.45

0.35

nmol/l

0.16

Ischemic heart diseases

442

3164

0.83

3.57

1.4

0.24

0.29

nmol/l

1.72

300

2237

Gingivitis and periodontal diseases

1071

4891

1.13

3.57

1.4

1.5

0.39

0.40

nmol/l

0.13

804

3804

Benign neoplasm of other and ill-defined parts of digestive system

124

873

1.43

3.57

1.4

0.30

0.34

nmol/l

0.32

629

Myocardial infarction

100

1024

0.68

3.56

1.2

1.5

0.19

0.22

nmol/l

0.46

685

Nonalcoholic fatty liver disease

104

709

1.48

3.56

1.4

0.25

0.35

nmol/l

1.13

521

Small fibre neuropathy

111

2.28

3.56

1.4

1.5

0.17

0.32

nmol/l

1.40

Speech and linguistic disorders, excluding more controls

119

781

1.44

3.54

1.9

1.4

0.33

0.44

nmol/l

1.00

102

644

Injuries to the ankle and foot

978

7384

1.13

3.53

1.5

0.33

0.41

nmol/l

3.69

771

5772

Biguanides

803

5552

0.87

3.53

1.6

1.4

0.38

0.39

nmol/l

0.02

614

4238

Viral hepatitis, IBD co-morbidity

470

1.59

3.53

1.4

1.5

0.24

0.46

nmol/l

3.13

374

Visual field defects

415

1.63

3.52

2.1

1.5

0.24

0.34

nmol/l

1.65

317

Emergency coronary revascularization (for ACS)

387

2840

0.82

3.51

1.3

1.4

0.23

0.27

nmol/l

0.88

258

1979

Disorders of eyelid, lacrimal system and orbit

929

5992

1.14

3.51

1.4

1.5

0.33

0.40

nmol/l

1.96

683

4608

Schizophrenia

1188

0.65

3.50

1.5

0.21

0.35

nmol/l

3.65

916

Zoster [herpes zoster], including avohilmo

419

3354

1.21

3.50

1.5

0.36

nmol/l

0.04

303

2498

Diseases of middle ear and mastoid

851

6094

1.14

3.49

1.6

1.5

0.37

0.44

nmol/l

1.21

679

4899

Other viral diseases, including avohilmo

598

5073

1.17

3.49

1.4

1.5

0.36

0.41

nmol/l

0.69

474

4035

Squamous cell neoplasms and carcinomas of the skin

2.33

3.49

1.1

1.2

0.13

0.19

nmol/l

1.05

194

1.94

3.47

1.2

1.6

0.54

0.31

nmol/l

0.64

150

Other disorders of eyelid

254

1884

1.27

3.46

1.4

0.27

0.31

nmol/l

0.62

176

1344

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

266

1.78

3.45

1.3

1.5

0.19

0.33

nmol/l

2.61

192

Dermatitis

666

5627

1.16

3.44

1.5

0.32

0.40

nmol/l

2.33

493

4330

Stroke, excluding SAH

173

1660

0.75

3.43

1.5

1.4

0.20

0.28

nmol/l

2.01

125

1158

Ischaemic heart disease, wide definition

292

2242

0.80

3.43

1.5

1.4

0.21

0.26

nmol/l

2.13

191

1543

Localized swelling, mass and lump of skin and subcutaneous tissue

305

2458

1.25

3.42

1.4

1.5

0.45

0.40

nmol/l

0.19

237

1861

Other bacterial intestinal infections, including avohilmo

211

1626

1.30

3.42

1.6

1.4

0.27

0.41

nmol/l

3.90

170

1238

Infections of the skin and subcutaneous tissue

666

5666

1.16

3.41

1.5

0.33

0.39

nmol/l

1.12

526

4407

Urticaria and erythema

491

4147

1.19

3.41

1.5

0.48

0.40

nmol/l

0.65

377

3218

Enterocolitis due to Clostridium difficile

450

1.59

3.40

1.6

1.5

0.20

0.35

nmol/l

3.48

352

Artificial opening status

181

1.95

3.39

1.8

1.5

0.32

0.34

nmol/l

0.05

137

In situ neoplasms

376

3101

1.22

3.38

1.4

1.5

0.45

0.43

nmol/l

0.18

281

2378

Attention to artificial openings

127

2.14

3.36

1.5

0.18

0.31

nmol/l

1.59

103

Other nonscarring hair loss

135

2.15

3.36

1.5

1.4

0.48

0.41

nmol/l

0.20

112

Emotionally unstable personality disorder

247

1953

1.28

3.34

1.5

0.44

0.45

nmol/l

0.03

196

1588

Balanced rearrangements and structural markers, not elsewhere classified

3.22

3.34

1.7

1.5

0.40

0.46

nmol/l

0.15

Intestinal stricture

181

1373

1.32

3.29

1.4

0.22

0.32

nmol/l

3.03

129

983

Diseases of inner ear

415

3313

1.20

3.27

1.4

0.29

0.37

nmol/l

2.70

299

2431

Vasomotor and allergic rhinitis

550

4602

1.17

3.25

1.5

0.36

0.41

nmol/l

0.50

424

3624

Basal cell carcinoma, including Hilmo

189

971

1.32

3.24

1.3

0.25

0.29

nmol/l

0.62

137

695

Benign neoplasm of colon, rectum, anus and anal canal

351

2435

1.22

3.24

1.4

0.30

0.29

nmol/l

0.06

253

1709

Diabetes medication

1031

6748

0.89

3.23

1.5

0.40

nmol/l

0.07

782

5249

Unspecified misadventure during surgical and medical care

317

1.69

3.23

1.5

1.4

0.35

0.34

nmol/l

0.09

248

Other disorders involving the immune mechanism, not elsewhere classified

185

1.92

3.22

2.1

1.4

0.49

0.33

nmol/l

0.32

150

Diaphragmatic hernia

217

1693

1.29

3.21

1.5

1.4

0.28

0.32

nmol/l

0.65

170

1202

Obesity due to excess calories

654

5682

1.15

3.21

1.5

0.33

0.43

nmol/l

3.28

512

4419

Hernia

736

5586

0.87

3.20

1.5

0.28

0.38

nmol/l

5.42

558

4228

Undetermined asthma, excluding more controls

136

994

1.37

3.18

1.5

1.4

0.29

0.38

nmol/l

1.25

763

Herpesviral [herpes simplex] infections, including avohilmo

383

3189

1.21

3.18

1.5

0.37

0.44

nmol/l

1.45

302

2484

Obstructed labour due to maternal pelvic abnormality

1291

0.69

3.17

1.3

1.4

0.38

0.34

nmol/l

0.09

895

Inflammatory bowel disease treatment related agents

1383

6939

1.11

3.17

1.5

0.33

0.41

nmol/l

4.46

1046

5457

Undetermined asthma

136

995

1.37

3.16

1.5

1.4

0.29

0.38

nmol/l

1.24

764

Disorders of optic nerve, not elsewhere classified

2.50

3.14

1.7

1.4

0.22

0.39

nmol/l

1.03

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

199

1032

1.30

3.12

1.3

0.27

0.29

nmol/l

0.38

140

742

Venous thromboembolism

356

2834

1.21

3.12

1.4

0.34

nmol/l

0.03

248

2080

Vestibular neuronitis

445

1.56

3.11

1.6

1.5

0.26

0.33

nmol/l

0.73

333

Postpartum hemorraghe, parous women as controls

579

4182

1.16

3.09

1.4

0.53

0.49

nmol/l

0.29

489

3325

Atrophic disorders of skin

162

1224

1.33

3.08

1.4

0.32

0.38

nmol/l

0.47

122

905

Other disorders of bladder

446

1.55

3.07

1.6

1.4

0.36

0.33

nmol/l

0.10

337

Other diseases of intestine

640

1.46

3.07

1.6

1.5

0.23

0.32

nmol/l

1.20

453

Ganglion

270

2178

1.25

3.07

1.4

1.5

0.34

0.43

nmol/l

1.91

215

1709

Pain in thoracic spine

179

1373

1.31

3.07

1.6

1.5

0.36

0.40

nmol/l

0.47

133

1046

conjunctival haemorrhage

261

1.73

3.06

1.8

1.4

0.28

0.31

nmol/l

0.16

190

STROKE

306

2519

0.82

3.06

1.4

0.26

0.32

nmol/l

1.59

217

1798

Benign neoplasm of brain and other parts of central nervous system

369

1.61

3.04

1.9

1.5

0.21

0.36

nmol/l

3.32

284

Intestinal adhesions without obstruction

307

1.67

3.04

1.3

1.5

0.27

0.31

nmol/l

0.37

219

Unspecified haematuria

222

1421

1.27

3.03

1.4

0.39

0.31

nmol/l

0.33

172

1042

Sarcoidosis

105

742

1.42

3.03

1.5

1.4

0.23

0.35

nmol/l

2.36

543

Disorders of endocrine glands in diseases classified elsewhere

10.67

3.03

2.6

2.2

0.15

0.33

nmol/l

—

Non-seminoma of testis, including Hilmo

4.41

3.02

2.6

1.5

0.13

0.19

nmol/l

—

Systemic connective tissue disorders

311

2551

1.22

3.01

1.5

0.34

0.40

nmol/l

0.75

234

1912

Retinal breaks without detachment

105

743

1.42

3.00

1.5

1.4

0.27

nmol/l

0.02

511

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

364

3039

1.21

2.99

1.4

1.5

0.51

0.46

nmol/l

0.27

299

2447

Complications of other internal prosthetic devices, implants and grafts

190

1.86

2.98

1.3

1.5

0.45

0.30

nmol/l

0.46

146

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

176

1.90

2.98

2.2

1.4

0.52

0.34

nmol/l

0.35

142

Autoimmune diseases related-to ILD

972

7256

1.12

2.97

1.5

0.35

0.41

nmol/l

1.45

739

5668

Vocal cord dysfunction

161

1074

1.33

2.96

1.5

1.4

0.30

0.42

nmol/l

1.83

113

822

Malignant neoplasm of cervix uteri, including Hilmo

199

1.84

2.93

1.3

1.4

0.37

0.44

nmol/l

0.21

174

Benign leiomyoma with endometriosis

135

1002

1.35

2.92

1.3

1.4

0.52

0.37

nmol/l

0.92

107

713

Other malignant neoplasms of skin (=non-melanoma skin cancer)

183

955

1.30

2.90

1.3

0.27

0.29

nmol/l

0.30

128

683

Abnormal serum enzyme levels

138

991

1.35

2.89

1.5

1.4

0.23

0.28

nmol/l

1.10

105

751

Other and unspecified epidermal thickening

171

1.90

2.88

1.6

1.4

0.26

0.36

nmol/l

0.84

137

Poisoning by drugs, medicaments and biological substances

338

2812

1.21

2.87

1.5

0.36

0.41

nmol/l

0.35

260

2222

Diseases of the myoneural junction and muscle

543

1.48

2.87

1.7

1.4

0.22

0.33

nmol/l

2.89

408

Other and unspecified myopathies

297

1.66

2.86

1.9

1.5

0.22

0.29

nmol/l

0.92

223

Benign neoplasm: Ascending colon

430

1.54

2.86

1.5

0.26

0.25

nmol/l

0.05

301

Asthma, unspecified (mode)

606

3801

1.15

2.86

1.5

1.4

0.35

0.41

nmol/l

1.49

440

2987

Nonhereditary hypogammaglobulinemia

2.45

2.84

1.6

1.4

0.28

0.29

nmol/l

0.06

Postmenopausal osteoporosis with pathological fracture

116

2.08

2.82

2.1

1.5

0.12

0.15

nmol/l

—

Degenerative diseases of the nervous system

432

0.57

2.82

1.3

1.5

0.16

nmol/l

0.02

297

Insulin, combination of fast acting with intermediate-acting or long-acting

348

3768

0.84

2.82

1.3

1.5

0.36

0.37

nmol/l

0.04

257

2878

Myocardial infarction, strict

906

0.70

2.81

1.2

1.5

0.15

0.20

nmol/l

1.43

608

Other viral diseases, not elsewhere classified, including avohilmo

393

3300

1.19

2.81

1.5

0.39

0.41

nmol/l

0.20

319

2601

Drug-induced polyneuropathy

3.65

2.80

5.2

1.4

0.20

0.14

nmol/l

—

Basal cell carcinoma

174

911

1.30

2.80

1.3

0.25

0.29

nmol/l

0.44

124

648

Papillary adenocarcinoma of thyroid gland

292

1.66

2.79

1.6

1.4

0.36

0.41

nmol/l

0.17

242

Malignant neoplasm of bladder, including Hilmo

156

1.90

2.78

1.3

0.19

0.17

nmol/l

0.15

120

Disorders of psychological development

202

1480

1.27

2.78

1.8

1.6

0.31

0.42

nmol/l

1.74

171

1201

Pregnancy with abortive outcome

1023

4785

1.12

2.77

1.5

0.46

0.41

nmol/l

0.61

790

3784

Haemorrhage in early pregnancy

493

4128

1.17

2.77

1.4

1.5

0.58

0.43

nmol/l

1.49

407

3217

Other salmonella infections, including avohilmo

293

1.66

2.76

1.6

1.4

0.49

0.37

nmol/l

0.28

226

Nerve, nerve root and plexus disorders

1170

6358

1.11

2.76

1.5

0.32

0.42

nmol/l

5.14

874

4948

Other and unspecified nonscarring hair loss

105

2.17

2.75

1.4

0.36

0.40

nmol/l

0.10

Other disorders of breast

199

1576

1.27

2.72

1.5

0.49

0.46

nmol/l

0.07

155

1223

Soft tissue disorders related to use, overuse and pressure

206

1636

1.26

2.72

1.4

1.5

0.31

0.35

nmol/l

0.51

151

1209

Malignant neoplasm of bone and articular cartilage of limbs

3.90

2.71

1.7

1.3

0.20

0.60

nmol/l

—

Respiratory conditions due to other external agents

2.53

2.71

1.5

1.4

0.41

0.26

nmol/l

—

Benign neoplasm: Sigmoid colon

624

1.43

2.71

1.5

1.4

0.31

0.26

nmol/l

0.40

436

Dermatophytosis

708

1.40

2.71

1.5

1.4

0.25

0.33

nmol/l

1.61

539

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

105

745

1.40

2.70

1.6

0.29

0.40

nmol/l

1.14

613

Tinnitus

190

1496

1.27

2.70

1.4

0.30

0.36

nmol/l

0.74

146

1088

Asthma, unspecified (mode), excluding more controls

603

3768

1.15

2.68

1.6

1.4

0.35

0.41

nmol/l

1.55

439

2959

Vasomotor rhinitis (mode)

487

1.49

2.67

1.3

1.5

0.24

0.36

nmol/l

1.68

370

Papilloedema, unspecified

213

1.77

2.67

1.6

1.5

0.31

0.41

nmol/l

0.52

175

Benign neoplasm of breast

129

967

1.34

2.66

1.4

0.31

0.41

nmol/l

1.65

104

735

Palmar fascial fibromatosis [Dupuytren]

319

1.60

2.65

1.2

1.5

0.20

nmol/l

0.03

239

Oral corticosteroids

1234

6578

1.10

2.65

1.5

0.34

0.42

nmol/l

3.89

930

5152

Malignant neoplasm, without specification of site, including Hilmo

2.34

2.64

1.9

1.3

0.12

0.24

nmol/l

2.29

Other specified and unspecified personality disorders

124

926

1.35

2.64

1.4

1.5

0.29

0.43

nmol/l

2.12

737

L04AD Calcineurin inhibitors

102

738

1.39

2.63

1.6

1.5

0.25

0.37

nmol/l

1.77

559

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

2.48

2.62

2.2

1.4

0.11

0.31

nmol/l

—

Rheumatism, unspecified

117

866

1.36

2.62

1.3

1.4

0.32

0.36

nmol/l

0.30

641

Varicella [chickenpox]

290

1.64

2.61

1.8

1.5

0.55

0.32

nmol/l

0.63

228

Cutaneous abscess, furuncle and carbuncle

286

2366

1.21

2.61

1.5

0.36

0.40

nmol/l

0.32

223

1837

Seborrhoeic keratosis

143

1090

1.32

2.61

1.4

0.24

0.31

nmol/l

1.20

108

743

Excessive vomiting in pregnancy

163

1269

1.30

2.60

1.3

1.5

0.41

0.45

nmol/l

0.33

133

1013

Other problems related to primary support group, including family circumstances

204

1586

1.26

2.60

1.4

1.5

0.31

0.41

nmol/l

0.97

159

1281

Other diseases of pancreas

298

1.62

2.59

1.5

0.22

0.28

nmol/l

0.72

222

Asthma and allergy

232

1857

1.24

2.59

1.7

1.5

0.54

0.43

nmol/l

0.51

187

1510

Any dementia

482

0.62

2.58

1.5

0.14

0.19

nmol/l

1.12

334

Recurrent aphthous stomatitis , including avohilmo

149

1146

1.31

2.57

1.6

1.5

0.50

0.40

nmol/l

0.53

110

893

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

2.76

2.56

1.2

1.3

0.62

0.37

nmol/l

—

Explicit bacterial Sepsis, including avohilmo

524

1.46

2.55

1.4

0.28

0.32

nmol/l

0.16

407

Other neurological diseases

535

3609

1.15

2.55

1.4

1.5

0.31

0.37

nmol/l

1.42

400

2681

Disorders of synovium and tendon

610

4548

1.14

2.54

1.4

1.5

0.32

0.42

nmol/l

4.23

439

3581

Mixed disorders of conduct and emotions, excluding more controls

278

1.65

2.53

1.4

1.5

0.32

0.48

nmol/l

1.22

243

Memory loss

231

1.70

2.52

1.4

1.6

0.23

0.26

nmol/l

0.26

174

Other and unspecified disorders of white blood cells

209

1.74

2.51

1.7

1.5

0.24

0.33

nmol/l

0.87

167

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1076

6577

1.10

2.51

1.6

1.5

0.35

0.40

nmol/l

0.86

828

5079

Other enthesopathies

295

2459

1.20

2.49

1.3

1.4

0.27

0.38

nmol/l

3.65

234

1834

Allergic asthma (mode)

358

2964

1.18

2.49

1.6

1.5

0.51

0.43

nmol/l

0.49

283

2382

Allergic asthma (mode), excluding more controls

358

2964

1.18

2.48

1.6

1.5

0.51

0.43

nmol/l

0.48

283

2381

Cervicalgia

192

1532

1.26

2.48

1.4

1.5

0.32

0.38

nmol/l

0.64

145

1155

Urticaria

414

3558

1.17

2.46

1.5

0.46

0.41

nmol/l

0.37

318

2760

Other bacterial intestinal infections

129

979

1.32

2.45

1.6

1.5

0.22

0.39

nmol/l

4.76

103

738

Asthma and allergy, excluding more controls

232

1870

1.23

2.45

1.7

1.5

0.54

0.43

nmol/l

0.49

187

1517

Sequelae of cerebrovascular disease

992

0.71

2.45

1.7

1.4

0.23

0.25

nmol/l

0.18

696

Complications of labour and delivery

922

4612

1.11

2.45

1.5

0.50

0.38

nmol/l

2.15

737

3530

Disorders of optic nerve and visual pathways

115

860

1.35

2.44

1.7

1.5

0.42

nmol/l

0.02

680

Other salmonella infections

196

1.75

2.44

1.6

1.5

0.53

0.34

nmol/l

0.33

155

Follow-up care involving plastic surgery

296

1.61

2.44

1.4

0.41

0.37

nmol/l

0.18

230

Other disorders starting during childhood or adolescence

709

1.38

2.43

1.7

1.6

0.24

0.41

nmol/l

2.74

585

Other and unspecified local infections of skin and subcutaneous tissue

656

1.40

2.42

1.4

1.5

0.31

0.39

nmol/l

0.76

505

Asthma-related pneumonia or sepsis

275

2276

1.21

2.42

1.5

0.34

0.37

nmol/l

0.32

205

1724

Asthma, hospital admissions 3, pneumonia

275

2276

1.21

2.42

1.5

0.34

0.37

nmol/l

0.32

205

1724

Coagulation defects, purpura and other haemorrhagic conditions

194

1555

1.25

2.42

1.8

1.5

0.45

0.40

nmol/l

0.18

151

1206

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

498

1.46

2.41

1.5

1.4

0.29

0.39

nmol/l

0.86

387

Herpesviral [herpes simplex] infections

128

974

1.32

2.41

1.4

0.29

0.42

nmol/l

2.49

752

Focal epilepsy, strict definition

160

1253

1.28

2.41

1.5

0.35

0.37

nmol/l

0.17

128

955

Mixed hyperlipidaemia

110

2.01

2.41

1.4

1.5

0.15

0.23

nmol/l

1.51

Benign neoplasm of other and unspecified female genital organs

289

1.61

2.41

1.7

1.4

0.45

0.37

nmol/l

0.37

224

Poisoning by narcotics and psychodysleptics [hallucinogens]

146

1.88

2.40

1.9

1.6

0.33

0.39

nmol/l

0.20

124

Kela-code for severe mental illness

395

3389

1.17

2.40

1.6

1.5

0.36

0.40

nmol/l

0.47

298

2634

Trochanteric bursitis

120

905

1.33

2.40

1.3

1.4

0.29

0.35

nmol/l

0.57

666

Aplastic and other anaemias

262

1981

1.21

2.39

1.7

1.4

0.27

0.36

nmol/l

1.77

209

1455

Metabolic disorders

968

5249

1.11

2.39

1.6

1.5

0.30

0.38

nmol/l

3.43

710

4005

Blepharochalasis

147

1140

1.29

2.39

1.5

1.4

0.22

0.26

nmol/l

0.56

767

Hypercalcemia

153

1.84

2.39

1.5

1.4

0.52

0.30

nmol/l

0.64

111

Unspecified lump in breast

174

1381

1.27

2.38

1.5

1.4

0.31

0.43

nmol/l

2.32

133

1044

Other inflammation of vagina/vulva

560

1.43

2.37

1.5

0.51

0.47

nmol/l

0.21

461

Insulin, fast-acting (human)

101

1357

0.74

2.37

1.3

1.5

0.34

0.44

nmol/l

1.20

1092

Persons encountering health services for specific procedures, not carried out

104

771

1.36

2.35

1.4

1.5

0.56

0.39

nmol/l

0.35

608

Other external causes of accidental injury

1034

4698

1.10

2.35

1.5

0.38

0.44

nmol/l

1.45

798

3722

Haemolytic anaemias

176

1.78

2.35

1.7

1.4

0.28

0.38

nmol/l

0.73

140

Symptoms and signs involving appearance and behaviour

2.37

2.35

1.2

1.6

0.35

0.41

nmol/l

—

Congenital malformations of genital organs

177

1404

1.26

2.34

1.6

1.5

0.48

0.47

nmol/l

0.05

145

1132

Ulcer of vagina/vulva

292

1.60

2.34

1.2

1.5

0.42

0.40

nmol/l

0.10

239

Neuralgia and neuritis, unspecified

371

1.52

2.34

1.5

0.48

0.39

nmol/l

0.22

301

Crohn's disease NAS

569

1.42

2.33

1.5

0.38

0.41

nmol/l

0.22

444

Monoplegia

2.21

2.33

1.6

1.5

0.39

nmol/l

0.01

GI-bleeding

167

1321

1.27

2.32

1.4

1.5

0.26

0.32

nmol/l

0.97

127

989

Malignant neoplasm of cervix uteri

170

1.80

2.32

1.3

0.39

0.43

nmol/l

0.12

150

Asthma-related pneumonia

273

2269

1.20

2.31

1.5

0.34

0.37

nmol/l

0.31

203

1718

Cholangitis (primary sclerosing, PSC)

276

1.60

2.31

1.4

1.5

0.36

0.32

nmol/l

0.16

212

Coronary atherosclerosis

199

1553

0.81

2.31

1.5

1.4

0.20

0.23

nmol/l

0.78

128

1064

229

1.66

2.30

2.1

1.4

0.35

0.36

nmol/l

0.06

185

Explicit bacterial Sepsis

511

1.43

2.30

1.4

0.27

0.32

nmol/l

0.24

397

Poisoning by medicine

304

2565

1.19

2.30

1.5

0.36

0.42

nmol/l

0.30

232

2028

Other and unspecified mood [affective] disorders

122

931

1.32

2.29

1.6

1.5

0.31

0.46

nmol/l

2.25

102

754

Diabetes mellitus in pregnancy

808

4620

1.12

2.29

1.5

0.52

0.42

nmol/l

1.20

659

3654

Stomatitis and related lesions

224

1837

1.22

2.28

1.6

1.5

0.45

0.40

nmol/l

0.29

167

1419

Implicit bacterial Sepsis

201

1393

1.24

2.27

1.6

1.4

0.27

0.31

nmol/l

0.47

148

1009

Diabetes, varying definitions

1051

6677

0.91

2.27

1.6

1.5

0.38

0.41

nmol/l

0.27

805

5188

Focal epilepsy, mode (most common among epilepsy diagnosis)

156

1229

1.27

2.27

1.5

0.32

0.38

nmol/l

0.51

123

943

Single delivery by forceps and vacuum extractor

386

1977

1.17

2.26

1.4

1.5

0.42

0.39

nmol/l

0.24

325

1606

Procedures for purposes other than remedying health state

209

1.70

2.26

1.5

1.4

0.40

0.35

nmol/l

0.24

163

Diabetes mellitus

1061

6709

0.91

2.26

1.6

1.5

0.38

0.41

nmol/l

0.28

812

5216

Other and unspecified disorders of autonomic nervous system

2.80

2.25

1.6

1.5

0.45

0.28

nmol/l

0.33

Zoster [herpes zoster]

117

888

1.32

2.25

1.6

1.4

0.26

0.34

nmol/l

1.42

660

Erythema multiforme

142

1.86

2.25

1.5

1.4

0.69

0.36

nmol/l

0.34

113

Other or unspecified ileus, impaction or obstruction

673

1.37

2.25

1.5

1.4

0.24

0.29

nmol/l

0.80

484

Benign neoplasm of mouth and pharynx

564

1.41

2.25

1.3

1.4

0.40

0.31

nmol/l

0.43

423

Nontoxic multinodular goitre

126

967

1.31

2.24

1.4

0.31

0.37

nmol/l

0.79

695

Insulin, intermediate and long-acting

294

3355

0.84

2.24

1.4

1.5

0.30

0.36

nmol/l

0.67

217

2540

Benign neoplasm: Transverse colon

334

1.53

2.24

1.1

1.5

0.24

0.26

nmol/l

0.14

243

Other coagulation defects

676

1.37

2.23

1.7

1.4

0.53

0.42

nmol/l

0.18

539

Other disorders of skin and subcutaneous tissue

649

4880

1.12

2.22

1.5

0.28

0.38

nmol/l

3.96

480

3678

Pruritus

135

1049

1.29

2.21

1.4

1.5

0.32

0.44

nmol/l

1.48

105

824

Lumbar disc prolapse

660

4357

1.12

2.21

1.5

1.4

0.31

0.41

nmol/l

3.91

497

3367

Other (not insulin) diabetes medications

887

5742

0.90

2.21

1.6

1.4

0.39

nmol/l

0.01

672

4410

Thyroiditis

643

1.38

2.21

1.4

0.39

0.41

nmol/l

0.11

505

Cramp and spasm

352

1.52

2.21

1.4

1.5

0.22

0.36

nmol/l

2.20

276

Diabetic nephropathy

644

0.64

2.20

1.5

1.6

0.26

0.38

nmol/l

1.04

496

Inguinal hernia

292

2300

0.84

2.20

1.4

1.5

0.22

0.34

nmol/l

4.19

217

1761

Colectomy operation

617

1.38

2.19

1.5

0.30

nmol/l

0.00

458

Injury of muscle and tendon at hip and thigh level

686

1.36

2.19

1.8

1.4

0.23

0.34

nmol/l

1.98

508

Nontoxic diffuse goitre

158

1.79

2.18

1.3

1.5

0.36

0.40

nmol/l

0.21

122

Heterophoria

109

826

1.33

2.16

1.5

0.30

0.45

nmol/l

0.99

648

Non-invasive ventilation

177

1890

0.81

2.16

1.5

1.4

0.44

0.43

nmol/l

0.03

144

1451

Leiomyoma of uterus

775

3909

1.11

2.16

1.4

0.43

0.42

nmol/l

0.09

575

2917

Type1 diabetes, definitions combined, early onset

857

0.69

2.15

1.4

1.5

0.36

0.44

nmol/l

0.48

707

Dyspnoea

926

6073

1.10

2.15

1.4

1.5

0.32

0.40

nmol/l

2.94

665

4721

Care involving use of rehabilitation procedures

621

4976

1.12

2.15

1.5

0.28

0.37

nmol/l

4.35

476

3762

Phlebitis and thrombophlebitis (not including DVT)

183

1480

1.24

2.15

1.3

1.4

0.32

0.37

nmol/l

0.54

120

1103

Other diseases of the digestive system

167

1336

1.25

2.14

1.4

1.5

0.25

0.30

nmol/l

0.83

127

998

Presbycusis

142

1.81

2.14

1.2

1.4

0.12

0.15

nmol/l

0.42

Immunodeficiency with predominantly antibody defects

197

1.70

2.14

1.8

1.4

0.23

0.38

nmol/l

2.18

155

Cerebrovascular diseases (FINNGEN)

196

1683

0.81

2.14

1.5

1.4

0.29

0.35

nmol/l

0.46

149

1238

Hepatic failure, not elsewhere classified

137

1.84

2.14

1.6

1.5

0.15

0.33

nmol/l

2.73

102

6-mercaptopurine

347

1.52

2.13

1.9

1.5

0.36

0.42

nmol/l

0.51

280

Peripheral artery disease

858

0.73

2.13

1.3

1.4

0.18

0.22

nmol/l

0.63

604

Abnormal findings on diagnostic imaging of lung

235

1846

1.21

2.12

1.4

0.25

0.29

nmol/l

0.96

168

1303

Collagenous colitis

588

1.39

2.12

1.6

1.5

0.29

0.39

nmol/l

1.10

454

Accessory breast

2.06

2.11

1.5

1.4

0.49

0.42

nmol/l

0.15

Maternal care for known or suspected disproportion

760

0.67

2.10

1.8

1.4

0.29

0.42

nmol/l

1.22

596

Pain in throat and chest

1024

5536

1.10

2.10

1.4

1.5

0.35

0.42

nmol/l

1.70

756

4398

Abnormalities of gait and mobility

446

1.44

2.10

1.9

1.5

0.31

0.30

nmol/l

0.05

337

Hydrocephalus

213

1.65

2.09

1.9

1.5

0.28

0.30

nmol/l

0.14

162

Gingival hyperplasia

229

1.63

2.09

1.5

0.29

0.33

nmol/l

0.18

180

Diagnoses used for exclusion with ILD

153

1216

1.26

2.09

1.5

1.4

0.27

0.33

nmol/l

0.68

105

878

COPD, hospital admissions 3, with asthma pneumonia sepsis

522

0.64

2.09

1.2

1.4

0.23

0.20

nmol/l

0.15

371

Alzheimer disease, including avohilmo

372

0.61

2.08

1.3

1.4

0.14

nmol/l

0.04

243

Other chronic obstructive pulmonary disease, including avohilmo

157

1610

0.80

2.08

1.5

1.4

0.22

0.25

nmol/l

0.59

1117

Pneumothorax

245

1.60

2.07

1.3

1.5

0.34

0.32

nmol/l

0.09

193

Disorders of lipoprotein metabolism and other lipidaemias

495

3414

0.88

2.07

1.4

0.25

0.32

nmol/l

1.84

354

2470

Disorders of choroid and retina

451

3599

0.88

2.07

1.5

1.4

0.29

0.35

nmol/l

1.17

336

2640

Shoulder lesions

679

3643

1.12

2.07

1.4

0.31

0.39

nmol/l

1.35

497

2801

Pulmonary heart disease

154

1227

1.26

2.06

1.5

1.4

0.30

0.32

nmol/l

0.16

109

879

Other disorders of ear

720

5161

0.90

2.06

1.4

1.5

0.29

0.37

nmol/l

4.02

547

3881

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

865

0.70

2.06

1.1

1.5

0.40

0.45

nmol/l

0.17

673

Iron deficiency anaemia secondary to blood loss (chronic)

102

771

1.33

2.06

1.3

1.5

0.47

0.37

nmol/l

0.46

591

Keratoconus

154

1.77

2.05

1.1

1.4

0.87

0.33

nmol/l

0.48

125

Osteonecrosis

246

1.59

2.04

1.5

0.25

0.30

nmol/l

0.42

175

Accidents

1026

4698

1.10

2.04

1.5

0.37

0.44

nmol/l

1.67

796

3722

Pulmonary embolism

154

1229

1.26

2.04

1.5

1.4

0.30

0.32

nmol/l

0.16

109

880

Other local infections of skin and subcutaneous tissue

695

1.34

2.04

1.4

1.5

0.30

0.39

nmol/l

0.73

534

Effects of foreign body entering through natural orifice

207

1707

1.22

2.03

1.4

1.5

0.29

0.36

nmol/l

0.93

157

1325

Other specified and unspecified strabismus

2.09

2.03

1.9

1.5

0.26

0.34

nmol/l

0.28

Melanocytic naevi, other sites/unspecified

739

1.33

2.03

1.3

1.5

0.46

0.41

nmol/l

0.22

576

Other and unspecified mental retardation

110

1.92

2.02

1.5

1.6

0.28

0.33

nmol/l

0.15

Other symptoms and signs involving the urinary system

458

1.43

2.02

1.8

1.5

0.28

0.33

nmol/l

0.51

354

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

241

2020

1.20

2.02

1.4

1.5

0.30

0.42

nmol/l

3.05

180

1589

Viral and other specified intestinal infections

317

2652

1.17

2.02

1.7

1.6

0.37

0.41

nmol/l

0.33

251

2185

Atherosclerosis, excluding cerebral and coronary sclerosis

708

0.71

2.02

1.3

1.4

0.15

0.20

nmol/l

1.57

500

ILD medications: azathioprine

162

1304

1.25

2.02

1.6

1.5

0.39

0.42

nmol/l

0.22

122

1011

Skin changes due to chronic exposure to nonionizing radiation

111

769

1.31

2.01

1.2

1.4

0.20

nmol/l

0.03

512

Impacted teeth

426

3202

1.15

2.01

1.7

1.6

0.40

0.45

nmol/l

0.61

364

2676

Fracture of neck

216

1.63

2.00

1.9

1.4

0.20

0.32

nmol/l

1.29

170

Bacterial Sepsis

261

1816

1.19

2.00

1.5

1.4

0.27

0.32

nmol/l

0.78

189

1327

Congenital malformations of uterus and cervix

354

1.50

2.00

1.5

1.4

0.49

0.43

nmol/l

0.25

310

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

470

4149

1.14

2.00

1.4

1.5

0.40

0.44

nmol/l

0.50

363

3337

Other disorders of white blood cells

296

1.53

1.98

1.6

1.4

0.25

0.34

nmol/l

0.89

234

Ischaemic Stroke, excluding all haemorrhages

163

1484

0.81

1.98

1.5

1.4

0.20

0.27

nmol/l

1.46

117

1040

Presbyopia

596

1.37

1.98

1.6

1.4

0.35

0.31

nmol/l

0.29

417

Other female pelvic inflammatory diseases

185

1515

1.23

1.97

1.5

0.45

0.43

nmol/l

0.14

141

1153

Urolithiasis

196

1613

1.22

1.97

1.3

1.4

0.27

0.35

nmol/l

1.29

147

1220

Mantle cell lymphoma, including Hilmo

3.36

1.97

2.7

1.6

0.22

0.26

nmol/l

—

Mental disorders, not otherwise specified

125

981

1.28

1.95

1.4

1.5

0.38

0.45

nmol/l

0.54

789

Thyrotoxicosis

265

2246

1.18

1.95

1.5

1.4

0.41

0.43

nmol/l

0.21

199

1688

Hernia of abdominal wall

340

2938

1.16

1.95

1.5

1.4

0.30

0.37

nmol/l

1.47

257

2209

Mental and behavioural disorders due to opioids

388

1.46

1.94

1.5

0.21

0.39

nmol/l

3.03

323

Deforming dorsopathies

266

2255

1.18

1.94

1.5

0.36

0.38

nmol/l

0.15

201

1714

Other and unspecified hydrocephalus

2.14

1.93

1.7

1.5

0.28

0.37

nmol/l

—

Other postsurgical states

355

1.47

1.92

1.6

1.5

0.35

nmol/l

0.01

269

Vasculitis limited to skin, not elsewhere classified

113

1.88

1.92

1.6

1.5

0.16

0.34

nmol/l

2.30

MS-disease / Multiple Sclerosis

852

0.71

1.92

1.5

1.4

0.44

0.43

nmol/l

0.04

682

Noninfectious colitis NAS

129

1018

1.27

1.92

1.6

1.5

0.30

0.39

nmol/l

1.41

786

Viral warts

117

913

1.29

1.91

1.7

1.5

0.45

0.42

nmol/l

0.12

718

Raynaud syndrome

115

896

1.29

1.91

1.7

1.5

0.35

0.44

nmol/l

0.71

710

Benign neoplasm: Brain, supratentorial

114

1.87

1.89

2.0

1.4

0.23

0.33

nmol/l

0.69

Type 2 diabetes, definitions combined

879

5593

0.91

1.89

1.6

1.4

0.38

0.39

nmol/l

0.13

665

4287

Brachial plexus disorders

133

1057

1.27

1.89

1.5

1.4

0.38

0.41

nmol/l

0.19

105

813

Rotator cuff syndrome

468

2844

1.13

1.89

1.4

0.26

0.34

nmol/l

2.98

346

2121

Angina pectoris

152

1250

0.81

1.88

1.3

1.4

0.19

0.22

nmol/l

0.60

103

835

Other abnormal findings of blood chemistry

292

1.52

1.88

1.5

1.4

0.36

0.40

nmol/l

0.21

229

Benign neoplasm: Rectum

584

1.36

1.87

1.4

0.27

0.25

nmol/l

0.10

407

Osteogenesis imperfecta

3.71

1.87

1.8

1.2

0.31

0.66

nmol/l

—

Other embolism and thrombosis

671

1.33

1.86

1.5

1.4

0.39

0.36

nmol/l

0.10

517

Type 2 diabetes, strict (exclude DM1)

882

5606

0.91

1.86

1.6

1.4

0.38

0.39

nmol/l

0.13

666

4298

Disorder of the sleep-wake schedule

152

1.74

1.85

2.7

1.5

0.22

0.36

nmol/l

1.64

122

Diseases of the digestive system

325

2790

1.16

1.85

1.5

0.33

0.37

nmol/l

0.56

245

2114

Other diseases of anus and rectum

210

1746

1.20

1.85

1.5

0.34

0.38

nmol/l

0.23

163

1282

Other leukaemias of specified cell type

4.34

1.84

2.2

2.1

0.15

0.47

nmol/l

—

Acute bronchitis

362

3096

1.15

1.84

1.5

0.33

0.40

nmol/l

1.45

266

2380

Acute laryngitis and tracheitis

190

1549

1.21

1.84

1.6

0.31

0.44

nmol/l

1.89

153

1268

Azathioprine

162

1320

1.23

1.84

1.6

1.5

0.39

0.42

nmol/l

0.23

122

1022

Complications following infusion, transfusion and therapeutic injection

2.15

1.83

1.2

1.4

0.35

0.25

nmol/l

—

Other facial nerve disorders

183

1.66

1.83

1.7

1.4

0.34

0.37

nmol/l

0.08

140

Bacterial intestinal infections, IBD co-morbidities

127

1007

1.26

1.82

1.6

1.5

0.22

0.37

nmol/l

3.64

103

764

Left bundle-branch block

222

1.58

1.81

1.5

0.37

0.24

nmol/l

0.30

165

Exposure to other specified electric current

234

0.46

1.81

2.1

1.4

0.11

0.35

nmol/l

7.74

188

Preterm labour and delivery

357

3118

1.15

1.81

1.6

1.4

0.53

0.39

nmol/l

1.03

277

2317

Other deformities of toe(s)

199

1.62

1.81

1.6

1.4

0.35

0.39

nmol/l

0.12

155

Iron deficiency anaemia

361

3092

1.15

1.81

1.4

1.5

0.41

0.40

nmol/l

0.06

287

2348

Benign neoplasm: Brain, unspecified

2.82

1.81

1.7

1.5

0.17

0.45

nmol/l

—

Statin medication

760

4699

0.91

1.80

1.4

1.5

0.31

0.43

nmol/l

6.02

547

3700

Type 1 diabetes, strict definition, subgroup 1

954

0.74

1.79

1.3

1.5

0.36

0.46

nmol/l

0.79

771

Type 1 diabetes, strict definition

999

0.74

1.79

1.3

1.5

0.35

0.45

nmol/l

0.83

805

DVT of lower extremities and pulmonary embolism

232

1951

1.19

1.79

1.5

1.4

0.36

0.32

nmol/l

0.17

166

1417

Degenerative macular diseases

287

1.50

1.79

1.6

1.5

0.24

0.27

nmol/l

0.19

209

Sicca syndrome [Sjögren]

547

1.36

1.78

1.4

0.32

0.40

nmol/l

0.27

406

Amblyopia ex anopsia

337

1.47

1.78

1.5

1.6

0.31

0.35

nmol/l

0.27

273

Hypertrophic disorders of skin

634

1.34

1.78

1.5

0.45

0.43

nmol/l

0.09

504

Helminthiases, including avohilmo

497

1.38

1.78

1.6

1.4

0.41

0.47

nmol/l

0.29

404

Tibial collateral bursitis [Pellegrini-Stieda]

2.12

1.78

1.1

1.6

0.40

0.32

nmol/l

—

Umbilical hernia

216

1816

1.19

1.77

1.5

0.32

0.38

nmol/l

0.79

173

1404

Alzheimer disease

315

0.61

1.77

1.3

1.4

0.13

0.14

nmol/l

0.12

211

Other shoulder lesions

101

782

1.30

1.77

1.4

0.50

0.39

nmol/l

0.19

617

Pure hypercholesterolaemia

392

2831

0.88

1.77

1.4

0.23

0.30

nmol/l

2.02

284

2026

Other disorders of central nervous system

1.97

1.77

1.4

0.22

0.33

nmol/l

—

Abnormal involuntary movements

113

888

1.28

1.76

1.4

1.5

0.32

0.36

nmol/l

0.16

691

Other viral diseases

395

3468

1.14

1.76

1.5

0.30

0.40

nmol/l

4.39

308

2737

Meniscus derangement

345

2624

0.87

1.76

1.3

1.4

0.28

0.35

nmol/l

1.38

252

1949

Dental operations

491

2241

1.13

1.76

1.4

1.5

0.35

0.38

nmol/l

0.49

374

1747

Other hearing loss

125

962

1.26

1.76

1.5

1.4

0.23

0.32

nmol/l

1.64

692

Dislocation, sprain and strain of joints and ligaments at neck level

227

1921

1.19

1.75

1.5

0.38

0.44

nmol/l

0.56

174

1517

Non-allergic asthma (mode), excluding more controls

168

1368

1.22

1.75

1.5

0.31

0.37

nmol/l

0.73

126

1058

Insulin, fast-acting or short human

228

2686

0.85

1.75

1.3

1.5

0.35

0.39

nmol/l

0.40

173

2076

Hypertrophic scar

593

1.34

1.75

1.4

1.5

0.46

0.42

nmol/l

0.14

474

Embedded and impacted teeth

546

3979

1.12

1.75

1.7

1.6

0.40

0.45

nmol/l

0.57

458

3302

Artificial joint operation, meniscal resection

544

3876

0.90

1.75

1.4

0.22

0.32

nmol/l

5.83

396

2814

Other bullous disorders

132

1.76

1.74

1.1

1.4

0.21

0.32

nmol/l

1.02

103

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

260

2225

1.17

1.74

1.4

1.5

0.28

0.37

nmol/l

2.40

210

1698

Other disorders of conjunctiva

618

1.33

1.74

1.6

1.4

0.34

0.32

nmol/l

0.08

450

Sacrococcygeal disorders, not elsewhere classified

290

1.50

1.74

1.4

1.5

0.81

0.40

nmol/l

0.39

231

Non-allergic asthma (mode)

168

1370

1.22

1.73

1.5

0.31

0.37

nmol/l

0.73

126

1061

Other diseases of oesophagus

380

1.43

1.73

1.4

1.5

0.27

0.32

nmol/l

0.44

288

Pregnancy hypertension

721

5874

1.10

1.73

1.4

1.5

0.46

nmol/l

0.00

585

4597

Other specified congenital malformation syndromes affecting multiple systems

171

1.66

1.73

1.3

1.4

0.45

0.36

nmol/l

0.20

134

Retinal detachments and breaks

179

1483

1.21

1.72

1.5

1.4

0.26

0.30

nmol/l

0.61

137

1033

Artificial joint re-operation

155

1.68

1.72

1.3

1.5

0.20

nmol/l

0.00

104

Invasive ventilation

331

1.46

1.72

1.6

1.4

0.19

0.32

nmol/l

2.66

257

Autoimmune thyroiditis

179

1.64

1.72

1.6

1.4

0.40

0.44

nmol/l

0.13

152

Fibroblastic disorders

134

1078

1.25

1.72

1.3

1.4

0.34

0.33

nmol/l

0.02

103

805

Calculus of kidney and ureter

185

1539

1.20

1.71

1.3

1.4

0.28

0.35

nmol/l

1.02

139

1164

Nontraumatic intracranial haemmorrhage

614

0.68

1.71

1.4

0.25

0.26

nmol/l

0.07

436

Benign neoplasm of bone and articular cartilage

699

1.31

1.71

1.5

1.4

0.35

0.39

nmol/l

0.28

539

Allergic colitis

267

1.52

1.70

1.7

1.6

0.21

0.32

nmol/l

1.24

207

Other specified/unspecified systemic involvement of connective tissue

433

1.40

1.69

1.5

1.4

0.33

0.37

nmol/l

0.36

332

Other and unspecified diseases of blood and blood-forming organs

111

1.82

1.69

1.6

1.5

0.35

0.33

nmol/l

0.05

Long labour

503

3821

1.12

1.69

1.5

0.57

0.41

nmol/l

1.55

421

2975

Elevated blood glucose level

501

1.36

1.69

1.5

1.4

0.29

0.35

nmol/l

0.60

378

Focal epilepsy

179

1487

1.21

1.69

1.5

0.33

0.39

nmol/l

0.63

141

1136

Tongue abnormality

308

1.47

1.68

1.4

0.25

0.33

nmol/l

0.96

234

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

492

3464

0.89

1.68

1.4

0.43

0.41

nmol/l

0.13

356

2700

Fracture of skull and facial bones

185

1543

1.20

1.68

1.5

0.25

0.39

nmol/l

3.63

142

1181

Glaucoma, exfoliation

141

1.71

1.67

1.9

1.5

0.20

0.19

nmol/l

0.05

100

Congenital deformities of feet

252

1.53

1.67

1.5

0.29

0.36

nmol/l

0.56

208

Schizophrenia or delusion, excluding more controls

292

2498

1.16

1.67

1.6

1.4

0.32

0.42

nmol/l

1.94

219

1943

Unspecified kidney failure

235

1.54

1.67

1.6

1.5

0.27

0.25

nmol/l

0.09

176

Other and unspecified coagulation defects

520

1.36

1.67

1.6

1.4

0.59

0.44

nmol/l

0.21

413

Varicella [chickenpox], including avohilmo

375

1.42

1.67

1.7

1.5

0.50

0.34

nmol/l

0.51

296

Pulmonary heart disease, diseases of pulmonary circulation

161

1325

1.22

1.67

1.5

1.4

0.29

0.33

nmol/l

0.26

115

944

Single delivery by caesarean section

417

2106

1.14

1.66

1.4

1.6

0.56

0.38

nmol/l

1.56

347

1696

Other/unspecified enthesopathies of lower limb, excluding foot

598

1.33

1.65

1.5

1.4

0.30

0.40

nmol/l

1.14

450

Injuries to the wrist and hand

1192

7354

1.08

1.65

1.5

0.33

0.41

nmol/l

2.99

919

5757

Benign neoplasm of eye and adnexa

546

1.34

1.65

1.8

1.5

0.58

0.33

nmol/l

1.06

411

Childhood asthma (age<16)

288

1948

1.16

1.65

1.6

1.5

0.43

0.46

nmol/l

0.22

240

1637

Agoraphobia

445

1.39

1.64

1.8

1.5

0.27

0.47

nmol/l

2.84

372

Spontaneous rupture of synovium and tendon

351

1.43

1.64

1.3

1.5

0.23

0.30

nmol/l

0.70

270

Disorders of continuity of bone

104

818

1.28

1.64

1.6

1.5

0.23

0.38

nmol/l

3.75

621

Postpartum haemorrhage due to retained placenta

279

2419

1.16

1.64

1.4

1.5

0.45

0.50

nmol/l

0.39

236

1918

Type 1 diabetes, wide definition

175

2091

0.83

1.63

1.3

1.5

0.39

0.42

nmol/l

0.15

138

1643

Functional dyspepsia

265

2286

1.16

1.63

1.4

1.5

0.38

0.40

nmol/l

0.11

206

1717

Aneurysms, operations, SAH

770

0.73

1.62

1.3

1.4

0.47

0.29

nmol/l

0.50

549

Childhood asthma (age<16), excluding more controls

288

1951

1.16

1.62

1.6

1.5

0.43

0.46

nmol/l

0.22

240

1640

Malignant neoplasm of colon, including Hilmo

409

1.39

1.61

1.4

0.21

0.25

nmol/l

0.43

298

Other acute lower respiratory infections

515

4413

1.11

1.61

1.5

0.31

0.38

nmol/l

2.00

393

3438

Exposure to other specified factors

951

7552

1.08

1.61

1.4

1.5

0.31

0.41

nmol/l

3.77

745

5897

Any dementia, excluding more controls

418

0.69

1.60

1.5

1.4

0.14

0.18

nmol/l

0.62

282

All chronic kidney diseases

299

2733

0.87

1.60

1.4

1.5

0.31

0.38

nmol/l

1.02

223

2064

Retention of urine

155

1030

1.22

1.60

1.7

1.5

0.28

0.33

nmol/l

0.54

116

782

Injuries to the neck

286

2486

1.15

1.60

1.5

0.34

0.43

nmol/l

1.24

219

1979

Benign neoplasm: Adrenal gland

320

1.44

1.59

1.6

1.5

0.30

0.28

nmol/l

0.09

229

Insulin, fast-acting

228

2659

0.86

1.58

1.3

1.5

0.35

0.39

nmol/l

0.38

173

2059

Allergic urticaria

105

832

1.27

1.58

1.7

1.5

0.54

0.41

nmol/l

0.26

659

Diabetic maculopathy

668

0.72

1.58

1.3

1.6

0.38

0.45

nmol/l

0.31

531

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

751

5976

1.09

1.58

1.4

1.5

0.46

0.45

nmol/l

0.04

612

4662

Hallux rigidus

559

1.33

1.57

1.2

1.4

0.27

0.31

nmol/l

0.27

375

Other specified/unspecified spondylopathies

2.21

1.57

1.3

1.7

0.16

0.26

nmol/l

0.94

Excessive earwax

467

3793

1.12

1.56

1.5

0.30

0.36

nmol/l

1.27

349

2849

COPD, hospital admission 2, with asthma infections

738

0.75

1.56

1.2

1.4

0.20

0.22

nmol/l

0.21

523

Volume depletion

305

1.45

1.55

1.3

1.5

0.23

0.31

nmol/l

0.75

233

Malignant neoplasm of stomach, including Hilmo

1.85

1.55

1.5

1.3

0.32

0.25

nmol/l

—

Convergence insufficiency and excess

161

1.65

1.55

1.5

1.4

0.17

0.39

nmol/l

3.82

133

Other retinal disorders

304

2639

0.87

1.55

1.5

1.4

0.30

0.37

nmol/l

0.82

226

1950

Trigeminal neuralgia

415

1.38

1.55

1.3

1.4

0.43

0.39

nmol/l

0.12

314

Atopic conjunctivitis

441

1.37

1.55

1.6

1.4

0.35

0.38

nmol/l

0.16

345

Other and unspecified iron deficiency

296

2580

1.15

1.54

1.5

0.39

0.41

nmol/l

0.18

235

1973

Benign neoplasm: Rectum, anus and anal canal

683

1.29

1.54

1.4

0.26

nmol/l

0.03

476

Lateral epicondylitis

129

1049

1.23

1.54

1.4

0.27

0.34

nmol/l

0.87

100

783

Atopic dermatitis, strict definition with reimbursement

524

4551

1.11

1.54

1.6

1.5

0.37

0.44

nmol/l

1.26

411

3653

Type 1 diabetes, wide definition, subgroup 1

169

2013

0.84

1.54

1.3

1.5

0.40

0.42

nmol/l

0.15

132

1587

Other meningitis

115

1.76

1.54

1.9

1.5

0.28

0.35

nmol/l

0.40

Tic and related disorders

100

1.82

1.54

1.2

1.5

0.41

0.33

nmol/l

0.25

Injuries involving multiple body regions

290

1.46

1.54

1.3

1.5

0.41

0.39

nmol/l

0.10

232

Disorders of sphingolipid metabolism and other lipid storage disorders

3.42

1.53

1.6

1.7

0.86

0.28

nmol/l

—

Benign thyroid growths and nodules

237

1892

1.17

1.53

1.4

0.30

0.39

nmol/l

1.96

162

1385

Demyelinating diseases of the central nervous system

987

0.77

1.53

1.4

0.46

0.44

nmol/l

0.08

790

129

942

1.23

1.53

1.2

1.4

0.21

0.22

nmol/l

0.13

631

Heart failure, not strict

341

2598

0.88

1.53

1.5

1.4

0.23

0.30

nmol/l

2.64

247

1840

Carbimazole or st.post thyroidectomy, condition for graves disease

236

2031

1.17

1.52

1.6

1.4

0.41

nmol/l

0.01

179

1532

Ptosis of eyelid

433

1.37

1.52

1.4

1.5

0.30

nmol/l

0.01

327

Laparoscopic right hemicolectomy

115

1.75

1.52

1.6

1.5

0.19

0.24

nmol/l

0.31

Gout

548

1.30

1.52

1.5

1.4

0.17

0.24

nmol/l

1.27

396

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.62

1.52

1.3

1.4

0.86

0.23

nmol/l

—

COPD, hospital admissions

106

1115

0.80

1.51

1.4

0.18

0.22

nmol/l

0.74

772

Impingement syndrome of shoulder

139

1142

1.22

1.50

1.4

0.22

0.30

nmol/l

1.70

809

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.92

1.50

2.2

1.3

0.27

0.30

nmol/l

—

Perioral dermatitis

284

1.46

1.50

1.2

1.4

0.35

0.48

nmol/l

0.70

233

181

2134

0.84

1.50

1.5

0.59

0.51

nmol/l

0.28

145

1756

Muscular dystrophy

2.48

1.49

1.2

1.5

0.16

0.27

nmol/l

—

Bruxism

227

1.52

1.49

1.5

1.4

0.27

0.36

nmol/l

0.86

185

Other and unspecified mononeuropathies, also in other diseases

139

1.67

1.49

1.8

1.4

0.29

0.34

nmol/l

0.22

110

Traumatic subdural haemorrhage

249

1.47

1.48

1.2

1.4

0.14

0.24

nmol/l

2.07

196

Congenital ovarian cysts

673

1.29

1.47

1.5

1.4

0.52

0.46

nmol/l

0.29

555

Type 2 diabetes

978

6083

0.93

1.45

1.6

1.4

0.38

0.41

nmol/l

0.26

743

4702

Other intervertebral disc disorders

868

4786

1.08

1.45

1.5

0.31

0.42

nmol/l

5.73

655

3721

Osteosarcoma, including Hilmo

2.80

1.45

1.3

1.5

0.11

0.74

nmol/l

—

Manic episode

228

1.50

1.45

1.3

1.4

0.29

0.40

nmol/l

1.03

181

Seborrhoeic dermatitis

585

1.30

1.45

1.4

1.5

0.25

0.38

nmol/l

1.14

448

Dizziness and giddiness

734

5251

1.09

1.44

1.4

1.5

0.29

0.39

nmol/l

5.95

545

4010

Other enthesopathy of foot (+metatarsalgia)

107

860

1.25

1.44

1.3

1.4

0.28

0.40

nmol/l

2.13

670

Heartburn

104

833

1.25

1.44

1.5

0.38

0.37

nmol/l

0.04

651

Sub-endpoint used in defining T1D endpoints

204

2341

0.86

1.44

1.4

1.5

0.37

0.41

nmol/l

0.32

160

1840

Other disorders of binocular movement

245

1.49

1.44

1.3

1.4

0.19

0.42

nmol/l

5.17

204

Nontoxic single thyroid nodule

438

1.35

1.44

1.4

0.32

0.44

nmol/l

1.18

333

Diabetic retinopathy, excluding more controls

129

881

0.82

1.44

1.3

1.6

0.30

0.38

nmol/l

0.70

671

Other disorders of eye and adnexa

162

1359

1.20

1.44

1.5

0.35

0.43

nmol/l

0.85

122

1055

Postpartum hemorraghe, all women as controls

579

5156

1.10

1.44

1.4

1.5

0.53

0.47

nmol/l

0.54

489

4129

Other vitreous opacities

204

1.53

1.43

1.8

1.4

0.31

0.33

nmol/l

0.04

154

Benign neoplasm: Tongue

110

1.74

1.43

1.3

1.4

0.56

0.35

nmol/l

0.22

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

145

1204

1.21

1.42

1.3

1.5

0.41

0.38

nmol/l

0.15

110

929

Contusion of toe(s) without damage to nail

287

1.44

1.42

1.3

1.5

0.39

nmol/l

0.02

238

COPD, early/later onset

108

1121

0.81

1.42

1.4

0.18

0.22

nmol/l

0.72

777

Other disorders of nervous system

278

1.45

1.42

1.4

0.30

0.33

nmol/l

0.10

203

Crohn disease

146

1215

1.21

1.42

1.5

0.36

0.42

nmol/l

0.83

119

952

Congenital deformities of feet, including avohilmo

397

1.37

1.42

1.6

1.5

0.33

0.36

nmol/l

0.14

326

Other congenital malformations of circulatory system

165

1.59

1.41

1.5

0.23

0.35

nmol/l

0.91

136

Benign neoplasm: Stomach

371

1.38

1.41

1.6

1.5

0.29

0.32

nmol/l

0.22

260

Other and unspecified nerve root and plexus disorders, also in other diseases

187

1592

1.18

1.40

1.5

1.4

0.33

0.38

nmol/l

0.62

148

1197

Drug-induced osteoporosis with pathological fracture

2.19

1.40

1.6

1.4

0.12

0.20

nmol/l

—

Subacute thyroiditis

271

1.45

1.40

1.3

1.5

0.37

0.45

nmol/l

0.36

212

Diffuse brain injury

189

1.54

1.40

1.5

1.4

0.18

0.40

nmol/l

4.25

157

Birth injury to peripheral nervous system

2.29

1.40

1.4

1.6

0.21

0.50

nmol/l

—

Actinic keratosis

694

1.26

1.40

1.1

1.4

0.18

0.17

nmol/l

0.19

457

Other chromosome abnormalities, not elsewhere classified

2.26

1.39

1.2

1.5

0.37

0.28

nmol/l

—

Hypotension

449

1.34

1.39

1.4

1.5

0.25

0.26

nmol/l

0.07

345

Exclusion endpoint for clefts

206

1.52

1.38

1.4

1.5

0.41

0.37

nmol/l

0.10

165

Mixed disorders of conduct and emotions

323

1.41

1.38

1.4

1.6

0.32

0.37

nmol/l

0.34

274

Cysts of oral region, not elsewhere classified

373

1.38

1.3

1.4

0.25

0.36

nmol/l

1.04

292

Congenital malformations of the nervous system

256

1.46

1.38

1.5

1.4

0.27

0.36

nmol/l

0.83

207

Primary open-angle glaucoma

651

1.27

1.38

1.6

1.4

0.19

0.20

nmol/l

0.08

433

273

1.45

1.38

1.7

1.6

0.23

0.35

nmol/l

1.09

228

Cholelithiasis, broad definition with cholecystitis

745

5365

0.92

1.37

1.4

0.36

0.41

nmol/l

0.77

575

4070

Other obstructed labour

959

0.78

1.37

1.4

0.48

0.40

nmol/l

0.30

726

Transient global amnesia

231

1.48

1.36

1.4

1.5

0.20

nmol/l

0.01

156

Ocular pain

102

823

1.25

1.36

1.4

1.5

0.39

0.43

nmol/l

0.20

645

Labour and delivery complicated by fetal stress [distress]

618

3686

1.09

1.35

1.5

0.51

0.42

nmol/l

1.44

524

2938

Benign neoplasm: Conjunctiva

183

1.54

1.35

2.0

1.5

0.72

0.35

nmol/l

0.63

141

Status epilepticus

151

1.60

1.35

1.3

1.5

0.22

0.36

nmol/l

2.11

124

Other peripheral vascular diseases

601

1.29

1.34

1.7

1.4

0.26

0.41

nmol/l

2.26

474

Rheumatoid arthritis

193

1989

0.86

1.34

1.4

1.5

0.28

0.39

nmol/l

2.23

144

1480

Astigmatism

548

1.30

1.34

1.7

1.5

0.24

0.40

nmol/l

2.76

431

Fentanyl

281

1.42

1.34

1.4

0.16

0.33

nmol/l

3.11

205

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

107

869

1.24

1.34

1.4

0.48

0.34

nmol/l

0.30

641

Disorders of lens

317

2217

0.89

1.33

1.4

0.23

0.29

nmol/l

1.20

218

1531

Mental retardation, excluding more controls

240

1.46

1.33

2.1

1.4

0.27

0.34

nmol/l

0.46

192

Conductive and sensorineural hearing loss

459

3364

0.90

1.33

1.4

0.25

0.34

nmol/l

4.12

348

2445

Unknown and unspecified causes of morbidity

436

1.34

1.33

1.8

1.4

0.21

0.47

nmol/l

4.79

352

Spinal stenosis

227

1449

1.16

1.32

1.4

0.27

0.26

nmol/l

0.10

153

998

Other superficial mycoses, including avohilmo

148

1245

1.19

1.31

1.4

1.5

0.42

0.44

nmol/l

0.16

126

988

Pediculosis and phthiriasis, including avohilmo

1.93

1.31

2.4

1.7

0.82

0.38

nmol/l

0.31

Anorexia

145

1.61

1.31

1.5

1.4

0.31

0.36

nmol/l

0.08

118

Myopia

199

1717

1.16

1.30

1.4

1.5

0.43

0.44

nmol/l

0.07

154

1358

Other contact dermatitis

693

0.75

1.30

1.3

1.5

0.38

0.43

nmol/l

0.25

545

Congenital malformations of spine and bony thorax, including avohilmo

1.98

1.30

2.3

1.6

0.18

0.31

nmol/l

1.09

Complications of the puerperium, not elsewhere classified

749

1.25

1.30

1.3

1.5

0.52

0.49

nmol/l

0.16

603

Protozoal diseases, including avohilmo

145

1.60

1.29

2.1

1.4

0.27

0.34

nmol/l

0.40

112

Other disorders of urethra and urinary system

807

5212

1.08

1.29

1.4

1.5

0.39

0.42

nmol/l

0.32

619

4048

Nail disorders

605

1.28

1.29

1.6

1.5

0.27

0.37

nmol/l

1.42

462

Alzheimer’s disease, strict definition

248

0.62

1.29

1.4

0.10

0.13

nmol/l

1.32

167

Other noninflammatory disorders of cervix uteri

169

1.55

1.29

2.0

1.4

0.58

0.31

nmol/l

0.72

112

Other heart diseases, wide

1001

6466

0.94

1.28

1.5

0.38

0.40

nmol/l

0.31

746

5039

Thyrotoxicosis with diffuse goitre

160

1358

1.18

1.28

1.7

1.4

0.46

0.43

nmol/l

0.18

122

1040

5-aminosalicylic acid

235

2054

1.15

1.28

1.6

1.5

0.39

0.42

nmol/l

0.29

182

1616

Medical abortion

810

4717

0.93

1.28

1.4

1.5

0.44

0.42

nmol/l

0.24

611

3722

Disorders of vitreous body

287

2415

1.13

1.27

1.4

0.23

0.30

nmol/l

1.66

194

1663

Etanercept

633

0.74

1.27

1.2

1.4

0.41

0.40

nmol/l

0.06

495

Allergic rhinitis

470

4224

1.10

1.27

1.6

1.5

0.37

0.41

nmol/l

0.27

364

3335

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

811

5508

0.93

1.27

1.4

0.36

0.39

nmol/l

0.34

595

4215

Diplopia

794

1.24

1.26

1.4

1.5

0.41

0.37

nmol/l

0.17

613

Dislocation, sprain and strain of joints and ligaments of head

423

1.33

1.26

1.4

0.26

0.42

nmol/l

2.14

332

Specific development disorders of scholastic skills

569

1.28

1.26

2.0

1.6

0.36

0.35

nmol/l

0.01

462

Other and unspecified vasculitis limited to skin

107

1.70

1.26

1.7

1.5

0.17

0.34

nmol/l

1.91

Other specified disorders of kidney and ureter

154

1.57

1.26

1.3

1.5

0.36

0.31

nmol/l

0.23

115

Chronic periodontitis, complicated

302

3304

0.89

1.25

1.5

1.4

0.36

0.32

nmol/l

0.15

203

2413

Oral lichen planus, including avohilmo , including avohilmo

397

1.34

1.25

1.3

1.5

0.24

0.36

nmol/l

0.75

286

Major anomalies of jaw size

228

1.46

1.25

1.5

0.54

0.31

nmol/l

0.77

181

Type 1 diabetes, strict (exclude DM2)

1109

0.81

1.25

1.4

1.5

0.33

0.43

nmol/l

1.07

887

Complications of internal orthopaedic prosthetic devices, implants and grafts

732

1.25

1.3

1.4

0.23

0.25

nmol/l

0.21

496

Deep bite

141

1041

1.19

1.24

1.6

1.5

0.43

0.35

nmol/l

0.40

106

821

Urethral stricture

115

1.66

1.24

1.4

1.6

0.35

0.22

nmol/l

0.55

Benign neoplasm of male genital organs

2.23

1.24

2.3

1.3

0.14

0.16

nmol/l

—

Other disorders of patella

213

1855

1.15

1.24

1.6

1.5

0.35

0.44

nmol/l

0.74

174

1442

Other necrotizing vasculopathies (FG)

187

1.50

1.24

1.6

1.5

0.21

0.39

nmol/l

2.10

144

Type 2 diabetes, definitions combined, including avohilmo

917

5668

0.93

1.23

1.6

1.4

0.37

0.40

nmol/l

0.26

694

4357

Other secondary coxarthrosis

139

1.59

1.23

1.6

1.5

0.26

nmol/l

0.03

101

Congenital malformations of ovaries, fallopian tubes and broad ligaments

102

835

1.23

1.4

1.5

0.52

0.46

nmol/l

0.28

680

Other and unspecified bullous disorders

1.99

1.23

1.0

1.4

0.14

0.39

nmol/l

—

Alcohol abuse, main dg, excluding more controls

116

960

1.21

1.23

1.4

0.30

0.40

nmol/l

1.09

756

Gonarthrosis,primary

491

3244

0.91

1.23

1.4

0.27

0.29

nmol/l

0.25

341

2289

Other chronic obstructive pulmonary disease

107

1064

0.82

1.23

1.4

0.18

0.23

nmol/l

0.88

742

Hallux valgus (acquired)

222

1817

0.87

1.23

1.5

1.4

0.26

0.35

nmol/l

2.56

170

1319

Nutritional anaemias

389

3348

1.11

1.23

1.4

1.5

0.39

0.40

nmol/l

0.06

308

2531

Sequelae of tuberculosis

2.64

1.21

1.6

1.4

0.32

0.11

nmol/l

—

Somnolence

101

1.71

1.21

1.5

0.26

0.35

nmol/l

0.57

Other and unspecified disorders of adult personality and behaviour

1.92

1.20

2.4

1.5

0.17

0.40

nmol/l

—

Single spontaneous delivery

416

2424

0.90

1.20

1.5

1.6

0.45

0.36

nmol/l

0.67

335

1921

Colorectal cancer, including Hilmo

602

1.26

1.20

1.4

0.32

0.25

nmol/l

0.38

429

Benign lipomatous neoplasm

206

1794

1.15

1.20

1.3

1.4

0.40

0.34

nmol/l

0.23

143

1303

Maternal care for other conditions predominantly related to pregnancy

447

3974

1.10

1.19

1.3

1.5

0.44

nmol/l

0.00

374

3150

Transport accidents

588

4510

1.09

1.19

1.6

1.5

0.35

0.45

nmol/l

1.94

477

3580

Flatulence and related conditions

1.90

1.19

1.9

1.5

0.36

0.39

nmol/l

—

Rash and other nonspecific skin eruption

666

1.25

1.19

1.6

1.4

0.46

0.37

nmol/l

0.25

508

Other strabismus

265

2340

1.13

1.19

1.5

0.36

0.43

nmol/l

0.42

188

1836

Internal derangement of knee

352

3139

1.11

1.18

1.6

1.5

0.33

0.40

nmol/l

0.80

257

2408

Senile cataract

224

1555

0.87

1.18

1.3

1.4

0.18

0.23

nmol/l

1.74

150

1036

Secondary hypertension

404

1.32

1.17

1.8

1.4

0.25

0.36

nmol/l

1.05

322

Gout, FINNGEN

662

1.25

1.17

1.5

0.17

0.20

nmol/l

0.44

489

Strabismus

294

2618

1.12

1.17

1.5

0.35

0.41

nmol/l

0.51

210

2044

Need for immunization against certain single viral diseases

2.61

1.17

1.2

1.6

0.33

0.50

nmol/l

—

Entropion and trichiasis of eyelid

141

1.56

1.17

1.8

1.5

0.38

0.26

nmol/l

0.49

105

Neuromuscular dysfunction of bladder

481

1.29

1.17

1.8

1.4

0.35

0.38

nmol/l

0.12

370

Other diseases of stomach and duodenum

248

1.42

1.16

1.4

1.5

0.45

0.30

nmol/l

0.56

179

Dementia

583

0.78

1.16

1.6

1.4

0.16

0.20

nmol/l

0.61

409

Bacterial, viral and other infectious agents, including avohilmo

731

1.24

1.16

1.4

1.5

0.59

0.39

nmol/l

0.46

568

Dementia in Alzheimer disease

156

0.54

1.16

1.3

1.4

0.16

0.13

nmol/l

—

110

Substance abuse, excluding more controls

485

3709

1.09

1.16

1.5

1.4

0.30

0.42

nmol/l

4.68

358

2877

Car occupant injured in noncollision transport accident

332

0.66

1.15

1.4

1.5

0.28

0.37

nmol/l

0.59

274

Sequelae of tuberculosis, including avohilmo

2.51

1.15

1.6

1.4

0.32

0.15

nmol/l

—

Open bite

770

1.23

1.14

1.6

1.5

0.51

0.45

nmol/l

0.14

624

Haemangioma, any site

625

1.25

1.14

1.4

0.26

0.39

nmol/l

1.33

475

Other puerperal infections

186

1619

1.16

1.14

1.3

1.5

0.52

nmol/l

0.02

156

1365

Seropositive rheumatoid arthritis, strict definition

934

0.80

1.13

1.6

1.4

0.26

0.37

nmol/l

1.70

682

Keratitis

343

3096

1.11

1.13

1.4

1.5

0.39

0.40

nmol/l

0.09

259

2380

Cholelithiasis

722

5287

0.93

1.13

1.4

0.36

0.41

nmol/l

0.74

556

4002

COPD, hospital admissions 1, only main diagnosis

756

0.79

1.13

1.4

0.17

0.22

nmol/l

1.65

535

Other diseases of gallbladder

175

1.49

1.13

1.3

1.4

0.16

0.33

nmol/l

2.15

133

Glomerular disorders in diseases classified elsewhere

586

0.75

1.12

1.8

1.5

0.52

0.36

nmol/l

0.37

452

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

396

1.32

1.12

1.4

1.5

0.30

0.31

nmol/l

0.03

286

Impacted cerumen

466

1.29

1.12

1.3

1.5

0.27

0.31

nmol/l

0.30

346

Nontoxic goitre/thyroid nodule

206

1804

1.14

1.12

1.4

0.30

0.37

nmol/l

1.71

145

1307

Medial epicondylitis

242

1.41

1.12

1.4

0.25

0.33

nmol/l

0.70

186

Protozoal diseases

127

1.59

1.12

1.7

1.4

0.29

0.32

nmol/l

0.15

Suicide or other Intentional self-harm

296

2654

1.12

1.11

1.4

1.5

0.35

0.40

nmol/l

0.64

214

2084

Other and unspecified glaucoma

143

1.54

1.11

1.2

1.4

0.19

0.26

nmol/l

0.62

104

Foreign body on external eye

100

826

1.21

1.11

1.3

1.5

0.33

0.32

nmol/l

0.05

655

Donors of organs and tissues

136

0.51

1.11

2.4

1.4

3.25

0.35

nmol/l

—

111

Atopic dermatitis, strict definition

498

4480

1.09

1.11

1.6

1.5

0.36

0.43

nmol/l

1.20

390

3608

Injury, poisoning and certain other consequences of external causes

710

3308

1.08

1.10

1.5

0.45

0.47

nmol/l

0.17

546

2645

Other neurotic disorders

209

1.44

1.10

1.7

1.4

0.19

0.34

nmol/l

1.98

159

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

128

1082

1.19

1.10

1.4

1.5

0.44

0.39

nmol/l

0.20

840

Disorder of external ear, unspecified

201

1.45

1.10

1.6

1.5

0.32

nmol/l

0.01

158

AV-block

406

1.28

1.09

1.3

1.5

0.23

0.26

nmol/l

0.11

313

Diabetic retinopathy

141

1026

0.85

1.09

1.3

1.6

0.28

0.37

nmol/l

0.85

104

786

Haemangioma and lymphangioma, any site

674

1.24

1.09

1.4

0.26

0.39

nmol/l

1.53

514

Organic, including symptomatic, mental disorders

127

1055

0.85

1.09

1.6

1.4

0.25

0.24

nmol/l

0.03

738

Thrombocytopenia, unspecified

355

1.33

1.08

1.7

1.4

0.95

0.34

nmol/l

0.60

275

Other blood glucose lowering drugs, excl. Insulins

445

0.72

1.08

1.1

1.5

0.15

0.24

nmol/l

2.18

302

Implicit bacterial Sepsis, including avohilmo

225

1650

1.13

1.08

1.6

1.4

0.28

0.31

nmol/l

0.41

165

1204

Maternal care for known or suspected abnormality of pelvic organs

552

3442

1.09

1.08

1.5

0.54

0.42

nmol/l

1.30

461

2719

Carcinoma in situ of skin

210

1.43

1.08

1.2

1.4

0.26

0.25

nmol/l

0.10

153

Motorcycle rider injured in other and unspecified transport accidents

461

1.29

1.08

1.6

0.23

0.30

nmol/l

0.91

363

Dipeptidyl peptidase 4 (DPP-4) inhibitors

196

1753

0.88

1.07

1.5

1.4

0.21

0.27

nmol/l

2.29

130

1221

Viral hepatitis

622

1.24

1.07

1.4

1.5

0.24

0.40

nmol/l

3.48

486

Respiratory and cardiovascular disorders specific to the perinatal period

203

1.42

1.07

1.7

1.6

0.17

0.25

nmol/l

1.37

161

Disorders of muscles

739

1.22

1.07

1.5

0.35

0.40

nmol/l

0.29

590

Sudden idiopathic hearing loss

479

1.28

1.07

1.6

1.5

0.23

0.32

nmol/l

1.06

360

Other and unspecified disorders of vitreous body

219

1890

1.13

1.06

1.3

1.4

0.21

0.27

nmol/l

1.55

146

1262

Adverse effects, not elsewhere classified

255

2275

1.12

1.06

1.6

1.5

0.47

0.43

nmol/l

0.15

190

1788

Enteropathic arthropathies

203

1.44

1.06

1.2

1.4

0.51

0.43

nmol/l

0.20

168

Injury of nerves at wrist and hand level

262

1.38

1.06

1.9

1.4

0.28

0.39

nmol/l

0.85

208

Infections, IBD-co-morbidities

152

917

1.17

1.06

1.6

1.4

0.24

0.44

nmol/l

5.35

122

717

Metatarsalgia

777

1.21

1.05

1.4

0.27

0.39

nmol/l

2.11

611

268

1.36

1.05

1.3

1.5

0.17

0.14

nmol/l

0.32

164

Other medical care

325

2463

1.11

1.05

1.6

1.4

0.34

0.35

nmol/l

0.04

214

1840

Fracture of rib(s), sternum and thoracic spine

164

1422

1.15

1.05

1.5

1.4

0.25

0.31

nmol/l

1.16

119

1044

Acute otitis externa, noninfective

1.68

1.04

1.3

1.4

0.22

0.38

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

297

1.35

1.04

1.4

1.5

0.57

0.35

nmol/l

0.41

234

Disorders of sclera, cornea, iris and ciliary body

536

4962

1.08

1.04

1.4

1.5

0.35

0.39

nmol/l

0.60

407

3779

Dyshidrosis [pompholyx]

151

0.52

1.04

1.3

1.4

0.18

0.36

nmol/l

—

124

Toxic effect of corrosive substances

1.96

1.03

1.7

1.6

0.50

0.41

nmol/l

—

Aortic aneurysm

515

1.26

1.03

1.4

1.5

0.16

0.19

nmol/l

0.41

389

Cholecystectomy

651

5150

1.07

1.03

1.4

0.35

0.40

nmol/l

0.83

496

3870

Other symptoms and signs involving the circulatory and respiratory systems

411

1.29

1.03

1.5

0.23

0.35

nmol/l

2.37

331

Inflammatory disease of uterus

239

2131

1.13

1.03

1.5

0.46

0.48

nmol/l

0.08

196

1696

Bacterial pneumoniae

233

2297

0.89

1.02

1.7

1.5

0.31

0.36

nmol/l

0.93

181

1735

Adalimumab

1029

0.82

1.02

1.5

0.29

0.40

nmol/l

1.62

803

Abnormal spermatozoa

196

1.43

1.02

1.4

1.5

0.11

0.14

nmol/l

1.24

143

Other obstructive and reflux uropathy

386

1.30

1.01

1.6

1.4

0.29

0.39

nmol/l

1.33

321

Pathological resorption of teeth

273

1.36

1.01

1.4

1.5

0.36

0.37

nmol/l

0.02

216

Venous complications and haemorrhoids in the puerperium

1.64

1.01

1.4

0.21

0.37

nmol/l

1.32

Inflammatory bowel disease

330

2995

1.10

1.01

1.5

0.36

0.41

nmol/l

0.71

265

2317

Ascites

273

1.36

1.00

1.2

1.5

0.13

0.32

nmol/l

4.80

204

Diabetic maculopathy, excluding more controls

664

0.78

1.00

1.3

1.5

0.37

0.40

nmol/l

0.11

521

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1.77

1.00

1.0

1.4

0.26

0.23

nmol/l

—

Other congenital malformations of the digestive system, including avohilmo

375

1.30

1.00

1.5

0.32

0.34

nmol/l

0.07

298

Pityriasis lichenoides chronica

2.21

0.99

1.0

1.6

0.13

0.32

nmol/l

—

Fissure and fistula of anal and rectal regions

198

1749

1.13

0.98

1.3

1.5

0.30

0.39

nmol/l

2.39

154

1321

Melanocytic naevi of upper limb, including shoulder

198

1.43

0.98

1.6

1.5

0.32

0.40

nmol/l

0.40

163

Chronic myeloid leukaemia, including Hilmo

2.19

0.98

2.6

1.4

0.26

0.31

nmol/l

—

Streptococcal septicaemia, including avohilmo

379

1.30

0.98

1.4

0.30

0.29

nmol/l

0.04

298

Chronic laryngitis and laryngotracheitis

100

839

1.19

0.97

1.5

1.4

0.33

0.37

nmol/l

0.34

617

Disorders of vitreous body and globe

291

2485

1.11

0.97

1.4

0.25

0.29

nmol/l

0.70

197

1714

Fitting and adjustment of other devices

127

1303

0.86

0.97

1.5

1.4

0.21

0.30

nmol/l

1.84

100

929

Melanocytic naevi of lower limb, including hip

389

1.29

0.97

1.7

1.4

0.37

0.40

nmol/l

0.17

314

Puerperal sepsis

1056

0.83

0.97

1.4

0.41

nmol/l

0.02

769

Other congenital malformations of the digestive system

325

1.32

0.97

1.5

0.36

0.33

nmol/l

0.20

258

Purpura and other haemorrhagic conditions

103

867

1.19

0.97

1.9

1.5

0.60

0.37

nmol/l

0.46

671

Oral leukoplakia, including avohilmo

100

1.61

0.97

1.5

0.23

0.35

nmol/l

—

Sacroiliitis, not elsewhere classified

559

1.24

0.96

1.7

1.5

0.36

0.43

nmol/l

0.39

455

Bell's palsy

776

1.20

0.96

1.4

0.28

0.39

nmol/l

1.07

588

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

362

3310

1.10

0.96

1.5

0.37

0.41

nmol/l

0.35

281

2582

Falls/tendency to fall

1344

6413

1.05

0.96

1.6

1.5

0.36

0.42

nmol/l

1.90

1016

5074

Operations for atrial fibrillation

0.00

0.96

0.0

1.4

—

0.15

—

Pneumonia due to other infectious organisms, not elsewhere classified

157

1.47

0.96

1.5

0.38

0.31

nmol/l

0.24

125

Presence of other functional implants

269

1654

1.11

0.96

1.4

0.27

0.28

nmol/l

0.16

170

1139

Pervasive developmental disorders excl. Autism + Asperger

131

1.53

0.96

1.4

1.5

0.22

0.33

nmol/l

0.91

104

Other and unspecified visual disturbances

731

1.21

0.96

1.5

0.45

0.38

nmol/l

0.27

569

Cardiomyopathy, other and unspecified

267

1.35

0.96

1.5

0.19

0.27

nmol/l

0.97

206

Peroneal tendinitis

141

1.50

0.95

1.4

1.5

0.20

0.42

nmol/l

2.21

111

Unspecific neurodegenerative disorder

461

0.79

0.95

1.5

1.4

0.14

0.17

nmol/l

0.72

309

Dystonia

390

1.29

0.95

1.4

0.29

0.37

nmol/l

0.99

294

Ventral hernia

150

1304

1.15

0.95

1.6

1.4

0.28

0.35

nmol/l

1.10

106

958

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

125

1.54

0.95

1.3

1.6

0.27

0.35

nmol/l

0.42

104

Fall on same level

1282

7166

0.95

0.94

1.5

0.33

0.41

nmol/l

3.76

971

5651

Pre-eclampsia

321

2924

1.10

0.94

1.5

0.52

0.47

nmol/l

0.18

259

2276

Enterobiasis, including avohilmo

365

1.30

0.94

1.6

1.4

0.33

0.51

nmol/l

1.53

308

Type 1 diabetes, definitions combined

1114

0.84

0.94

1.4

1.5

0.33

0.43

nmol/l

1.14

891

Bullous disorders

225

1.38

0.94

1.1

1.5

0.24

0.31

nmol/l

0.66

176

Scoliosis

105

889

1.19

0.94

1.7

1.6

0.34

0.39

nmol/l

0.54

722

Superficial injury of lower leg

240

2672

0.90

0.94

1.5

0.30

0.41

nmol/l

2.73

183

2091

Maternal care for other known or suspected fetal problems

596

3487

1.08

0.94

1.4

1.5

0.41

0.42

nmol/l

0.12

481

2799

Malignant neoplasm of colon

320

1.31

0.94

1.5

1.4

0.23

0.26

nmol/l

0.18

241

Myositis

101

1.59

0.94

1.3

1.5

0.55

0.36

nmol/l

0.27

Benign neoplasm: Liver

226

1.38

0.93

1.2

1.4

0.23

0.37

nmol/l

1.72

184

Superficial injury of hip and thigh

100

843

1.19

0.93

1.3

1.5

0.23

0.40

nmol/l

3.05

658

Pre-eclampsia or eclampsia

332

3032

1.10

0.93

1.5

0.52

0.47

nmol/l

0.21

266

2360

Sequelae of other external causes

365

1.29

0.93

1.6

1.4

0.35

0.36

nmol/l

0.04

279

Anxious personality disorder

218

1.39

0.92

1.4

1.5

0.29

0.39

nmol/l

0.83

184

Streptococcal septicaemia

365

1.29

0.92

1.4

0.29

nmol/l

0.01

289

Bacterial pneumonia, not elsewhere classified

218

2141

0.89

0.92

1.7

1.5

0.31

0.37

nmol/l

0.83

170

1620

Other and unspecified effects of external causes

353

3233

1.09

0.92

1.6

1.5

0.44

0.41

nmol/l

0.11

253

2555

COPD

119

1126

0.86

0.92

1.3

1.4

0.18

0.23

nmol/l

1.38

786

Ankylosing spondylitis, strict definition

361

0.72

0.92

1.8

1.5

0.24

0.35

nmol/l

1.05

282

All-cause Heart Failure

143

1144

0.87

0.91

1.3

1.5

0.21

nmol/l

0.03

104

773

Malignant neoplasm of stomach

1.67

0.91

1.3

1.4

0.38

0.23

nmol/l

—

Lymphangioma, anys site

1.77

0.91

2.6

1.5

0.24

0.41

nmol/l

1.02

Use of interferon beta-1a

290

0.68

0.91

1.5

1.4

0.53

0.42

nmol/l

0.24

238

Ulcerative colitis, NAS

138

1198

1.16

0.91

1.4

1.5

0.38

0.41

nmol/l

0.17

112

937

Glaucoma suspect

181

1599

1.13

0.91

1.4

0.22

0.32

nmol/l

3.89

132

1126

Hemiplegia

296

1.32

0.91

1.5

1.4

0.21

0.40

nmol/l

3.24

230

UC patients in KELA-register (code 208), prior to 1994

176

1.43

0.90

1.4

0.17

0.27

nmol/l

1.35

121

Symptoms and signs involving cognition, perception, emotional state and behaviour

1036

6570

1.05

0.90

1.5

0.29

0.41

nmol/l

8.30

786

5092

Other specified and unspecified disorders of eyelid

1.76

0.90

1.2

1.4

0.17

0.28

nmol/l

1.30

Bleeding

518

3902

0.93

0.90

1.5

0.24

0.36

nmol/l

7.09

389

2903

Diseases of arteries, arterioles and capillaries

281

2272

0.91

0.90

1.5

1.4

0.22

0.32

nmol/l

4.88

219

1642

Colorectal cancer

540

1.23

0.90

1.4

0.35

0.24

nmol/l

0.48

383

Other disorders of the genitourinary system

573

1.22

0.89

1.4

0.24

0.32

nmol/l

1.30

410

Diseases of arteries, arterioles and capillaries (FINNGEN)

791

0.84

0.89

1.5

1.4

0.19

0.27

nmol/l

1.86

564

Other and unspecified follicular disorders

306

1.31

0.89

1.4

1.5

0.56

0.39

nmol/l

0.33

247

Adjustment and management of implanted device

501

1.24

0.89

1.4

0.28

0.25

nmol/l

0.16

375

Mental and behavioural disorders due to sedatives or hypnotics

556

1.23

0.89

1.6

1.5

0.24

0.39

nmol/l

1.83

436

Implicit Sepsis

588

4047

1.07

0.88

1.5

0.31

0.37

nmol/l

1.44

442

3057

Combined immunodeficiencies

1.81

0.88

1.8

1.3

0.16

0.37

nmol/l

—

Tumor necrosis factor alpha inhibitors

160

1815

0.88

1.5

0.33

0.42

nmol/l

1.60

121

1410

Mandibular retrognathia

780

0.81

0.88

1.4

1.5

0.34

0.38

nmol/l

0.25

614

Impacted maxillary molar

131

1138

1.16

0.88

1.8

1.6

0.46

0.44

nmol/l

0.08

114

939

Substance use, excluding alcohol

206

1841

1.12

0.88

1.6

1.5

0.23

0.40

nmol/l

6.25

145

1439

Ulcerative ileocolitis

342

1.29

0.88

1.9

1.4

0.42

0.38

nmol/l

0.21

270

Diseases of spleen

103

1.57

0.88

1.3

1.5

0.18

0.36

nmol/l

1.92

Heart failure, strict

147

1168

0.87

1.4

0.21

nmol/l

0.01

108

792

Psoas tendinitis

2.03

0.87

1.0

1.6

0.28

0.32

nmol/l

—

Oesophageal varices

103

1.56

0.87

1.3

1.6

0.25

0.23

nmol/l

0.08

Striking against or struck by other objects

355

3257

1.09

0.87

1.5

1.6

0.28

0.40

nmol/l

5.48

262

2556

Diseases of pulp and periapical tissues, including avohilmo

1213

5981

1.05

0.87

1.5

0.42

0.40

nmol/l

0.23

931

4713

Other diseases of arteries and capillaries

449

1.25

0.87

1.5

1.4

0.20

0.34

nmol/l

2.95

345

Other condition

1140

0.85

0.87

1.4

1.5

0.26

0.37

nmol/l

1.48

878

Other and unspecified iridocyclitis

334

0.72

0.87

2.0

1.4

0.32

0.35

nmol/l

0.10

265

Artrosis, including avohilmo

765

4439

0.94

0.87

1.4

1.5

0.33

0.41

nmol/l

2.11

569

3435

Benign neoplasm: salivary glands, exclude unknown (D119)

403

0.74

0.87

1.3

1.5

0.11

0.29

nmol/l

8.29

294

Cellulitis

181

1607

1.13

0.86

1.4

1.5

0.28

0.39

nmol/l

2.15

146

1221

Assault

154

1354

1.14

0.86

1.4

1.5

0.26

0.42

nmol/l

4.08

101

1067

Diseases of external ear

293

2671

1.10

0.86

1.4

1.5

0.41

0.39

nmol/l

0.12

220

2035

Idiopathic urticaria

256

1.34

0.86

1.6

1.4

0.54

0.41

nmol/l

0.26

209

Type of accident

224

2487

0.90

0.86

1.5

0.28

0.39

nmol/l

2.88

162

1925

Overexertion and strenuous or repetitive movements

732

1.19

0.85

1.4

1.5

0.25

0.39

nmol/l

2.97

571

Lung cancer and mesothelioma

361

0.75

0.85

1.3

1.4

0.18

nmol/l

0.04

249

Calcific tendinitis of shoulder

379

1.27

0.85

1.2

1.4

0.29

0.32

nmol/l

0.16

282

Melanocytic naevi of scalp and neck

213

1.37

0.85

1.9

1.5

0.32

0.35

nmol/l

0.16

176

Malignant neoplasm of bronchus and lung, including Hilmo

326

0.74

0.85

1.3

0.18

0.20

nmol/l

0.17

235

Seronegative juvenile rheumatoid arthritis

257

1.34

0.84

1.8

1.5

0.23

0.36

nmol/l

1.86

213

Postprocedural disorders of digestive system, not elsewhere classified

162

1.43

0.84

1.2

1.5

0.24

0.33

nmol/l

0.93

128

Other keratitis

117

1011

1.16

0.84

1.5

0.37

0.43

nmol/l

0.45

793

Cerebral aneurysm, nonruptured

446

0.76

0.84

1.3

1.4

0.52

0.32

nmol/l

0.34

323

Problems related to lifestyle

113

974

1.16

0.84

1.5

0.29

0.46

nmol/l

2.39

769

Toxic effect of contact with venomous animals

320

0.71

0.84

1.6

1.5

0.78

0.37

nmol/l

0.42

260

Other viral diseases, not elsewhere classified

207

1851

1.12

0.84

1.5

0.29

0.40

nmol/l

2.89

164

1432

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

151

1331

1.14

0.84

1.4

0.34

0.46

nmol/l

1.94

121

1046

Benign neoplasm: Skin of eyelid, including canthus

752

1.19

0.83

1.6

1.4

0.52

0.34

nmol/l

0.87

546

Aortic valve malfunction, age under 60 years

515

1.23

0.83

1.3

1.5

0.61

0.27

nmol/l

0.87

378

Vulvovaginal ulceration/inflammation in other diseases

123

1069

1.16

0.83

1.4

1.5

0.62

0.47

nmol/l

0.58

870

Unspecified abortion

516

1.23

0.83

1.7

1.4

0.43

0.34

nmol/l

0.52

366

Viral hepatitis, including avohilmo

671

1.20

0.82

1.4

1.5

0.23

0.40

nmol/l

3.79

519

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

197

1.38

0.82

1.6

1.4

0.41

0.37

nmol/l

0.10

151

Visual impairment including blindness (binocular or monocular)

319

1.29

0.82

1.4

1.5

0.25

0.35

nmol/l

0.98

254

Autoimmune hepatitis, wide definition

284

1.31

0.82

1.5

0.22

0.39

nmol/l

2.60

221

Cholesteatoma of middle ear

180

1.39

0.82

1.4

1.5

0.25

0.29

nmol/l

0.24

139

Infective dermatitis

699

0.81

0.82

1.5

0.18

0.40

nmol/l

4.66

543

Other specified/unspecified inflammatory spondylopathies

472

1.24

0.81

1.3

1.5

0.36

0.41

nmol/l

0.33

370

Somnolence, stupor and coma

232

1.34

0.81

1.5

1.6

0.26

0.34

nmol/l

0.75

195

Type 1 diabetes

205

2274

0.90

0.81

1.4

1.5

0.37

0.41

nmol/l

0.40

161

1780

Use of biperiden

283

0.70

0.81

1.5

0.27

0.35

nmol/l

0.39

209

Familial hypercholesterolemia, with ischemic heart disease

130

1.46

0.80

1.1

1.5

0.13

0.16

nmol/l

0.44

Unequal limb length (acquired)

106

1.53

0.80

1.8

1.5

0.26

0.41

nmol/l

—

Other infectious diseases, including avohilmo

518

1.22

0.80

1.5

0.24

0.40

nmol/l

1.71

406

Changes in corneal membranes

0.00

0.80

0.0

1.5

—

0.31

—

Injuries to the hip and thigh

311

2558

1.09

0.80

1.6

1.5

0.27

0.35

nmol/l

2.00

234

1905

Achilles tendinitis

646

1.20

0.79

1.7

1.4

0.38

0.34

nmol/l

0.22

458

Implicit parasitic Sepsis, including avohilmo

1.84

0.79

2.5

1.3

0.29

0.32

nmol/l

—

Cardiac murmurs and other cardiac sounds

108

922

1.16

0.79

1.6

1.5

0.34

0.37

nmol/l

0.15

734

Scleritis and episcleritis

537

1.22

0.79

1.3

1.4

0.30

0.40

nmol/l

1.05

418

Infections of genitourinary tract in pregnancy

111

1278

0.87

0.79

1.4

1.6

0.66

0.47

nmol/l

0.76

1039

Abscess of anal and rectal regions

555

1.21

0.79

1.3

1.5

0.26

0.39

nmol/l

1.08

416

Other aneurysm

139

1.44

0.79

1.2

1.5

0.19

0.21

nmol/l

0.18

105

Other and unspecified intracranial injuries

156

1.42

0.79

1.7

1.5

0.32

0.33

nmol/l

0.01

123

Other follicular disorders

767

1.18

0.79

1.4

1.5

0.42

0.43

nmol/l

0.01

600

Other viral hepatitis

574

1.21

0.79

1.4

1.5

0.23

0.42

nmol/l

3.61

455

Benign neoplasm: Caecum

321

1.28

0.79

1.3

1.5

0.22

0.28

nmol/l

0.67

230

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

1.67

0.78

1.3

1.4

0.10

0.22

nmol/l

—

Hypoglycaemia, other or unspecified

456

1.23

0.78

1.5

0.23

0.40

nmol/l

3.00

363

Persons encountering health services for specific procedures and health care

1256

7099

1.04

0.78

1.5

0.33

0.41

nmol/l

2.22

946

5567

Intracranial injury

550

4811

1.07

0.78

1.6

1.5

0.26

0.39

nmol/l

8.33

403

3741

Hydrocele

199

1.36

0.78

1.9

1.5

0.13

0.12

nmol/l

0.32

150

Other congenital malformations of skin

349

1.27

0.77

1.4

0.39

0.38

nmol/l

0.04

283

Caught, crushed, jammed or pinched in or between objects

417

0.76

0.77

1.4

1.5

0.22

0.33

nmol/l

1.00

332

Seropositive rheumatoid arthritis, wide

133

1511

0.88

0.77

1.4

0.27

0.37

nmol/l

1.59

1095

Mucosal proctocolitis

132

1160

1.14

0.77

1.6

1.5

0.41

0.40

nmol/l

0.04

103

919

Anogenital herpesviral [herpes simplex] infection

112

974

1.16

0.77

1.5

0.48

nmol/l

0.03

799

Arthropathic psoriasis

748

0.83

0.77

1.4

0.37

nmol/l

0.00

561

Schistosomiasis [bilharziasis], including avohilmo

2.22

0.77

1.0

1.7

0.29

0.37

nmol/l

—

Injury of eye and orbit

129

1132

1.14

0.77

1.4

1.5

0.25

0.41

nmol/l

3.95

102

881

Other specified disorders of muscle

157

1.41

0.77

2.1

1.4

0.28

0.39

nmol/l

0.46

129

Dental caries, including avohilmo

642

3095

1.06

0.76

1.4

1.5

0.32

0.37

nmol/l

1.10

476

2434

Benign neoplasm: Liver/bile ducts

235

1.33

0.76

1.2

1.5

0.23

0.37

nmol/l

1.64

188

Episcleritis

476

1.22

0.76

1.3

1.5

0.30

0.39

nmol/l

0.91

372

Progressive vascular leukoencephalopathy

1.77

0.76

2.0

1.4

0.15

0.13

nmol/l

—

Acute tubulo-interstitial nephritis

567

5082

0.94

0.76

1.5

0.36

0.40

nmol/l

0.78

414

3950

Hyperkinetic disorders (excl. ADHD)

206

1.35

0.76

1.8

1.6

0.23

0.36

nmol/l

1.62

166

Benign neoplasm of thyroid gland

183

1.37

0.76

1.4

0.27

0.35

nmol/l

0.49

137

Supplementary factors related to causes of morbidity and mortality classified elsewhere

252

2759

0.91

0.76

1.5

0.28

0.39

nmol/l

3.33

186

2132

Algoneurodystrophy

315

1.28

0.75

1.4

0.24

0.38

nmol/l

1.74

248

Chronic suppurative otitis media

426

0.77

0.75

1.6

1.5

0.23

0.39

nmol/l

3.11

347

Benign neoplasm: Connective and other soft tissue of thorax

2.11

0.75

1.6

1.5

0.19

0.26

nmol/l

—

Maxillary prognathism

1.67

0.74

1.1

1.5

1.32

0.28

nmol/l

—

Exclusion endpoint for supernumerary teeth

132

0.60

0.74

1.8

1.5

0.47

0.36

nmol/l

—

107

Cutaneous lupus erythematosus

133

1.44

0.74

1.3

1.4

0.30

0.34

nmol/l

0.22

103

Speech and linguistic disorders

121

1017

1.14

0.74

1.9

1.6

0.32

0.40

nmol/l

0.64

104

824

Other/unspecified seropositive rheumatoid arthritis

131

1483

0.88

0.73

1.5

1.4

0.27

0.37

nmol/l

1.65

1076

Birth asphyxia

1.64

0.73

1.9

1.6

0.19

0.28

nmol/l

—

False labour

645

3782

1.06

0.73

1.5

0.52

0.41

nmol/l

1.14

528

2981

Congenital malformations of spine and bony thorax

1.70

0.73

2.3

1.6

0.20

0.30

nmol/l

—

Other benign neoplasms of uterus

150

1.40

0.73

1.7

1.5

0.34

0.33

nmol/l

0.02

118

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

388

1.24

0.73

1.3

1.5

0.20

0.41

nmol/l

3.36

316

Implicit parasitic Sepsis

2.03

0.73

2.8

1.3

0.32

0.31

nmol/l

—

Parkinson's disease, excluding more controls

185

1.34

0.73

1.2

1.5

0.19

0.20

nmol/l

0.07

137

Otorrhagia

2.02

0.73

1.6

0.77

0.28

nmol/l

—

Benign neoplasm: Parotid gland

368

0.76

0.73

1.3

1.5

0.10

0.29

nmol/l

9.90

267

Superficial injury of wrist and hand

218

2396

0.91

0.73

1.6

1.5

0.29

0.42

nmol/l

1.77

170

1896

Viral conjunctivitis

211

1.34

0.72

1.4

1.5

0.45

0.38

nmol/l

0.28

171

Other arrhythmias

582

4603

0.94

0.72

1.5

0.35

0.39

nmol/l

0.36

428

3513

Conjunctivitis (acute, non atopic)

320

2946

1.08

0.72

1.6

1.5

0.38

0.40

nmol/l

0.18

250

2297

Emphysema

142

1.41

0.72

1.2

1.4

0.15

0.21

nmol/l

0.81

107

Other juvenile arthritis

526

1.20

0.72

1.7

1.5

0.32

0.43

nmol/l

0.92

430

Oesophagitis

220

1.32

0.71

1.3

1.4

0.27

0.32

nmol/l

0.35

173

Cardiac arrhythmias

737

4971

0.95

0.71

1.5

0.36

0.42

nmol/l

0.77

559

3877

Complications predominantly related to the puerperium

440

4122

1.07

0.71

1.4

1.5

0.50

0.49

nmol/l

0.09

362

3276

Mixed conductive and sensorineural hearing loss

489

1.21

0.71

1.3

1.5

0.28

0.32

nmol/l

0.44

363

Deep bite that required surgery

143

1.42

0.71

1.5

1.4

0.30

0.40

nmol/l

0.44

115

Benign neoplasm: Retina

1.95

0.71

2.0

1.4

0.73

0.26

nmol/l

—

Open wound of hip and thigh

238

1.31

0.71

1.9

1.6

0.30

0.34

nmol/l

0.19

185

Arthropod-borne viral fevers and viral haemorrhagic fevers

526

1.20

0.71

1.3

1.5

0.44

0.38

nmol/l

0.13

398

Neuroendocrine tumor and carcinoma of lung

1.94

0.71

1.2

0.08

0.36

nmol/l

—

Lichen simplex chronicus

177

1.36

0.71

2.2

1.5

0.19

0.35

nmol/l

1.60

133

Ingrowing nail

381

1.24

0.70

1.6

1.5

0.25

0.41

nmol/l

1.62

295

Need for other prophylactic measures

336

1.25

0.70

1.5

0.22

0.33

nmol/l

1.34

253

Spinal instabilities

169

1.37

0.70

1.1

1.5

0.28

0.36

nmol/l

0.39

120

Special screening examination for other diseases and disorders

103

897

1.15

0.69

1.6

1.5

0.44

0.42

nmol/l

0.04

706

Lesion of ulnar nerve

100

870

1.15

0.69

1.6

1.4

0.35

nmol/l

0.03

653

Spirochaetal infections, other/unspecified

500

1.20

0.69

1.5

1.4

0.36

0.33

nmol/l

0.14

376

Foreign body in respiratory tract

382

1.24

0.69

1.5

0.32

0.40

nmol/l

0.47

300

Meralgia paraesthetica

204

1.33

0.69

1.2

1.4

0.45

0.38

nmol/l

0.24

160

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

329

1.26

0.69

1.4

0.67

0.41

nmol/l

0.58

275

Other inflammatory liver diseases

373

1.24

0.69

1.4

1.5

0.20

0.37

nmol/l

3.30

279

malignant neoplasm of male genital organs

343

1.19

0.69

1.5

0.12

nmol/l

0.01

251

Implicit Sepsis, including avohilmo

716

4857

1.05

0.68

1.5

0.31

0.37

nmol/l

1.80

537

3708

Psoriatic arthropathies, ICD10

694

0.83

0.68

1.3

1.4

0.35

0.36

nmol/l

0.03

521

Psoriatic arthropathies

694

0.83

0.68

1.3

1.4

0.35

0.39

nmol/l

0.18

522

Fracture of foot, except ankle

237

2585

0.92

0.68

1.5

0.30

0.42

nmol/l

2.02

175

1993

Wet age-related macular degeneration

180

1.34

0.68

1.5

1.4

0.11

0.13

nmol/l

0.63

116

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

131

1473

0.89

0.68

1.5

1.4

0.27

0.37

nmol/l

1.69

1070

Otalgia

723

1.17

0.68

1.3

1.5

0.35

0.39

nmol/l

0.24

567

Maternal care for known or suspected malpresentation of fetus

461

3088

1.07

0.67

1.4

1.5

0.58

0.44

nmol/l

1.06

372

2471

Pneumococcal septicemia

170

1.36

0.67

1.2

1.5

0.42

0.31

nmol/l

0.22

136

Malignant neoplasm of digestive organs, including Hilmo

143

936

1.12

0.67

1.4

0.31

0.26

nmol/l

0.39

664

416

3962

0.94

0.67

1.4

1.5

0.31

0.37

nmol/l

1.14

311

3054

Alcohol dependence

119

1345

0.88

0.67

1.4

1.5

0.30

0.32

nmol/l

0.11

991

Multiple gestation

180

1631

1.11

0.67

1.9

1.5

0.45

0.46

nmol/l

0.04

147

1272

Faecal incontinence

420

1.22

0.67

1.4

0.29

0.34

nmol/l

0.28

315

Benign neoplasm: Choroid

267

1.28

0.67

1.7

1.5

0.47

0.31

nmol/l

0.37

198

Pustulosis palmaris et plantaris

283

0.74

0.66

1.8

1.5

0.45

0.38

nmol/l

0.10

209

Heart failure and coronary heart disease

667

0.86

0.66

1.2

1.5

0.18

0.17

nmol/l

0.25

460

Alzheimer’s disease (Late onset)

196

0.71

0.66

1.4

0.11

0.12

nmol/l

0.34

132

Paranoid personality disorder

145

1.39

0.66

1.4

0.42

0.37

nmol/l

0.09

121

Causalgia

128

1.42

0.66

2.0

1.3

0.25

0.34

nmol/l

0.64

102

Pollen allergy

312

2856

1.08

0.66

1.6

0.43

0.42

nmol/l

0.04

244

2285

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

489

4556

1.06

0.66

1.4

1.5

0.43

0.46

nmol/l

0.22

375

3681

Other disorders of bone

199

1812

1.10

0.66

1.6

1.5

0.28

0.41

nmol/l

3.35

164

1392

Other psoriatic arthropathies

680

0.84

0.66

1.3

1.4

0.34

0.36

nmol/l

0.11

510

Eustachian salpingitis and obstruction

108

950

1.14

0.66

1.6

1.4

0.57

0.45

nmol/l

0.22

777

453

4187

0.94

0.66

1.4

1.5

0.31

0.37

nmol/l

1.26

334

3231

Heart failure,strict

141

1101

0.89

0.66

1.4

0.21

0.22

nmol/l

0.03

103

754

Reimbursement for rheumatic diseases

458

4834

0.94

0.66

1.5

0.35

0.38

nmol/l

0.37

342

3660

Erysipelas, including avohilmo

474

3728

0.94

0.65

1.6

1.4

0.28

0.35

nmol/l

1.26

332

2781

Hyperkalaemia

128

1.41

0.65

2.2

1.5

0.14

0.25

nmol/l

1.33

Disorders of gallbladder, biliary tract and pancreas

889

5778

0.96

0.65

1.4

1.5

0.35

0.40

nmol/l

1.00

676

4405

Meningitis

349

1.24

0.65

1.6

1.4

0.31

0.36

nmol/l

0.31

279

Other viral hepatitis, including avohilmo

615

1.18

0.65

1.4

1.5

0.23

0.40

nmol/l

3.64

486

Erysipelas

317

2537

1.08

0.65

1.6

1.4

0.29

0.32

nmol/l

0.23

216

1877

Radial styloid tenosynovitis [de Quervain]

569

1.18

0.65

1.6

1.4

0.31

0.39

nmol/l

0.56

456

Necrosis of pulp, including avohilmo

621

6456

0.95

0.65

1.4

1.5

0.42

0.39

nmol/l

0.22

485

4974

Injury of muscle and tendon at lower leg level

883

0.86

0.64

1.3

1.5

0.27

0.35

nmol/l

1.11

679

Benign neoplasm of major salivary glands

427

0.79

0.64

1.4

1.5

0.13

0.28

nmol/l

6.40

310

Use of disulfiram, acamprosate or naltrexone

523

1.19

0.64

1.4

1.5

0.30

0.33

nmol/l

0.22

389

Delirium, not induced by alcohol and other psychoactive substances

259

1.27

0.64

1.4

1.5

0.32

0.24

nmol/l

0.27

194

Fibrosis of liver

1.74

0.64

2.6

1.4

0.46

0.21

nmol/l

—

Papulosquamous disorders

254

2752

0.92

0.64

1.4

1.5

0.28

0.36

nmol/l

1.89

185

2032

Myocardial infarction, without ST-elevation

806

0.86

0.64

1.3

1.5

0.17

0.18

nmol/l

0.10

571

Graves disease, strict definition

127

1132

1.13

0.63

1.7

1.4

0.50

0.43

nmol/l

0.55

887

Thoracic aortic aneurysm

377

1.22

0.63

1.5

0.18

0.21

nmol/l

0.21

284

Other specified/unspecified hearing loss

359

1.23

0.63

1.5

0.28

0.31

nmol/l

0.23

266

Peripheral arterial reconstruction

292

0.75

0.63

1.0

1.5

0.12

0.17

nmol/l

2.19

209

Disturbances of smell and taste

234

1.29

0.63

1.8

1.4

0.18

0.33

nmol/l

3.11

182

Seropositive rheumatoid arthritis

133

1477

0.89

0.63

1.4

0.27

0.37

nmol/l

1.81

1084

Juvenile osteochondrosis

333

1.24

0.63

1.4

1.5

0.30

0.36

nmol/l

0.50

274

Foreign body or object entering through skin

442

1.20

0.63

1.3

1.5

0.42

0.36

nmol/l

0.12

351

Multiple delivery

1124

0.88

0.62

2.2

1.5

0.38

0.41

nmol/l

0.20

861

Psoriasis

187

2050

0.91

0.62

1.4

1.5

0.28

0.36

nmol/l

1.33

134

1524

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

270

1.26

0.62

1.3

1.4

0.28

0.31

nmol/l

0.25

206

Certolizumab pegol

235

1.29

0.62

1.9

1.5

0.37

0.43

nmol/l

0.27

200

Acute nasopharyngitis (common cold)

714

1.16

0.62

1.3

1.5

0.46

0.35

nmol/l

0.50

569

Short stature starting before birth

1.69

0.62

1.4

1.3

0.09

0.36

nmol/l

—

Habit and impulse disorders

130

1.39

0.61

1.3

1.4

0.20

0.34

nmol/l

1.43

105

Other/unspecified rheumatoid arthritis

512

0.82

0.61

1.3

1.4

0.26

0.32

nmol/l

0.26

373

Heart failure and hypertrophic cardiomyopathy

1.67

0.61

3.2

1.5

0.13

0.28

nmol/l

—

Failure of sterile precautions during surgical operation

0.00

0.61

0.0

1.5

—

0.16

—

Tobacco use

434

0.80

0.61

1.3

1.5

0.43

0.39

nmol/l

0.09

356

Subarachnoid haemorrhage

368

0.79

0.61

1.4

1.5

0.31

0.26

nmol/l

0.26

269

Corneal pigmentations and deposits

0.00

0.61

0.0

1.7

—

0.58

—

Presence of other devices

110

959

1.13

0.60

1.3

1.4

0.26

0.35

nmol/l

1.43

713

Tooth agenesis EXCLUDE clefts and syndromes

536

1.18

0.60

1.5

1.6

0.37

0.36

nmol/l

0.02

445

Chronic apical periodontitis

1202

6983

0.96

0.60

1.4

1.5

0.38

0.41

nmol/l

0.26

905

5505

Atlantoaxial subluxation

0.00

0.60

0.0

1.6

—

0.24

—

Complications peculiar to reattachment and amputation

0.00

0.60

0.0

1.5

—

0.16

—

Epileptic seizures related to alcohol

0.00

0.59

0.0

1.5

—

0.18

—

Nummular dermatitis

408

1.20

0.59

1.8

1.5

0.21

0.31

nmol/l

1.18

309

Other demyelinating diseases of the central nervous system

454

0.81

0.59

1.4

0.41

0.45

nmol/l

0.18

367

Other chondrocalcinosis

0.00

0.59

0.0

1.1

—

0.21

—

Placenta praevia

856

1.14

0.59

1.5

0.53

0.47

nmol/l

0.31

682

Carpal tunnel syndrome

546

4488

1.05

0.59

1.4

0.31

0.39

nmol/l

2.83

396

3357

Sensorineural hearing loss

403

2855

0.94

0.59

1.4

0.24

0.32

nmol/l

3.23

303

2041

Examination and encounter for administrative purposes

299

1.24

0.59

1.4

0.27

0.38

nmol/l

0.41

227

Injuries to the head

1197

7353

0.96

0.59

1.5

0.29

0.41

nmol/l

12.57

908

5773

Spondylolisthesis/Spondylolysis

119

1062

1.12

0.59

1.3

1.4

0.41

0.32

nmol/l

0.28

765

Other/unspecified synovitis and tenosynovitis

836

1.14

0.59

1.3

1.4

0.33

0.39

nmol/l

0.42

659

Ankylosing spondylitis, ICD10

660

0.85

0.59

1.6

1.5

0.26

0.36

nmol/l

1.57

509

Open wound of forearm

687

1.15

0.58

1.5

0.28

0.37

nmol/l

1.12

548

Other specified and unspecified retinal disorders

140

1.36

0.58

1.8

1.4

0.91

0.33

nmol/l

0.38

104

Pneumonia derived septicemia

175

1.32

0.58

1.2

1.5

0.42

0.31

nmol/l

0.22

137

Allergic contact dermatitis

136

1507

0.90

0.58

1.4

1.5

0.40

0.44

nmol/l

0.30

105

1172

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

387

0.80

0.58

1.5

1.4

0.50

0.43

nmol/l

0.09

283

Certain conditions originating in the perinatal period

133

1062

1.11

0.58

1.7

1.6

0.26

0.35

nmol/l

1.78

114

864

Other congenital malformations of nervous system

141

1.36

0.57

1.4

1.5

0.38

0.42

nmol/l

0.15

119

Inflammatory diseases of the central nervous system

567

1.17

0.57

1.7

1.4

0.29

0.36

nmol/l

0.58

435

Schizotypal disorder

207

0.72

0.57

1.4

1.5

0.47

0.39

nmol/l

—

171

Other congenital malformations of skin, including avohilmo

811

1.14

0.57

1.4

1.5

0.38

0.41

nmol/l

0.14

637

Dislocation, sprain and strain of joints and ligaments of thorax

247

1.26

0.57

1.2

1.5

0.52

0.31

nmol/l

0.35

194

Other infectious diseases

383

1.20

0.57

1.4

1.5

0.20

0.36

nmol/l

3.60

307

Other necrotizing vasculopathies

247

1.26

0.56

2.0

1.5

0.21

0.33

nmol/l

1.86

190

Rheumatoid arthritis, including avohilmo

239

2578

0.93

0.56

1.4

0.33

0.39

nmol/l

0.60

179

1891

Carcinoma in situ of skin of other and unspecified parts of face

1.43

0.56

1.6

1.4

0.15

0.18

nmol/l

—

Other bacterial diseases

835

5304

1.04

0.56

1.6

1.5

0.28

0.37

nmol/l

3.31

597

4029

Budesonide

144

1305

1.11

0.56

1.5

0.45

0.44

nmol/l

0.02

118

1008

Contracture of joint

1.55

0.56

1.5

1.3

0.15

0.42

nmol/l

—

Dementia, including avohilmo

653

0.88

0.55

1.5

1.4

0.16

0.19

nmol/l

0.86

463

Family history of certain disabilities and chronic diseases leading to disablement

635

1.15

0.55

1.9

1.5

0.34

0.48

nmol/l

1.07

513

Other superficial mycoses

195

1.29

0.54

1.1

1.5

0.72

0.39

nmol/l

0.43

158

Acute appendicitis, no complications

643

6111

1.05

0.54

1.5

0.47

0.40

nmol/l

0.75

502

4735

925

5612

0.96

0.54

1.5

0.35

0.42

nmol/l

1.99

695

4424

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

925

5612

0.96

0.54

1.5

0.35

0.42

nmol/l

1.99

695

4424

Lactose intolerance

258

1.25

0.54

1.6

1.5

0.53

0.38

nmol/l

0.34

211

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

450

1.18

0.54

1.3

1.5

0.32

0.31

nmol/l

0.07

330

Benign neoplasm: Cranial nerves

125

1.37

0.54

1.5

1.6

0.20

0.33

nmol/l

1.16

Acute pancreatitis

103

919

1.12

0.53

1.6

1.4

0.23

0.32

nmol/l

1.72

678

Valvular heart disease excluding rheumatic fever

198

1533

0.92

0.53

1.4

1.5

0.39

0.29

nmol/l

0.57

139

1114

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.44

0.53

1.8

1.5

0.37

0.34

nmol/l

0.08

Assault by bodily force

788

1.13

0.53

1.4

1.5

0.24

0.40

nmol/l

3.68

622

Lesion of radial nerve

196

1.28

0.52

1.6

1.4

0.21

0.35

nmol/l

1.27

148

Chronic tubulo-interstitial nephritis

196

1.28

0.52

1.4

0.26

0.30

nmol/l

0.20

149

Biological medication for rheuma

182

1976

0.92

0.52

1.5

0.32

0.41

nmol/l

2.01

134

1528

Hereditary deficiency of other clotting factors

100

0.59

0.52

3.5

1.4

0.14

0.39

nmol/l

—

Varicose veins of other sites

250

1.24

0.52

1.6

0.19

0.25

nmol/l

0.86

188

Coxarthrosis [arthrosis of hip](FG)

250

1846

0.93

0.52

1.5

1.4

0.23

0.27

nmol/l

1.03

177

1279

Chronic gastritis

115

1035

1.11

0.51

1.4

0.34

0.29

nmol/l

0.35

726

Dermatitis due to substances taken internally

397

1.19

0.51

1.5

0.23

0.39

nmol/l

2.56

315

Caries of dentine, including avohilmo

735

3602

1.04

0.51

1.4

1.5

0.34

0.38

nmol/l

0.82

538

2840

Diseases of appendix

808

6948

1.04

0.51

1.5

0.45

0.40

nmol/l

0.54

629

5385

Bicipital tendinitis

224

1.25

0.51

1.1

1.4

0.38

0.30

nmol/l

0.42

165

Sequelae of injuries of head

325

0.80

0.51

1.0

1.5

0.30

0.32

nmol/l

0.13

257

Left ventricular outflow tract obstruction (LVOTO), broad definition

593

1.15

0.50

1.4

1.5

0.57

0.28

nmol/l

0.78

438

Other disorders of cornea

537

1.16

0.50

1.4

1.5

0.60

0.35

nmol/l

0.48

408

Cardiodefibrillation

788

1.13

0.50

1.2

1.5

0.15

0.20

nmol/l

1.08

557

Use of rivastigmine

170

1.29

0.50

1.4

0.15

0.14

nmol/l

0.04

118

Tic disorders

127

1.35

0.50

1.1

1.5

0.43

0.36

nmol/l

0.20

104

Other CVD (FINNGEN)

345

1.17

0.50

1.4

1.5

0.27

0.32

nmol/l

0.33

271

Other Crohn's disease

660

1.14

0.50

1.5

0.44

0.42

nmol/l

0.11

518

Benign neoplasm: Duodenum

1.50

0.49

1.3

0.34

0.26

nmol/l

—

Paralytic strabismus

316

1.21

0.49

1.7

1.5

0.20

0.31

nmol/l

1.54

239

Injuries to the thorax

301

2828

1.06

0.49

1.3

1.5

0.33

0.37

nmol/l

0.30

211

2127

Combinations of oral blood glucose lowering drugs

1019

0.89

0.49

1.4

0.14

0.26

nmol/l

5.92

712

Smoking dependency

594

0.86

0.49

1.4

0.25

0.35

nmol/l

1.16

450

Brain astrocytoma, helper endpoint

1.54

0.49

2.1

1.6

0.16

0.39

nmol/l

—

Superficial injury of neck

223

0.76

0.49

1.1

1.5

0.27

0.40

nmol/l

0.88

183

Pedal cyclist injured in noncollision transport accidents

965

0.89

0.48

2.0

1.5

0.29

0.37

nmol/l

1.06

746

Other disorders of glucose regulation and pancreatic internal secretion

558

1.15

0.48

1.5

0.28

0.38

nmol/l

0.86

440

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

235

2194

1.07

0.48

1.4

0.27

0.33

nmol/l

0.89

162

1599

Glucagon-like peptide-1 (GLP-1) analogues

235

2194

1.07

0.48

1.4

0.27

0.33

nmol/l

0.89

162

1599

Disorders of acoustic nerve

119

1.35

0.48

1.5

1.6

0.21

0.33

nmol/l

0.94

Other benign neoplasms of skin

262

2456

1.07

0.48

1.7

1.4

0.41

0.37

nmol/l

0.24

197

1819

Obstructed labour due to malposition and malpresentation of fetus

433

3815

1.05

0.48

1.4

1.5

0.56

0.41

nmol/l

1.24

352

2931

Benign neoplasm: Pharynx, unspecified

1.50

0.48

1.0

1.5

0.45

0.44

nmol/l

—

Vitiligo

102

1.38

0.48

1.6

1.3

0.14

0.40

nmol/l

—

Lyme disease, including avohilmo

264

2476

1.07

0.48

1.5

1.4

0.32

0.36

nmol/l

0.70

202

1822

Lyme disease

264

2476

1.07

0.48

1.5

1.4

0.32

0.36

nmol/l

0.70

202

1822

Acute epiglottitis

102

1.38

0.47

1.2

1.5

0.25

0.33

nmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

710

1.13

0.47

1.7

1.5

0.22

0.37

nmol/l

4.21

573

Other spirochaetal diseases, including avohilmo

273

2564

1.07

0.47

1.6

1.4

0.32

0.37

nmol/l

0.99

209

1887

Appendicitis, broad definition

803

6944

1.04

0.47

1.5

0.45

0.40

nmol/l

0.56

626

5382

Other spirochaetal diseases

268

2516

1.07

0.47

1.5

1.4

0.32

0.36

nmol/l

0.79

204

1850

Cyst of Bartholin Gland

448

1.17

0.47

1.4

1.5

0.45

0.44

nmol/l

0.03

354

Other diseases of spinal cord

155

1.30

0.47

1.5

1.4

0.25

0.32

nmol/l

0.37

122

Other/unspecified soft tissue disorders related to use, overuse and pressure

227

1.24

0.47

1.4

0.39

0.37

nmol/l

0.07

181

Benign neoplasm of other and unspecified sites

164

1.29

0.46

2.0

1.4

0.25

0.31

nmol/l

0.23

127

Arnold-Chiari syndrome

129

1.33

0.46

1.5

0.39

0.42

nmol/l

0.08

111

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

327

1.19

0.46

1.4

1.6

0.47

0.40

nmol/l

0.23

269

Gilbert syndrome

1.44

0.46

1.3

1.4

0.41

0.50

nmol/l

—

Prolonged pregnancy

325

2931

0.94

0.46

1.4

1.5

0.55

0.44

nmol/l

1.04

268

2383

Fracture of shoulder and upper arm

236

2205

1.07

0.46

1.6

1.5

0.28

0.35

nmol/l

0.80

167

1621

Galactorrhea

147

1.31

0.46

1.4

1.5

0.42

nmol/l

0.00

127

Infectious mononucleosis, including avohilmo

141

1294

1.09

0.46

1.4

1.5

0.30

0.45

nmol/l

3.49

109

1043

Infectious mononucleosis

141

1294

1.09

0.46

1.4

1.5

0.30

0.45

nmol/l

3.49

109

1043

Superficial injury of forearm

112

1016

1.10

0.46

1.5

0.40

0.42

nmol/l

0.07

810

Lichen simplex chronicus and prurigo

319

1.19

0.46

1.8

1.5

0.18

0.32

nmol/l

2.11

231

Congenital malformations of the circulatory system

132

1172

1.10

0.46

1.5

0.39

0.37

nmol/l

0.08

916

Psoriasis vulgaris

115

1264

0.91

0.45

1.5

0.24

0.35

nmol/l

1.74

942

377

1.16

0.45

1.4

0.16

0.14

nmol/l

0.19

236

Acute appendicitis

763

6827

1.04

0.45

1.5

0.45

0.40

nmol/l

0.54

597

5285

Aggressive periodontitis

103

1.37

0.45

1.3

1.4

2.20

0.37

nmol/l

—

Other conjunctival vascular disorders and cysts

103

1.36

0.45

1.5

1.4

0.63

0.32

nmol/l

—

Early onset COPD

865

0.89

0.45

1.3

1.4

0.21

0.25

nmol/l

0.66

607

Gluteal tendinitis

292

1.20

0.45

1.4

0.35

nmol/l

0.00

213

Chronic ulcer of skin, not elsewhere classified

237

1.23

0.45

1.3

1.5

0.27

0.29

nmol/l

0.10

172

Other disorders of skin and subcutaneous tissue, not elsewhere classified

779

1.12

0.45

1.7

1.5

0.21

0.36

nmol/l

3.92

594

Acute renal failure

675

1.13

0.45

1.6

1.5

0.21

0.26

nmol/l

0.61

489

Contact with heat and hot substances

406

0.84

0.45

1.4

1.5

0.29

0.37

nmol/l

0.77

325

Conduction disorders

137

1005

1.09

0.45

1.4

1.5

0.33

0.30

nmol/l

0.17

104

742

Other and specified injuries of hip and thigh

112

1.34

0.45

1.3

1.6

0.16

0.35

nmol/l

2.30

Malignant neoplasm of corpus uteri, including Hilmo

201

1.25

0.44

1.4

1.3

0.19

0.31

nmol/l

1.27

140

Additional codes for the location of defect, injury or illness

395

0.83

0.44

1.4

0.30

0.37

nmol/l

0.50

308

Coeliac disease

112

1018

1.10

0.44

1.6

1.5

0.41

0.39

nmol/l

0.11

793

Mental and behavioural disorders due to tobacco

588

0.87

0.44

1.4

0.25

0.35

nmol/l

1.25

447

Acute pancreatitis (for exclusion)

103

932

1.11

0.44

1.6

1.4

0.23

0.32

nmol/l

1.73

695

Other and unspecified tonsillitis

518

4122

1.05

0.44

1.6

1.5

0.33

0.46

nmol/l

5.48

400

3402

Ulcerative colitis

237

2223

1.07

0.44

1.5

0.38

0.41

nmol/l

0.31

187

1731

Disorder of lipoprotein metabolism, unspecified

348

1.18

0.44

1.3

1.4

0.19

0.24

nmol/l

0.45

246

Failed induction of labour

139

1279

1.09

0.44

1.4

1.6

0.50

0.46

nmol/l

0.18

124

1051

Contact with sharp object, undetermined intent

208

0.77

0.44

1.4

1.5

0.47

0.30

nmol/l

0.25

170

Ulcerative colitis (strict definition, require KELA)

147

1594

0.92

0.44

1.5

0.41

nmol/l

0.01

112

1241

Adenocarcinoma and ductal carcinoma of pancreas

1.37

0.44

1.3

1.4

0.14

0.24

nmol/l

—

Carcinoma in situ of cervix uteri, endocervix

185

0.75

0.44

1.3

0.35

0.44

nmol/l

—

157

Nephropathy related operations

526

1.14

0.43

1.5

0.19

0.29

nmol/l

3.33

394

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1.37

0.43

1.2

1.4

0.10

0.21

nmol/l

—

Myocardial infarction, with ST-elevation

329

0.82

0.43

1.2

1.5

0.18

0.17

nmol/l

0.07

239

Fracture of forearm

476

4466

0.96

0.43

1.4

1.5

0.36

0.38

nmol/l

0.19

353

3372

Finngen Rheumatological endpoints

1123

6559

0.97

0.43

1.5

0.33

0.42

nmol/l

4.73

855

5190

Bacterial, viral and other infectious agents

649

1.13

0.43

1.4

1.5

0.71

0.39

nmol/l

0.57

508

Pedestrian injured in transport accident

501

0.86

0.43

1.8

1.5

0.27

0.38

nmol/l

1.46

394

Benign neoplasm: Orbit, unspecified

1.63

0.43

2.0

1.5

0.37

0.48

nmol/l

—

Spirochaetal infections, other/unspecified, including avohilmo

266

2507

1.06

0.43

1.5

1.4

0.32

0.36

nmol/l

0.81

204

1847

Corns and callosities

350

0.83

0.43

1.4

0.14

0.33

nmol/l

5.87

262

Abscess of Bartholin gland

371

0.83

0.43

1.7

1.5

0.69

0.45

nmol/l

0.32

304

Pre-eclampsia or poor fetal growth

554

5298

1.04

0.43

1.5

0.46

0.47

nmol/l

0.04

452

4220

Chronic viral hepatitis

499

1.15

0.43

1.4

1.5

0.22

0.42

nmol/l

4.36

401

Primary coxarthrosis, bilateral

801

1.11

0.43

1.3

1.4

0.28

0.21

nmol/l

0.77

514

Juvenile arthritis (FINNGEN)

584

1.13

0.43

1.8

1.5

0.31

0.44

nmol/l

1.11

476

malignant neoplasm of male genital organs, including Hilmo

360

1.13

0.42

1.5

0.12

0.13

nmol/l

0.24

263

Familial hypercholesterolemia

368

1.17

0.42

1.3

1.5

0.20

0.23

nmol/l

0.23

265

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.43

0.42

1.4

0.29

0.35

nmol/l

—

Speech therapy

142

1539

0.92

0.42

1.4

0.23

0.34

nmol/l

3.23

113

1115

Non-rheumatic valve diseases

198

1513

0.93

0.42

1.4

0.39

0.29

nmol/l

0.58

139

1101

Nail dystrophy

1.57

0.42

1.6

1.7

0.51

0.47

nmol/l

—

Injuries to the elbow and forearm

703

6239

0.96

0.42

1.5

0.34

0.38

nmol/l

0.67

535

4812

Birth trauma

1.45

0.42

1.5

0.19

0.37

nmol/l

—

Dermatitis due to ingested food

442

1.15

0.42

1.6

1.7

0.23

0.35

nmol/l

1.15

346

Sequelae of infectious and parasitic diseases

462

1.15

0.42

1.3

1.4

0.27

0.43

nmol/l

1.96

355

Maltreatment syndromes

632

1.13

0.42

1.3

1.5

0.44

0.38

nmol/l

0.18

513

Noonan syndrome

0.00

0.42

0.0

1.3

—

0.21

—

Pacemaker

101

851

1.10

0.42

1.3

1.5

0.18

0.23

nmol/l

1.18

609

All influenza

188

1753

1.07

0.42

1.4

1.5

0.29

0.37

nmol/l

1.38

147

1357

Congenital heart conduction disorder

0.00

0.42

0.0

1.3

—

0.39

—

Infections with a predominantly sexual mode of transmission

491

4697

1.04

0.42

1.4

1.5

0.38

0.46

nmol/l

2.00

419

3742

All dysplastic lesions of the vulva

413

0.84

0.41

1.3

1.4

0.24

0.35

nmol/l

1.22

313

Pustular psoriasis

305

0.82

0.41

1.7

1.5

0.36

0.37

nmol/l

0.01

224

Rosacea

134

1234

1.09

0.41

1.4

1.5

0.44

0.40

nmol/l

0.18

100

946

Allergic purpura

240

1.21

0.41

2.4

1.4

0.30

0.37

nmol/l

0.21

193

Accidental poisoning by and exposure to pesticides

0.00

0.41

0.0

1.7

—

0.17

—

Hypertensive diseases (excluding secondary)

661

3704

1.04

0.41

1.5

1.4

0.35

0.41

nmol/l

1.36

470

2889

Asthma/COPD (KELA code 203)

1078

6996

1.03

0.41

1.5

0.40

nmol/l

0.11

823

5510

Panniculitis affecting regions of neck and back

222

1.22

0.41

1.6

0.36

0.38

nmol/l

0.07

167

Autoimmune diseases excluding thyroid diseases, strict definition

997

5584

0.97

0.41

1.5

0.36

0.39

nmol/l

0.76

755

4390

Cerebral atherosclerosis

0.00

0.40

0.0

1.2

—

0.11

—

Open wound of shoulder and upper arm

138

0.72

0.40

1.5

0.35

nmol/l

—

110

Sequelae of infectious and parasitic diseases, including avohilmo

464

1.14

0.40

1.3

1.4

0.27

0.43

nmol/l

1.95

357

Post-traumatic wound infection, not elsewhere classified

150

1.27

0.40

1.6

1.5

0.32

0.30

nmol/l

0.06

118

Lumbosacral plexus disorders

0.00

0.40

0.0

1.4

—

0.19

—

Other intracranial haemorrhages

1.34

0.40

1.3

1.4

0.15

0.25

nmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

455

1.14

0.40

1.3

1.5

0.26

0.32

nmol/l

0.59

354

Twin gestation

171

1596

1.07

0.39

1.8

1.5

0.46

nmol/l

0.01

140

1245

Coxarthrosis

243

1663

0.94

0.39

1.5

1.4

0.23

0.29

nmol/l

1.64

172

1163

Contact with nonpowered hand tool

214

1.22

0.39

1.5

1.6

0.32

0.29

nmol/l

0.21

166

Nonspecific lymphadenitis

496

0.86

0.39

1.4

1.5

0.25

0.36

nmol/l

1.64

375

Bacterial pneumonia (organism specified)

258

2470

0.94

0.39

1.7

1.5

0.32

0.37

nmol/l

0.71

199

1860

Benign mammary dysplasia

902

1.10

0.39

1.6

1.4

0.40

0.41

nmol/l

0.06

658

Dialysis, with operation codes

531

1.13

0.39

1.4

1.5

0.19

0.29

nmol/l

3.13

394

Intentional self-harm by unspecified means

178

1.25

0.39

1.2

1.6

0.16

0.36

nmol/l

4.04

152

Cyst of kidney

214

1.22

0.39

1.2

1.5

0.16

0.29

nmol/l

1.88

159

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

465

1.14

0.39

1.5

0.23

nmol/l

0.03

337

Other fibroblastic disorders

0.00

0.39

0.0

1.4

—

0.28

—

Other bursitis of hip

106

1.33

0.39

1.5

1.4

0.47

0.34

nmol/l

—

Superficial injury of shoulder and upper arm

100

912

1.10

0.39

1.3

1.5

0.29

0.38

nmol/l

1.04

704

Disorders of orbit

288

1.18

0.39

1.7

1.5

0.36

nmol/l

0.00

222

Viral meningitis, including avohilmo

372

1.16

0.39

2.1

1.5

0.29

0.40

nmol/l

0.61

301

COPD related to multimorbidity

829

0.91

0.39

1.4

0.16

0.20

nmol/l

1.45

571

Tic and related disorders

142

1.28

0.39

1.2

1.5

0.41

0.34

nmol/l

0.20

116

Other specified and unspecified disorders of eye and adnexa

242

1.20

0.39

1.6

1.5

0.33

0.34

nmol/l

0.03

187

Mental retardation

304

1.18

0.39

2.1

1.5

0.27

0.33

nmol/l

0.41

234

Early syphilis, including avohilmo

1.38

0.38

1.5

1.6

0.25

0.34

nmol/l

—

Other and unspecified injuries of ankle and foot

438

1.15

0.38

1.2

1.6

0.27

0.41

nmol/l

2.00

348

Retinal detachment with retinal break

447

1.14

0.38

1.2

1.4

0.22

0.26

nmol/l

0.53

319

Macular pucker

344

1.16

0.38

1.5

0.20

0.18

nmol/l

0.14

225

Ulcerative colitis (strict definition, all Crohn cases excluded)

121

1312

0.92

0.38

1.5

0.43

0.41

nmol/l

0.08

1035

Acute lymphadenitis

542

1.13

0.38

1.7

1.5

0.26

0.43

nmol/l

2.69

431

Convalescence

382

1.15

0.38

1.2

1.5

0.26

0.38

nmol/l

1.44

297

N06DA Anticholinesterases

374

0.87

0.38

1.5

1.4

0.13

nmol/l

0.13

244

Use of anticholinesterases

374

0.87

0.38

1.5

1.4

0.13

nmol/l

0.13

244

Mental retardation, wide definition

314

1.17

0.38

2.1

1.5

0.26

0.34

nmol/l

0.52

239

Viral pneumonia (unknown virus, not influenza)

429

1.14

0.38

1.6

1.5

0.30

0.36

nmol/l

0.33

342

L04AX Other immunosuppressants

498

5170

0.96

0.37

1.5

0.36

0.38

nmol/l

0.21

376

3932

Peritonsillar abscess

250

2367

1.06

0.37

1.4

1.5

0.37

0.42

nmol/l

0.55

191

1889

Paroxysmal tachycardia

210

1641

1.06

0.37

1.4

1.5

0.34

0.39

nmol/l

0.36

165

1256

Intracranial trauma

640

4471

0.97

0.37

1.5

0.29

0.44

nmol/l

6.47

465

3572

Unstable angina pectoris

678

0.90

0.37

1.2

1.5

0.17

0.18

nmol/l

0.05

464

Plantar fascial fibromatosis

762

1.10

0.37

1.3

1.4

0.41

0.37

nmol/l

0.17

583

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

407

1.13

0.37

1.4

0.32

0.22

nmol/l

0.37

293

Chalazion

877

1.10

0.37

1.4

1.5

0.37

0.39

nmol/l

0.10

676

Scabies, including avohilmo

180

1918

0.94

0.37

1.6

1.5

0.31

0.40

nmol/l

1.01

142

1524

Melanocytic naevi of other and unspecified parts of face

525

1.13

0.37

1.5

1.4

0.42

nmol/l

0.01

412

Suggestive for eosinophilic asthma

450

0.87

0.36

1.6

1.5

0.26

0.31

nmol/l

0.59

347

Viral haemorrhagic fevers, not elsewhere classified/unspecified

459

1.14

0.36

1.3

1.5

0.49

0.35

nmol/l

0.24

345

Colonic or urogenital fistula

206

1941

1.06

0.36

1.3

1.5

0.29

0.38

nmol/l

2.48

162

1470

Synovial cyst of popliteal space [Baker]

332

0.84

0.36

1.1

1.5

0.60

0.31

nmol/l

0.89

253

Special screening examination for neoplasms

244

1.19

0.36

1.1

1.5

0.50

0.29

nmol/l

0.84

176

Convergent concomitant strabismus

597

0.89

0.36

1.6

1.5

0.29

0.41

nmol/l

1.18

470

Charcot foot

0.63

0.35

1.2

1.5

0.25

0.34

nmol/l

—

Open wound of ankle and foot

774

1.10

0.35

1.5

0.24

0.40

nmol/l

4.34

601

Otitis externa

211

1992

1.06

0.35

1.3

1.5

0.46

0.39

nmol/l

0.29

160

1536

Carcinoma in situ of cervix uteri

180

1913

0.94

0.35

1.4

1.5

0.56

0.50

nmol/l

0.24

141

1584

Injury of unspecified body region

522

0.88

0.35

1.5

0.28

0.36

nmol/l

0.85

408

Myocardial infarction, unclassifiable

305

0.85

0.35

1.2

1.4

0.16

0.17

nmol/l

0.17

221

Sulfasalazine

227

2396

0.95

0.34

1.5

0.34

0.41

nmol/l

1.16

159

1848

Viral pneumonia

785

1.10

0.34

1.5

0.29

0.38

nmol/l

0.93

617

Crohn's disease of large intestine

452

1.13

0.34

1.5

1.4

0.34

0.43

nmol/l

0.51

360

Other disorders of kidney and ureter

556

1.12

0.34

1.3

1.4

0.27

0.28

nmol/l

0.11

411

Impetigo

452

1.13

0.34

1.5

0.36

0.35

nmol/l

0.04

361

Failed attempted abortion

232

0.81

0.34

1.2

1.4

0.40

0.47

nmol/l

0.35

196

Second line medication for Crohn's disease

528

5459

0.97

0.34

1.5

0.36

0.38

nmol/l

0.19

399

4161

Other disorders of veins

338

3182

1.05

0.34

1.3

1.4

0.38

nmol/l

0.02

250

2335

Urethritis and urethral syndrome

154

1.24

0.34

1.6

1.4

0.35

0.37

nmol/l

0.08

126

!Aliquae complicationes praecoces traumatis

246

1.18

0.34

1.5

1.6

0.33

0.31

nmol/l

0.09

196

Early complications of trauma

246

1.18

0.34

1.5

1.6

0.33

0.31

nmol/l

0.09

196

Viral conjunctivitis, including avohilmo

415

1.14

0.34

1.3

1.5

0.35

0.39

nmol/l

0.23

333

Open wound of abdomen, lower back and pelvis

237

1.19

0.34

2.0

1.5

0.31

0.34

nmol/l

0.19

186

Viral infections of the central nervous system, including avohilmo

624

1.11

0.33

1.8

1.5

0.29

0.41

nmol/l

1.13

484

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

145

1550

0.93

0.33

1.5

0.41

nmol/l

0.02

111

1208

Colon adenocarcinoma

200

1.20

0.33

1.5

1.3

0.18

0.20

nmol/l

0.09

146

Glomerular diseases

970

0.92

0.33

1.6

1.5

0.39

0.36

nmol/l

0.14

741

Primary open-angle glaucoma, strict

556

1.11

0.33

1.7

1.4

0.17

0.20

nmol/l

0.49

368

Concussion

579

4342

1.03

0.33

1.5

0.28

0.44

nmol/l

9.94

417

3458

Flat foot [pes planus] (acquired)

656

0.90

0.33

1.5

1.4

0.21

0.38

nmol/l

3.55

474

Other abortion

146

1.25

0.33

1.1

1.5

0.26

0.37

nmol/l

0.68

118

Unspecified privation

740

1.10

0.33

1.9

1.5

0.31

0.39

nmol/l

1.04

578

Benign neoplasm of urinary organs

173

1.22

0.32

1.2

1.4

0.20

0.29

nmol/l

0.83

131

Calcific aortic valvular stenosis

520

0.89

0.32

1.3

1.4

0.55

0.17

nmol/l

0.73

374

Calcific aortic valvular stenosis, operated

520

0.89

0.32

1.3

1.4

0.55

0.17

nmol/l

0.73

374

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

370

0.86

0.32

1.3

1.5

0.37

0.33

nmol/l

0.22

270

Malignant neoplasm of digestive organs

117

830

1.08

0.32

1.4

0.32

0.25

nmol/l

0.54

590

Heart failure and antihypertensive medication

643

0.92

0.32

1.5

1.4

0.22

0.28

nmol/l

1.05

453

Sequelae of injuries of lower limb

686

0.90

0.32

1.9

1.5

0.26

0.39

nmol/l

1.83

534

Care involving dialysis

338

0.86

0.32

1.4

0.18

0.29

nmol/l

2.22

260

Corneal ulcer

169

1592

1.06

0.32

1.3

1.5

0.35

0.40

nmol/l

0.57

123

1231

Myocarditis

257

1.17

0.32

2.3

1.5

0.22

0.33

nmol/l

1.35

204

Non-allergic asthma

502

1.12

0.32

1.6

1.5

0.29

0.37

nmol/l

0.60

382

Foreign body in alimentary tract

323

1.15

0.31

1.7

1.5

0.32

0.30

nmol/l

0.09

254

Ulcerative rectosigmoiditis

694

1.10

0.31

1.5

0.41

0.39

nmol/l

0.07

537

COPD (mode)

665

0.91

0.31

1.4

0.19

0.20

nmol/l

0.09

455

LSIL lesion of the cervix uteri, vagina or vulva

224

2354

0.95

0.31

1.5

0.36

0.48

nmol/l

2.00

186

1853

Tuberculosis, wide, including avohilmo

156

1.22

0.31

1.7

1.4

0.28

0.27

nmol/l

0.04

116

Bicornuate uterus

120

1.26

0.31

1.0

1.5

0.55

0.41

nmol/l

—

100

Ulcerative enterocolitis

249

1.17

0.30

1.6

1.4

0.27

0.38

nmol/l

0.72

199

Polyarthritis, unspecified

221

1.18

0.30

2.2

1.4

0.55

0.37

nmol/l

0.49

171

Bitten or struck by other mammals

131

1398

0.94

0.30

1.5

0.27

0.43

nmol/l

3.90

109

1105

Calcific aortic valvular stenosis, including rheumatic fever

516

0.89

0.30

1.3

1.4

0.55

0.17

nmol/l

0.74

370

LSIL lesion of the cervix uteri

192

2023

0.95

0.30

1.5

0.38

0.50

nmol/l

1.61

160

1621

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

175

1.20

0.29

1.3

1.5

0.38

0.31

nmol/l

0.18

137

Lichen planus

588

0.90

0.29

1.4

1.5

0.25

0.32

nmol/l

0.76

416

Nasal polyp

952

0.92

0.29

1.4

0.35

0.33

nmol/l

0.12

703

Inflammatory disorders of breast

982

0.92

0.29

1.4

1.5

0.53

0.52

nmol/l

0.03

798

Transitory endocrine and metabolic disorders specific to fetus and newborn

127

1.24

0.29

2.3

1.6

0.15

0.23

nmol/l

0.93

Decubitus ulcer and pressure area

148

1.22

0.29

1.4

1.5

0.14

0.27

nmol/l

1.82

114

Pedal cyclist injured in other and unspecified transport accidents

871

1.08

0.29

1.8

1.5

0.39

0.37

nmol/l

0.05

676

Exposure to other and unspecified animate mechanical forces

345

1.13

0.29

1.5

0.50

0.39

nmol/l

0.18

279

Other arthrosis

370

2387

1.04

0.28

1.3

1.4

0.28

0.33

nmol/l

0.92

255

1744

Other mental disorders due to brain damage and dysfunction and to physical disease

326

1.14

0.28

1.9

1.6

0.29

0.26

nmol/l

0.21

243

Superficial injury of ankle and foot

155

1464

1.06

0.28

1.6

1.5

0.34

0.42

nmol/l

1.06

118

1156

Gonarthrosis [arthrosis of knee](FG)

517

3068

0.97

0.28

1.4

0.29

0.33

nmol/l

0.64

359

2245

Gout, strict definition

364

1.13

0.28

1.2

1.5

0.13

0.16

nmol/l

1.29

268

Acute appendicitis, with complications

120

1280

0.94

0.28

1.5

1.4

0.36

0.35

nmol/l

0.02

948

Other infective otitis externa

431

1.12

0.28

1.4

0.40

0.41

nmol/l

0.02

333

Lichen planus, including avohilmo

991

0.93

0.28

1.4

0.23

0.34

nmol/l

1.96

707

Congenital dislocation of hip, unilateral

1.28

0.28

1.4

1.5

0.20

0.29

nmol/l

—

Malignant neoplasm of rectum

195

1.18

0.28

1.4

0.57

0.23

nmol/l

0.60

150

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

280

0.85

0.28

1.8

1.5

0.30

0.38

nmol/l

0.38

230

Cardiomyopathy

593

1.10

0.28

1.8

1.5

0.16

0.24

nmol/l

2.36

445

Burns and corrosions of external body surface, specified by site

866

0.92

0.28

1.3

1.5

0.32

0.37

nmol/l

0.37

674

Tuberculosis, IBD comorbidity

149

1.21

0.27

1.8

1.4

0.30

0.28

nmol/l

0.06

111

Operations 2 for CAVS

513

0.90

0.27

1.3

1.4

0.55

0.17

nmol/l

0.74

368

Calcific aortic valvular stenosis, diagnosis (helper)

513

0.90

0.27

1.3

1.4

0.55

0.17

nmol/l

0.74

368

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

149

1364

1.06

0.27

1.6

1.5

0.41

0.39

nmol/l

0.08

119

1068

Benign neoplasm: Skin of other and unspecified parts of face

537

1.10

0.27

1.8

1.4

0.23

0.39

nmol/l

2.73

409

Adhesive capsulitis of shoulder

903

1.08

0.27

1.3

1.5

0.29

0.32

nmol/l

0.23

674

Benign neoplasm: Small intestine

104

1.25

0.26

1.2

1.5

0.29

0.25

nmol/l

—

Other appendicitis

635

0.91

0.26

1.4

0.41

0.38

nmol/l

0.13

489

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

654

1.09

0.26

1.5

0.21

0.38

nmol/l

4.36

524

Other orthopaedic follow-up care

338

1.13

0.26

1.9

1.5

0.28

0.35

nmol/l

0.47

265

Maternal care for cervical incompetence

405

1.11

0.26

2.4

1.5

0.57

0.42

nmol/l

0.31

340

Glucosamine medication

129

969

1.06

0.26

1.7

1.4

0.22

0.21

nmol/l

0.11

624

Ménière disease

424

1.11

0.26

1.7

1.5

0.26

0.32

nmol/l

0.55

310

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

905

5973

1.02

0.26

1.5

0.33

0.38

nmol/l

0.94

687

4618

Burns and corrosions

104

1110

0.94

0.26

1.3

1.5

0.36

0.40

nmol/l

0.31

865

Injuries to the shoulder and upper arm

720

5685

0.98

0.26

1.5

0.27

0.37

nmol/l

4.44

539

4315

Glomerulonephritis

549

1.09

0.25

1.6

1.4

0.39

0.34

nmol/l

0.13

417

Otosclerosis

341

0.88

0.25

1.4

1.5

0.27

0.34

nmol/l

0.51

245

Malignant neoplasm of rectum, including Hilmo

244

1.15

0.25

1.5

1.4

0.47

0.24

nmol/l

0.52

184

Chronic suppurative otitis media, including avohilmo

540

0.91

0.25

1.8

1.5

0.21

0.39

nmol/l

3.69

437

Diverticular disease of intestine

420

2531

1.03

0.25

1.4

0.27

0.30

nmol/l

0.34

298

1773

Embedded teeth, including avohilmo

134

1417

0.94

0.25

1.6

0.41

0.46

nmol/l

0.25

108

1169

Other obstetric trauma

995

0.93

0.25

1.4

1.5

0.69

0.42

nmol/l

1.29

783

Other (seronegative) rheumatoid arthritis, wide

1057

0.94

0.25

1.4

0.28

0.36

nmol/l

0.84

774

Exposure to other and unspecified inanimate mechanical forces

627

1.09

0.25

1.6

1.5

0.31

0.38

nmol/l

0.65

485

Retinal vascular occlusion

254

1.14

0.25

2.1

1.5

0.20

0.26

nmol/l

0.30

187

Tuberculosis, wide

151

1.19

0.25

1.8

1.4

0.30

0.27

nmol/l

0.07

113

Hidradenitis suppurativa

464

1.10

0.25

1.4

0.33

0.45

nmol/l

0.88

377

Other congenital malformations of face and neck

287

0.87

0.25

1.2

1.5

0.26

0.41

nmol/l

1.33

235

Other and/or unspecified nontoxic goitre

416

1.11

0.25

1.5

1.4

0.25

0.39

nmol/l

1.39

302

Car occupant injured in other and unspecified transport accidents

220

2109

1.04

0.24

1.3

1.5

0.41

0.43

nmol/l

0.09

181

1670

Abnormal findings on antenatal screening of mother

185

1936

0.95

0.24

1.4

1.6

0.64

0.47

nmol/l

1.04

157

1618

Hyperlipidaemia, other/unspecified

136

1156

1.06

0.24

1.4

0.27

0.23

nmol/l

0.26

785

Desensitization to allergens

756

0.92

0.24

1.5

0.48

0.41

nmol/l

0.19

612

Vitamin B12 deficiency anaemia

340

1.12

0.24

1.5

1.4

0.23

0.32

nmol/l

0.85

251

Anomalies of pupillary function

189

1.17

0.24

1.6

0.34

nmol/l

0.01

154

Acute suppurative otitis media

424

3835

1.03

0.24

1.6

0.33

0.43

nmol/l

3.13

343

3144

Unspecified acute lower respiratory infection

110

1035

1.06

0.24

1.6

1.5

0.35

0.39

nmol/l

0.28

831

LeFortI or BSSO operation

506

0.91

0.24

1.3

1.5

0.40

nmol/l

0.01

404

Other and unspecified psoriasis

360

1.11

0.23

1.6

1.4

0.25

0.34

nmol/l

0.88

272

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

109

1009

1.06

0.23

1.6

1.5

0.61

0.46

nmol/l

0.32

822

Other and unspecified disorders of skin and subcutaneous tissue

370

0.89

0.23

2.3

1.4

0.17

0.36

nmol/l

5.11

278

Normotensive glaucoma

152

1.19

0.23

1.8

1.4

0.25

0.17

nmol/l

0.35

102

Congenital malformations of the urinary system, including avohilmo

464

0.90

0.23

1.5

0.39

0.38

nmol/l

0.03

366

Oral lichen planus

115

1.22

0.23

1.1

1.5

0.49

0.33

nmol/l

—

Leisure time condition

135

1423

0.95

0.23

1.5

0.28

0.38

nmol/l

2.13

1105

Eclampsia

1.30

0.23

1.4

1.6

0.45

0.35

nmol/l

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

122

1.21

0.23

2.3

1.6

0.12

0.23

nmol/l

—

Chondrocostal junction syndrome [Tietze]

285

0.88

0.23

1.6

1.5

0.24

0.37

nmol/l

1.03

231

Retinal vascular disorders

256

1.13

0.23

2.1

1.5

0.20

0.26

nmol/l

0.31

188

Later onset COPD

280

0.89

0.23

1.4

0.11

0.12

nmol/l

0.20

200

Seronegative rheumatoid arthritis

650

0.92

0.23

1.4

0.24

0.40

nmol/l

2.12

481

Injury of nerves at forearm level

0.76

0.22

1.7

1.5

0.20

0.28

nmol/l

—

Mumps, including avohilmo

153

1.18

0.22

1.1

1.5

0.22

0.31

nmol/l

0.72

113

Other and unspecified corneal deformities and disorders

200

1.15

0.22

1.5

1.4

0.30

0.38

nmol/l

0.68

161

Chronic Coagulation defects

238

1.14

0.22

1.9

1.5

0.29

0.41

nmol/l

0.99

196

Otitis externa, unspecified

107

1010

1.06

0.22

1.3

1.5

0.53

0.42

nmol/l

0.25

806

Injuries to the abdomen, lower back, lumbar spine and pelvis

325

3102

1.03

0.22

1.4

1.5

0.37

0.40

nmol/l

0.30

250

2398

Lichen ruber planus, wide definition including periferal and oral lichen planus

131

1244

1.05

0.22

1.3

1.4

0.24

0.34

nmol/l

1.63

879

Pregnancy, childbirth and the puerperium

319

1721

0.97

0.22

1.5

1.6

0.42

0.32

nmol/l

1.22

268

1370

Ectropion of eyelid

1.22

0.22

1.4

1.5

0.11

0.18

nmol/l

—

Fracture of lumbar spine and pelvis

103

969

1.06

0.22

1.3

1.5

0.41

0.35

nmol/l

0.28

731

Injuries to unspecified part of trunk, limb or body region

710

0.93

0.21

1.5

0.34

0.38

nmol/l

0.28

553

Coxarthrosis, primary

215

1855

0.96

0.21

1.5

1.4

0.22

0.23

nmol/l

0.18

156

1231

Contact with other sharp object(s)

681

1.07

0.21

1.6

1.5

0.31

0.38

nmol/l

0.64

545

Follicular keratosis (Darier-White)

0.00

0.21

0.0

1.8

—

0.11

—

Vascular dementia (multiple infarctions)

0.00

0.21

0.0

1.5

—

0.09

—

Fall on and from stairs and steps

209

2010

1.04

0.21

1.4

1.5

0.30

0.38

nmol/l

1.30

157

1523

Whooping cough, including avohilmo

201

1.15

0.21

1.5

1.4

0.48

0.39

nmol/l

0.31

169

Sequelae of hyperalimentation

0.00

0.21

0.0

1.7

—

0.12

—

Diabetic retinopathy, strict definition

840

0.94

0.21

1.3

1.6

0.31

0.41

nmol/l

0.91

657

Lipomatosis, not elsewhere classified

0.00

0.21

0.0

1.7

—

0.32

—

Fluid overload

0.00

0.21

0.0

1.6

—

0.11

—

Benign neoplasm: Heart

0.00

0.21

0.0

1.3

—

0.09

—

Crushed, pushed or stepped on by crowd or human stampede

771

0.93

0.21

1.6

1.5

0.21

0.38

nmol/l

4.29

614

Follicular keratosis (Darier-White), including avohilmo

0.00

0.21

0.0

1.7

—

0.11

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.16

0.21

1.2

1.3

0.15

0.28

nmol/l

—

Specific development disorders of speech and language

517

1.08

0.21

1.7

1.6

0.25

0.39

nmol/l

1.32

408

Glaucoma

251

2057

1.04

0.21

1.4

0.22

0.30

nmol/l

3.24

180

1461

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.5

—

0.17

—

Use of riluzole

0.00

0.21

0.0

1.4

—

0.15

—

Superficial injury of abdomen, lower back and pelvis

151

1443

1.05

0.21

1.4

1.5

0.34

0.42

nmol/l

0.78

116

1155

Mental and behavioural disorders due to use of other stimulants, including caffeine

303

0.89

0.20

1.3

1.5

0.16

0.38

nmol/l

5.42

250

Otitis media, unspecified

150

1320

1.05

0.20

1.8

1.6

0.27

0.37

nmol/l

2.50

116

1068

Acute and transient psychotic disorders

934

0.94

0.20

1.6

1.5

0.37

nmol/l

0.00

714

Intentional self-harm by jumping or lying before moving object

0.00

0.20

0.0

1.5

—

0.21

—

All influenza (not pneumonia)

105

994

1.06

0.20

1.5

1.6

0.31

0.35

nmol/l

0.48

790

Diseases of pulp and periapical tissues and dental caries

561

2810

1.02

0.20

1.4

1.5

0.33

0.37

nmol/l

0.75

432

2217

214

1.14

0.20

1.7

0.19

0.22

nmol/l

0.29

168

Surgical ablation of atrial fibrillation

0.00

0.20

0.0

1.3

—

0.16

—

Alopecia areata

259

1.12

0.20

1.4

1.5

0.41

0.42

nmol/l

0.06

216

Diseases of peritoneum

499

1.08

0.20

1.5

0.38

0.33

nmol/l

0.22

373

Herpesviral keratitis and keratoconjunctivitis

240

1.13

0.20

1.6

1.5

0.25

0.33

nmol/l

0.60

188

Nonischemic cardiomyopathy

316

1.11

0.20

1.2

1.5

0.17

0.26

nmol/l

1.48

234

Conductive hearing loss, unspecified

567

1.08

0.20

1.4

1.5

0.27

0.37

nmol/l

1.28

433

Other osteochondropathies

552

0.92

0.20

1.6

1.4

0.32

0.40

nmol/l

0.52

424

Superficial injury of head

187

1796

1.04

0.20

1.5

0.31

0.40

nmol/l

1.34

138

1370

Sequelae of injuries, of poisoning and of other consequences of external causes

171

1781

0.96

0.20

1.5

0.32

0.37

nmol/l

0.28

131

1363

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

136

1299

1.05

0.20

1.3

1.5

0.36

0.50

nmol/l

2.24

111

1047

Amputation of ankle bones

1.20

0.19

1.0

1.3

0.14

0.32

nmol/l

—

Pyogenic granuloma

127

1.18

0.19

1.5

0.22

0.35

nmol/l

1.05

103

Viral agents as the cause of diseases classified to other chapters, including avohilmo

212

1.14

0.19

1.2

1.4

0.25

0.41

nmol/l

1.04

176

Malignant neoplasm of respiratory system and intrathoracic organs

350

1.09

0.19

1.4

1.3

0.35

0.21

nmol/l

0.47

258

Mental and behavioural disorders due to hallucinogens

1.18

0.19

1.5

1.6

0.33

0.35

nmol/l

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

1.18

0.19

1.2

1.6

0.15

0.25

nmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

159

1480

1.04

0.19

1.6

1.5

0.40

0.39

nmol/l

0.04

127

1158

Osteomyelitis

231

1.13

0.19

1.2

1.5

0.29

0.27

nmol/l

0.07

181

Other specified and unspecified disorders of conjunctiva

1.18

0.19

1.0

1.5

0.19

0.40

nmol/l

—

Benign lipomatous neoplasm of other sites/unspecified

333

0.90

0.19

1.3

1.5

0.20

0.28

nmol/l

0.70

248

Other maltreatment syndromes

241

1.12

0.19

1.5

0.29

0.34

nmol/l

0.26

183

Alzheimer disease, excluding more controls

155

0.88

0.19

1.4

1.6

0.13

0.15

nmol/l

0.25

111

Other sexually transmitted chlamydial diseases

106

1115

0.95

0.19

1.5

0.32

0.49

nmol/l

3.28

928

Renal failure

172

1407

1.04

0.19

1.5

1.4

0.23

0.29

nmol/l

0.98

132

1001

Mandibular retrognathia AND surgery (BSSO)

301

0.89

0.19

1.4

0.31

0.39

nmol/l

0.47

243

Bronchitis, not specified as acute or chronic

472

1.08

0.19

1.6

1.4

0.45

0.38

nmol/l

0.16

376

Other diseases of pleura

172

1436

1.04

0.19

1.4

0.23

0.29

nmol/l

1.25

124

1027

Fall on same level involving ice and snow

520

5085

1.02

0.18

1.5

0.33

0.38

nmol/l

0.69

392

3847

Other pleural conditions

251

1.12

0.18

1.1

1.5

0.10

0.26

nmol/l

6.02

193

Reactive arthropathies, FINNGEN

521

1.08

0.18

1.4

0.38

0.41

nmol/l

0.13

401

Gout, idiopatic and unspecified

579

1.07

0.18

1.4

1.5

0.15

0.19

nmol/l

1.43

422

Thyrotoxicosis with toxic multinodular goitre

238

0.88

0.18

1.4

0.32

0.31

nmol/l

—

177

Other specified/unspecified dorsopathies

194

1.14

0.18

1.4

1.5

0.24

0.37

nmol/l

0.99

147

Fracture at wrist and hand level

293

3005

0.97

0.18

1.6

1.5

0.26

0.39

nmol/l

4.20

225

2310

Autoimmune hyperthyroidism

599

1.07

0.18

1.9

1.4

0.45

0.42

nmol/l

0.14

475

Other otitis externa (chronic)

477

0.92

0.18

1.4

1.5

0.35

0.36

nmol/l

0.05

368

Fibrosis and cirrhosis of liver

290

1.10

0.18

1.4

1.5

0.21

0.31

nmol/l

0.83

203

Dislocation, sprain and strain of joints and ligaments of elbow

619

1.07

0.18

1.6

1.5

0.25

0.37

nmol/l

1.61

490

Persistent delusional disorders

396

1.09

0.18

1.6

1.5

0.49

0.33

nmol/l

0.60

295

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

121

0.82

0.18

1.2

1.5

0.36

0.33

nmol/l

—

Sequelae of injuries of upper limb

658

1.06

0.18

1.5

0.39

0.34

nmol/l

0.12

504

Parkinson's disease, including avohilmo

300

0.90

0.18

1.2

1.5

0.19

0.20

nmol/l

0.10

212

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

785

1.06

0.17

1.3

1.4

0.27

0.42

nmol/l

2.94

612

Chronic pancreatitis

435

1.08

0.17

1.5

0.27

0.26

nmol/l

0.07

318

Event of undetermined intent

542

1.07

0.17

1.6

1.5

0.35

0.36

nmol/l

0.05

426

L04AA Selective immunosuppressants

179

1855

0.96

0.17

1.4

1.5

0.30

0.38

nmol/l

1.47

136

1408

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

175

1.14

0.17

1.6

0.28

0.34

nmol/l

0.27

146

Congenital malformations of eye, ear, face and neck

698

1.06

0.17

1.4

1.5

0.31

0.41

nmol/l

0.64

567

Childhood allergy (age < 16)

303

2431

1.03

0.17

1.8

1.6

0.38

0.43

nmol/l

0.47

257

2060

Use of peginterferon beta-1a

0.75

0.17

1.2

1.5

0.32

0.43

nmol/l

—

Presence of cardiac and vascular implants and grafts

105

810

0.95

0.17

1.2

1.5

0.26

0.22

nmol/l

0.15

569

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

407

1.08

0.17

1.4

0.33

0.40

nmol/l

0.47

335

Chronic iridocyclitis

330

0.91

0.17

1.6

1.5

0.25

0.37

nmol/l

1.23

262

Septal defects

522

1.07

0.17

1.6

1.5

0.47

0.33

nmol/l

0.36

413

Other gastritis (incl. Duodenitis)

110

1051

1.05

0.16

1.5

1.4

0.30

0.33

nmol/l

0.17

766

Other lesions of median nerve

101

1.19

0.16

1.5

1.4

0.17

0.32

nmol/l

—

Other specified/unspecified arthritis

223

2163

1.03

0.16

1.4

1.5

0.33

0.41

nmol/l

1.30

162

1654

Retained placenta and membranes, without haemorrhage

133

1384

0.96

0.16

1.7

1.5

0.59

0.42

nmol/l

0.88

107

1037

Heart failure and bmi 25plus

638

0.95

0.16

1.4

1.5

0.18

0.19

nmol/l

0.26

430

Injury of muscle and tendon at ankle and foot level

177

1.13

0.16

1.5

0.20

0.33

nmol/l

1.34

141

Trigger finger

105

1003

1.05

0.16

1.2

1.4

0.27

0.36

nmol/l

1.10

765

Chronic kidney disease

100

918

1.05

0.16

1.4

0.24

0.29

nmol/l

0.54

672

Malignant neoplasm of head and neck, including Hilmo

225

1.11

0.16

1.5

1.4

0.25

0.26

nmol/l

0.04

171

Contact with sharp glass

370

1.08

0.16

1.4

0.26

0.38

nmol/l

1.62

300

Assault by unspecified means

193

0.88

0.16

1.6

1.5

0.39

0.33

nmol/l

0.13

154

Intestinal malabsorption

312

1.09

0.16

1.7

1.5

0.51

0.33

nmol/l

0.74

247

Perineal laceration during delivery

372

3070

0.98

0.15

1.5

0.58

0.43

nmol/l

1.79

331

2507

Other abnormal findings in urine

1.10

0.15

1.9

1.4

0.36

0.37

nmol/l

—

Pneumonitis due to solids and liquids

214

0.89

0.15

1.6

1.5

0.46

0.29

nmol/l

0.33

163

Gonarthrosis, primary, with knee surgery

222

1676

1.03

0.15

1.3

1.4

0.22

nmol/l

0.08

148

1095

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

164

1697

0.97

0.15

1.5

0.39

0.41

nmol/l

0.11

127

1323

Monoarthritis, not elsewhere classified

297

0.91

0.15

1.3

1.4

0.29

0.38

nmol/l

0.61

233

Granulomatous disorders of skin and subcutaneous tissue

224

0.89

0.15

1.5

1.4

0.38

0.41

nmol/l

0.09

182

Toxic effect of other and unspecified substances

140

0.85

0.15

1.4

1.5

0.18

0.36

nmol/l

—

111

Other heart diseases

568

3755

0.98

0.15

1.4

1.5

0.38

0.39

nmol/l

0.14

423

2919

Psoriasis (vulgaris), strict definition

207

1.11

0.15

1.1

1.5

0.25

0.33

nmol/l

0.45

168

Cholecystitis

585

1.06

0.15

1.5

1.4

0.50

0.36

nmol/l

0.53

443

Other secondary gonarthrosis

207

1.11

0.15

1.4

1.5

0.63

0.33

nmol/l

0.48

153

Early lumbar disc prolapse, operated

130

1252

1.04

0.15

1.8

1.5

0.38

0.42

nmol/l

0.38

1000

Use of ropinirole

1.10

0.15

1.1

1.5

0.23

0.22

nmol/l

—

Other benign neoplasms of connective and other soft tissue

644

1.06

0.15

1.4

0.42

0.37

nmol/l

0.28

494

Other arthritis (FG)

258

2515

1.03

0.14

1.5

0.35

0.40

nmol/l

0.60

189

1906

Inflammatory disease of cervix uteri

391

1.08

0.14

1.6

1.4

0.34

0.40

nmol/l

0.23

292

Pediculosis, acariasis and other infestations, including avohilmo

205

2109

0.97

0.14

1.7

1.5

0.35

0.41

nmol/l

0.39

164

1669

Mumps

150

1.14

0.14

1.1

1.5

0.23

0.31

nmol/l

0.55

111

Maxillary retrognathism

198

1.11

0.14

1.6

0.21

0.34

nmol/l

1.77

156

Antepartum haemorrhage, not elsewhere classified

170

1648

1.03

0.14

1.4

1.5

0.50

0.48

nmol/l

0.08

139

1315

Gonococcal infection

179

1.12

0.14

1.5

1.6

0.62

0.28

nmol/l

0.48

130

Reactive arthropathies

616

1.06

0.14

1.5

1.4

0.37

0.39

nmol/l

0.09

476

Inguinal or femoral hernia, bilateral

256

1.09

0.14

1.2

1.5

0.16

0.21

nmol/l

0.71

192

DVT of lower extremities

910

1.04

0.14

1.5

1.4

0.42

0.34

nmol/l

0.26

669

Delivery, wide proxy

402

2090

1.02

0.14

1.5

1.6

0.50

0.35

nmol/l

1.39

343

1655

Acute bronchiolitis

609

1.05

0.14

1.6

1.7

0.22

0.31

nmol/l

1.12

486

ILD medications: immunosuppressive drugs

655

5841

1.02

0.14

1.5

0.34

0.41

nmol/l

1.53

507

4528

Pilonidal cyst

832

1.05

0.14

1.5

0.42

nmol/l

0.01

663

Bilateral sagittal split ramus osteotomy operation

402

1.07

0.14

1.3

1.5

0.39

nmol/l

0.01

322

Pyoderma

103

1.17

0.14

1.3

1.4

0.13

0.36

nmol/l

—

FESS (DNB20)

950

1.04

0.13

1.4

1.5

0.34

0.40

nmol/l

0.45

740

Nonsuppurative otitis media

329

2914

0.98

0.13

1.6

0.39

0.44

nmol/l

0.29

270

2414

Spondyloarthritis

147

1422

1.03

0.13

1.5

0.32

0.41

nmol/l

1.15

107

1101

Congenital malformations of the respiratory system

100

0.80

0.13

1.6

1.4

0.20

0.29

nmol/l

—

Fracture of femur

679

1.05

0.13

1.7

1.5

0.31

0.26

nmol/l

0.28

483

Other and unspecified injuries of wrist and hand

344

1.08

0.13

1.8

1.5

0.46

0.37

nmol/l

0.15

275

Malignant neoplasm of corpus uteri

170

1.12

0.13

1.5

1.3

0.19

0.30

nmol/l

0.93

116

Contusion of other and unspecified parts of foot

598

1.05

0.13

1.6

1.5

0.36

0.39

nmol/l

0.12

475

Primary gonarthrosis, bilateral

196

1686

0.97

0.13

1.4

0.22

0.24

nmol/l

0.22

135

1120

Other cataract

198

1512

0.97

0.13

1.4

0.25

0.29

nmol/l

0.51

143

1061

Fracture of lower leg, including ankle

463

4466

1.02

0.13

1.5

0.25

0.37

nmol/l

6.67

332

3374

Lung diseases due to external agents

432

1.07

0.13

1.5

0.42

0.28

nmol/l

0.54

326

Other congenital malformations of tongue, mouth and pharynx

141

1.13

0.13

1.6

0.33

0.36

nmol/l

0.13

114

Open wound of wrist and hand

439

4167

1.02

0.13

1.5

0.29

0.40

nmol/l

3.90

334

3256

Congenital malformations of the urinary system

427

0.94

0.12

1.4

1.5

0.40

0.38

nmol/l

0.06

342

Crohn's disease of small intestine

648

1.05

0.12

1.6

1.5

0.37

0.40

nmol/l

0.15

507

HSIL lesion of the cervix uteri, vagina or vulva

362

3688

0.98

0.12

1.5

0.50

0.48

nmol/l

0.12

292

2965

Generalized epilepsy

437

0.94

0.12

1.3

1.5

0.33

0.43

nmol/l

0.33

355

Intrahepatic Cholestasis of Pregnancy (ICP)

132

1278

1.03

0.12

1.4

1.5

0.36

0.50

nmol/l

2.22

109

1034

Neonatal jaundice from other and unspecified causes

119

1.14

0.12

2.5

1.7

0.35

0.22

nmol/l

—

Contact with machinery

404

1.06

0.12

1.2

1.6

0.19

0.25

nmol/l

0.93

309

Scabies

375

0.93

0.12

1.6

1.5

0.30

0.34

nmol/l

0.22

301

Anterior Iridocyclitis

142

1464

0.97

0.12

1.5

0.27

0.37

nmol/l

2.50

105

1106

Biomechanical lesions, not elsewhere classified

268

1.08

0.12

1.3

1.4

0.29

0.35

nmol/l

0.42

203

Alcoholic liver disease

313

0.93

0.12

1.5

1.6

0.23

0.22

nmol/l

0.04

227

Schizophrenia or delusion

292

2979

0.98

0.12

1.6

1.5

0.32

0.40

nmol/l

1.30

219

2297

Other diseases of biliary tract

317

1.07

0.12

1.1

1.5

0.21

0.31

nmol/l

0.97

231

D07AA Corticosteroids, weak (group I)

175

1793

0.97

0.11

1.6

1.5

0.38

0.44

nmol/l

0.54

137

1417

Benign neoplasm: Descending colon

199

0.90

0.11

1.3

1.5

0.20

0.24

nmol/l

0.51

145

Schizophrenia, schizotypal and delusional disorders

292

2977

0.98

0.11

1.6

1.5

0.32

0.40

nmol/l

1.28

219

2299

Unspecified fall

410

3958

1.02

0.11

1.6

1.5

0.29

0.37

nmol/l

2.20

306

3016

Other predominantly sexually transmitted diseases, not elsewhere classified

264

2587

1.02

0.11

1.5

0.38

0.47

nmol/l

2.00

228

2071

Nonsuppurative otitis media, including avohilmo

470

4002

1.02

0.11

1.6

0.38

0.44

nmol/l

0.53

387

3245

Recurrent dislocation of patella

828

1.04

0.11

1.4

1.5

0.44

0.51

nmol/l

0.24

685

All dysplastic lesions of the cervix uteri

497

4960

0.99

0.11

1.5

0.47

0.48

nmol/l

0.08

406

3977

Complications following abortion and ectopic and molar pregnancy

219

0.91

0.11

1.2

1.5

0.28

0.35

nmol/l

0.55

160

Other and unspecified paralytic syndromes

1.17

0.11

1.1

1.5

0.27

0.35

nmol/l

—

Pyogenic arthritis

289

1.07

0.11

1.3

1.5

0.15

0.35

nmol/l

4.79

226

Dislocation, sprain and strain of joints and ligaments of knee

730

6521

1.01

0.11

1.5

0.33

0.42

nmol/l

2.70

577

5097

Diseases of oesophagus, stomach and duodenum

1099

6545

0.99

0.11

1.5

0.38

0.41

nmol/l

0.37

845

5070

Overjet

307

1.07

0.11

1.5

1.6

0.22

0.31

nmol/l

1.84

248

Gonarthrosis

468

2604

1.02

0.10

1.4

0.30

0.35

nmol/l

0.68

327

1913

Femoral hernia

163

1.11

0.10

1.4

1.5

0.19

0.30

nmol/l

0.89

123

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

299

1.07

0.10

1.2

1.5

0.23

0.30

nmol/l

0.69

223

Divergent concomitant strabismus

652

1.04

0.10

1.4

0.55

0.42

nmol/l

0.25

501

Other/unspecified reactive arthropathies

495

0.95

0.10

1.4

1.5

0.42

0.41

nmol/l

0.01

389

Later onset COPD, excluding more controls

198

1.08

0.10

1.4

0.11

nmol/l

0.10

134

Hypertensive heart and/or renal disease

447

1.05

0.10

1.2

1.5

0.20

nmol/l

0.04

320

Cardiomyopathy (excluding other)

362

0.94

0.10

1.1

1.6

0.14

0.24

nmol/l

2.41

283

Ill-defined and unknown causes of mortality

208

0.91

0.10

1.4

1.5

0.26

0.21

nmol/l

—

156

Coronary artery bypass grafting

314

0.94

0.10

1.1

1.5

0.19

0.14

nmol/l

0.61

226

Other respiratory disorders and diseases

682

1.04

0.10

1.6

1.4

0.20

0.27

nmol/l

1.73

501

Other diseases of the respiratory system

682

1.04

0.10

1.6

1.4

0.20

0.27

nmol/l

1.73

501

Methotrexate

958

1.03

0.10

1.4

0.31

0.36

nmol/l

0.62

714

Alcohol abuse, main dg

116

1126

1.03

0.10

1.4

1.5

0.30

0.37

nmol/l

0.62

874

Ankylosing spondylitis

596

0.96

0.10

1.6

1.5

0.26

0.39

nmol/l

1.91

462

Melanocytic naevi of ear and external auricular canal

1.14

0.10

1.4

1.5

0.29

nmol/l

—

Tooth eruption problems

265

2512

1.02

0.10

1.6

0.42

nmol/l

0.03

210

2101

Asthma mixed form (mode), excluding more controls

339

1.06

0.10

1.3

1.4

0.29

0.37

nmol/l

0.55

265

Gastric ulcer

545

1.05

0.10

1.5

1.4

0.75

0.28

nmol/l

0.54

396

Intentional self-harm by sharp object

310

1.07

0.10

1.8

1.6

0.21

0.33

nmol/l

2.66

257

Adenocarcinoma of pancreas

1.11

0.10

1.0

1.4

0.09

0.25

nmol/l

—

Intermittent heterotropia

655

0.96

0.09

1.4

1.5

0.43

0.46

nmol/l

0.06

534

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

550

5363

1.01

0.09

1.5

0.37

0.42

nmol/l

0.95

442

4247

Bronchiectasis

203

1.08

0.09

1.4

0.32

0.25

nmol/l

0.21

151

Ulcer of lower limb, not elsewhere classified

432

0.95

0.09

1.1

1.5

0.22

0.27

nmol/l

0.68

322

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

136

1326

1.03

0.09

1.3

1.5

0.36

0.51

nmol/l

2.61

111

1068

Asthma mixed form (mode)

340

1.06

0.09

1.3

1.4

0.29

0.37

nmol/l

0.53

267

Other peripheral vertigo

462

0.95

0.09

1.5

0.32

0.35

nmol/l

0.10

348

Condition for Implicit Sepsis (Organ dysfunction codes)

748

5127

1.01

0.09

1.5

0.30

0.37

nmol/l

1.98

561

3907

Thiazolidinediones

311

1.06

0.09

1.4

1.5

0.14

0.22

nmol/l

1.63

219

Acute alcohol intoxication ICD-9

1.14

0.09

1.0

1.5

0.19

0.21

nmol/l

—

Distal bite

468

0.95

0.09

1.3

1.6

0.19

0.30

nmol/l

3.18

377

Missing teeth due to accident, extraction or parodontitis

369

3248

1.01

0.09

1.4

0.36

0.35

nmol/l

0.04

254

2368

Hordeolum and other deep inflammation of eyelid

488

1.05

0.09

1.7

1.5

0.53

0.40

nmol/l

0.21

388

Unspecified urinary incontinence

439

1.05

0.08

1.6

1.4

0.45

0.37

nmol/l

0.30

324

Squamous cell neoplasms and carcinoma of cervix

1.07

0.08

1.5

1.4

0.49

0.51

nmol/l

—

Transient ischemic attack

196

1591

0.98

0.08

1.3

1.4

0.27

0.28

nmol/l

0.14

128

1117

Benign neoplasm: Skin of lip

1.05

0.08

1.3

1.4

0.16

0.31

nmol/l

—

Late syphilis

1.05

0.08

1.2

1.6

0.17

0.34

nmol/l

—

Periapical abscess

377

3820

0.99

0.08

1.4

1.5

0.40

0.36

nmol/l

0.19

288

2857

Alcohol use disorder, Swedish definition

383

3525

0.99

0.08

1.4

1.5

0.32

0.36

nmol/l

0.87

285

2702

Inguinal hernia, bilateral

253

1.07

0.08

1.2

1.5

0.15

0.21

nmol/l

1.00

189

Colon adenocarcinoma, helper endpoint

257

0.93

0.08

1.5

0.18

nmol/l

0.00

185

Delivery

457

2437

0.99

0.08

1.5

1.6

0.48

0.36

nmol/l

1.04

372

1928

Optic neuritis

481

0.96

0.08

1.7

1.4

0.59

0.46

nmol/l

0.30

387

Other injuries of lower limb, level unspecified

0.82

0.08

1.6

1.4

0.84

0.36

nmol/l

—

Hypertensive diseases

794

4516

0.99

0.08

1.5

1.4

0.31

0.39

nmol/l

1.96

559

3454

Other and unspecified urticaria

221

2172

1.02

0.08

1.4

1.5

0.43

0.42

nmol/l

0.03

168

1691

Valgus deformity, not elsewhere classified

0.77

0.08

2.2

1.5

0.16

0.33

nmol/l

—

Status post-ami

357

0.96

0.08

1.1

1.5

0.16

0.15

nmol/l

0.18

255

Gestational [pregnancy-induced] hypertension

451

4549

0.99

0.07

1.4

1.5

0.46

0.47

nmol/l

0.04

364

3615

Injuries to the knee and lower leg

1336

7172

1.01

0.07

1.4

1.5

0.30

0.41

nmol/l

8.78

1013

5632

Polymorphous light eruption

0.81

0.07

1.5

0.29

0.33

nmol/l

—

Female pelvic inflammatory disorders in diseases classified elsewhere

1.07

0.07

1.6

1.5

0.40

0.45

nmol/l

—

Spondylopathies (FG)

135

1321

1.02

0.07

1.6

1.5

0.33

0.44

nmol/l

1.23

1035

Hypertension

794

4512

0.99

0.07

1.5

1.4

0.31

0.39

nmol/l

1.97

559

3453

Pediculosis, acariasis and other infestations

449

0.96

0.07

1.6

1.5

0.31

0.36

nmol/l

0.41

354

All dysplastic lesions of the cervix uteri, vagina or vulva

535

5267

0.99

0.07

1.5

0.45

0.47

nmol/l

0.16

437

4187

Speech disturbances, not elsewhere classified

392

1.05

0.07

1.7

1.4

0.22

0.33

nmol/l

2.11

292

Disorders resulting from impaired renal tubular function

143

0.91

0.07

1.5

0.18

0.29

nmol/l

—

102

Open wound of head

365

3467

0.99

0.07

1.6

1.5

0.32

0.36

nmol/l

0.82

266

2619

Pityriasis rosea

0.84

0.07

1.9

1.5

0.28

0.40

nmol/l

—

Substance abuse

485

4459

1.01

0.07

1.5

0.30

0.37

nmol/l

2.16

358

3466

Hydronephrosis

570

1.04

0.07

1.3

1.5

0.18

0.33

nmol/l

4.32

443

L01XX Other antineoplastic agents

122

0.90

0.07

1.4

0.27

0.22

nmol/l

—

Contact with hypodermic needle

1.13

0.07

2.1

1.6

0.27

0.40

nmol/l

—

Congenital malformations of heart and great arteries

105

1042

0.98

0.07

1.6

1.5

0.41

0.35

nmol/l

0.22

817

Infections of breast associated with childbirth

650

0.97

0.07

1.4

1.5

0.63

0.50

nmol/l

0.68

533

Open wound of lower leg

105

1026

1.02

0.07

1.5

0.25

0.36

nmol/l

2.65

808

Viral infections of the central nervous system

561

1.03

0.06

1.8

1.5

0.31

0.41

nmol/l

0.65

431

Valvular operations

346

0.95

0.06

1.1

1.5

0.14

0.21

nmol/l

1.30

265

Atrial septal defect, secundum type

235

1.06

0.06

2.0

1.5

0.65

0.36

nmol/l

0.29

186

Tubulo-interstitial nephritis, not specified as acute or chronic

417

0.96

0.06

1.4

0.30

0.39

nmol/l

0.79

325

Polypectomy (DHB20)

285

0.95

0.06

1.6

1.5

0.43

0.28

nmol/l

0.33

215

Parkinson's disease

285

0.95

0.06

1.2

1.5

0.19

0.17

nmol/l

0.11

199

Acute alcohol intoxication

159

1618

0.98

0.06

1.4

1.5

0.29

0.36

nmol/l

1.02

116

1227

Sequelae of other and unspecified infectious and parasitic diseases

433

1.04

0.06

1.3

1.4

0.28

0.44

nmol/l

1.92

335

Cellulitis of external ear

101

0.89

0.06

1.8

1.5

0.43

0.34

nmol/l

—

Other, unspecified and serous retinal detachments

1.11

0.06

2.6

1.4

0.18

0.35

nmol/l

1.53

Use of memantine

261

1.05

0.06

1.3

1.4

0.14

nmol/l

0.01

180

Use of other anti-dementia drugs

261

1.05

0.06

1.3

1.4

0.14

nmol/l

0.01

180

Pleural effusion

443

1.04

0.06

1.3

1.5

0.21

0.26

nmol/l

0.61

328

Bacterial meningitis

197

1.07

0.06

1.3

1.5

0.39

0.35

nmol/l

0.13

158

Other and unspecified injuries of lower leg

770

0.97

0.06

1.4

1.5

0.31

0.38

nmol/l

0.77

609

HSIL lesion of the cervix uteri

348

3516

0.99

0.06

1.5

0.51

0.49

nmol/l

0.18

280

2841

Cardiomyopathies, Primary/intrinsic

345

0.96

0.06

1.2

1.5

0.14

0.24

nmol/l

2.34

271

Toxic effects of substances chiefly nonmedicinal as to source

100

979

1.02

0.06

1.5

0.43

0.41

nmol/l

0.08

769

Gout, unspecified

444

1.04

0.06

1.4

1.5

0.16

0.19

nmol/l

0.77

327

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

132

1297

1.02

0.05

1.4

1.5

0.36

0.52

nmol/l

2.63

109

1052

Arthrosis

610

3366

0.99

0.05

1.5

1.4

0.32

0.39

nmol/l

1.62

448

2551

Gastroduodenal ulcer

798

1.02

0.05

1.5

1.4

0.56

0.26

nmol/l

0.51

565

Mental and behavioural disorders due to cannabinoids

306

1.05

0.05

1.7

1.5

0.28

0.35

nmol/l

0.35

251

Focal brain injury

243

0.95

0.05

1.2

1.5

0.80

0.32

nmol/l

0.34

192

Poor fetal growth

266

2690

0.99

0.05

1.5

0.40

0.50

nmol/l

1.12

225

2205

Lichen sclerosus et atrophicus

722

1.03

0.05

1.5

1.4

0.33

0.39

nmol/l

0.48

521

Interstitial lung disease

425

0.96

0.05

1.9

1.4

0.18

0.27

nmol/l

1.32

307

Interstitial lung disease endpoints

425

0.96

0.05

1.9

1.4

0.18

0.27

nmol/l

1.32

307

Other interstitial pulmonary diseases

425

0.96

0.05

1.9

1.4

0.18

0.27

nmol/l

1.32

307

Alcohol withdrawal state with delirium

202

0.94

0.05

1.1

1.5

0.13

0.23

nmol/l

2.01

149

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

435

1.04

0.05

1.3

1.4

0.28

0.44

nmol/l

1.92

336

Vitreous haemorrhage

445

0.97

0.05

1.4

1.5

0.25

0.31

nmol/l

0.58

335

Disorders of eyelid in diseases classified elsewhere

208

1.06

0.05

1.2

1.5

0.31

0.34

nmol/l

0.19

168

Other disorders of optic disc

100

1.10

0.05

1.8

1.5

0.52

0.38

nmol/l

—

Mental and behavioural disorders due to alcohol

376

3611

0.99

0.05

1.4

1.5

0.31

0.37

nmol/l

1.03

278

2795

Congenital malformations of the respiratory system, including avohilmo

110

0.91

0.05

1.5

1.4

0.27

0.28

nmol/l

—

Colorectal adenocarcinoma

410

1.04

0.05

1.4

0.39

0.21

nmol/l

0.53

288

Infliximab

228

1.05

0.05

1.7

1.5

0.34

0.39

nmol/l

0.26

187

Schizoaffective disorder

717

0.98

0.05

1.5

0.26

0.41

nmol/l

1.54

557

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

169

1.07

0.05

1.2

1.4

0.27

0.32

nmol/l

0.28

129

Abnormalities of forces of labour

160

1578

1.01

0.05

1.3

1.4

0.49

0.42

nmol/l

0.27

132

1164

Other bursopathies

634

1.03

0.05

1.2

1.5

0.39

0.34

nmol/l

0.25

487

Alcohol use disorder, ICD-based

278

2754

1.01

0.04

1.4

1.5

0.32

0.36

nmol/l

0.47

208

2112

IBD patients in KELA-register

236

2336

1.01

0.04

1.5

0.40

0.42

nmol/l

0.13

185

1830

Covid-19 suspected case

269

2665

1.01

0.04

1.5

0.51

0.43

nmol/l

0.40

223

2109

Lactose intolerance, other/unspecified

219

1.05

0.04

1.6

1.5

0.67

0.35

nmol/l

0.58

176

Erythema nodosum

221

0.95

0.04

1.7

1.4

0.21

0.38

nmol/l

2.00

186

Other and unspecified injuries of shoulder and upper arm

221

0.95

0.04

1.5

1.4

0.39

0.34

nmol/l

0.08

175

Acute generalized exanthematous pustulosis

312

0.96

0.04

1.5

1.4

0.21

0.33

nmol/l

1.66

245

Early lumbar disc prolapse operation

134

1359

0.99

0.04

1.8

1.5

0.38

0.43

nmol/l

0.50

103

1079

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

675

1.02

0.04

1.6

1.5

0.44

0.42

nmol/l

0.09

535

Perforation of tympanic membrane

685

0.98

0.04

1.5

0.26

0.40

nmol/l

2.23

536

Other sexually transmitted chlamydial diseases, including avohilmo

190

1921

0.99

0.04

1.5

1.6

0.32

0.46

nmol/l

3.09

161

1600

Coxarthrosis, primary, with hip surgery

142

1334

0.99

0.04

1.4

0.18

0.21

nmol/l

0.64

104

867

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

339

3416

0.99

0.04

1.6

1.5

0.36

0.45

nmol/l

2.58

289

2750

Bicuspidal aortic valve syndrome

180

0.94

0.04

1.3

1.5

0.34

0.30

nmol/l

—

137

Foreign body entering into or through eye or natural orifice

503

0.97

0.04

1.3

1.5

0.30

0.32

nmol/l

0.18

391

Other ill-defined and unspecified causes of mortality

180

0.94

0.04

1.4

1.6

0.26

0.22

nmol/l

—

134

Iridocyclitis

163

1649

0.99

0.04

1.5

0.25

0.38

nmol/l

4.02

122

1251

Acute alcohol intoxication, ICD10

144

1458

0.99

0.04

1.5

0.30

0.37

nmol/l

0.99

107

1129

Arthropathies in other diseases classified elsewhere

200

0.95

0.03

1.3

1.4

0.30

0.40

nmol/l

0.67

159

Suppurative and unspecified otitis media

533

4693

1.01

0.03

1.6

1.5

0.34

0.45

nmol/l

3.84

429

3826

ILD, hospital admissions

422

0.97

0.03

1.9

1.4

0.18

0.27

nmol/l

1.33

305

Acute and subacute iridocyclitis

140

1383

1.01

0.03

1.5

0.27

0.37

nmol/l

2.46

104

1048

Toxic effect of ethanol

341

0.97

0.03

1.6

1.5

0.37

0.36

nmol/l

0.02

278

Viral meningitis

349

1.03

0.03

2.3

1.5

0.31

0.38

nmol/l

0.30

283

257

1.04

0.03

1.6

1.7

0.18

0.23

nmol/l

0.61

206

Non-ischemic cardiomyopathy

717

0.98

0.03

1.4

1.5

0.23

0.22

nmol/l

0.04

491

Other disorders of pigmentation

260

1.04

0.03

1.2

1.5

0.36

0.31

nmol/l

0.14

198

Other fall from one level to another

200

1981

1.01

0.03

1.4

1.5

0.32

0.38

nmol/l

0.66

157

1562

severe traumatic brain injury, does not include concussion

803

0.98

0.03

1.3

1.5

0.32

nmol/l

0.01

601

Crohn disease (strict definition, all UC cases excluded)

471

0.98

0.03

1.5

0.37

0.36

nmol/l

0.05

376

Biological medicines for asthma

201

1.05

0.03

1.8

1.4

0.48

0.34

nmol/l

0.24

165

Spondylopathies

611

3626

1.00

0.03

1.5

1.4

0.29

0.37

nmol/l

2.57

423

2734

Extreme obesity with alveolar hypoventilation

209

0.96

0.03

1.4

0.20

0.31

nmol/l

1.59

154

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

266

1.03

0.02

1.9

1.5

0.19

0.30

nmol/l

1.76

193

Pedal cyclist injured in transport accident

203

2045

0.99

0.02

1.8

1.5

0.32

0.40

nmol/l

0.80

161

1588

Follicular cysts of skin and subcutaneous tissue

127

1283

0.99

0.02

1.5

1.4

0.48

0.36

nmol/l

0.60

100

957

Kidney transplant status

291

1.03

0.02

1.6

1.5

0.20

0.30

nmol/l

2.07

217

Other ulcerative colitis

500

0.98

0.02

1.5

0.37

0.42

nmol/l

0.23

392

Recurrent dislocation and subluxation of joint

709

1.02

0.02

1.3

1.4

0.26

0.42

nmol/l

2.90

563

Other bacterial diseases, including avohilmo

1025

6377

1.00

0.02

1.6

1.5

0.29

0.40

nmol/l

5.77

737

4937

Chorioretinal inflammation

172

1.05

0.02

2.0

1.4

0.34

0.32

nmol/l

0.09

138

Crohn disease (strict definition, require KELA, min 2 HDR)

620

0.98

0.02

1.6

1.5

0.47

0.42

nmol/l

0.25

494

Diabetic neuropathy

379

1.02

0.02

1.2

1.5

0.31

0.32

nmol/l

0.02

281

Gonococcal infection, including avohilmo

228

0.96

0.02

1.5

1.6

0.58

0.29

nmol/l

0.43

170

Haemorrhagic and haematological disorders of fetus and newborn

174

1.04

0.02

2.1

1.7

0.28

0.22

nmol/l

0.25

134

Mental and behavioural disorders due to alcohol, excluding acute intoxication

296

2919

1.00

0.02

1.4

1.5

0.32

0.35

nmol/l

0.47

222

2242

Ethmoidectomy

980

1.01

0.02

1.4

0.34

0.40

nmol/l

0.41

755

Crohn disease (strict definition, require KELA)

629

0.99

0.02

1.6

1.5

0.46

0.42

nmol/l

0.24

502

Labour and delivery complicated by umbilical cord complications

681

1.01

0.01

1.3

1.4

0.73

0.40

nmol/l

1.18

516

Other and unspecified rosacea

739

0.99

0.01

1.5

1.4

0.30

0.40

nmol/l

0.87

560

Malignant neoplasm of prostate

289

0.98

0.01

1.3

1.4

0.12

nmol/l

0.02

217

Other disorders of amniotic fluid and membranes

278

2694

1.00

0.01

1.3

1.5

0.41

0.46

nmol/l

0.52

230

2175

Muscle strain

277

0.97

0.01

1.1

1.6

0.26

0.38

nmol/l

1.65

227

Generalized skin eruption due to drugs and medicaments

283

1.03

0.01

1.5

0.21

0.34

nmol/l

1.63

223

Myeloproliferative diseases

303

1.02

0.01

1.8

1.5

0.23

0.29

nmol/l

0.63

227

Polyhydramnios

878

0.99

0.01

1.3

1.5

0.52

0.46

nmol/l

0.20

708

Residual foreign body in soft tissue

357

0.98

0.01

1.4

1.5

0.35

0.37

nmol/l

0.04

283

Superficial injury of thorax

100

1008

0.99

0.01

1.3

1.5

0.41

0.36

nmol/l

0.16

775

Struck by thrown, projected or falling objec

383

1.02

0.01

1.3

1.5

0.39

0.35

nmol/l

0.14

305

Other hammer toe(s) (acquired)

548

1.01

0.01

1.5

1.4

0.17

0.30

nmol/l

2.00

353

Hypertension, essential

759

4294

1.00

0.01

1.5

1.4

0.31

0.37

nmol/l

1.51

529

3274

Injury of muscle and tendon at wrist and hand level

833

1.01

0.01

1.6

1.5

0.28

0.35

nmol/l

0.63

635

114

1.05

0.00

1.3

1.6

0.26

0.34

nmol/l

—

Mental and behavioural disorders due to psychoactive substance use

506

4624

1.00

0.00

1.5

0.29

0.37

nmol/l

2.42

368

3586

Malignant neoplasm of prostate, including Hilmo

299

0.99

0.00

1.3

1.5

0.12

nmol/l

0.05

222

Polyarthrosis

705

1.01

0.00

1.4

0.27

0.26

nmol/l

0.04

456

Congenital malformations of aortic and mitral valves

224

1.03

0.00

1.5

1.6

0.34

0.29

nmol/l

0.13

171

Pedal cyclist injured in collision with motor vehicle

254

1.02

0.00

1.3

1.5

0.22

0.39

nmol/l

1.98

203

Injury of other and unspecified intrathoracic organs

264

1.02

0.00

1.1

1.6

0.22

0.29

nmol/l

0.75

195

ILD, hospital admission 2, with pulmonary infections

264

1.02

0.00

1.8

1.5

0.19

0.27

nmol/l

0.85

198

Autoimmune diseases excluding thyroid diseases

1084

5867

1.00

0.00

1.5

0.36

0.39

nmol/l

0.79

826

4595

Other respiratory diseases principally affecting the interstitium

516

0.99

0.00

1.8

1.4

0.17

0.26

nmol/l

1.92

371

Other and unspecified injuries of head

434

1.01

0.00

1.7

1.4

0.27

0.35

nmol/l

0.92

329

Other disorders of the musculoskeletal system and connective tissue

773

1.00

0.00

1.3

1.4

0.25

0.35

nmol/l

1.44

577

Hypertensive Heart Disease

410

1.00

0.00

1.2

1.5

0.21

0.19

nmol/l

0.12

291

Idiopathic gout

202

0.99

0.00

1.5

0.13

0.22

nmol/l

1.47

149

Inflammatory bowel disease, strict (require KELA)

236

2363

1.00

0.00

1.5

0.40

0.42

nmol/l

0.10

185

1851

Left ventricular outflow tract obstruction, narrow definition

294

0.99

0.00

1.5

1.6

0.32

0.29

nmol/l

0.08

224

Use of donepezil

217

1.01

0.00

1.6

1.4

0.09

0.13

nmol/l

1.32

146

Benign neoplasm: Skin of trunk

289

1.00

0.00

1.7

1.5

0.39

0.37

nmol/l

0.06

226

Stenosis and insufficiency of lacrimal passages

515

1.01

0.00

1.5

0.46

0.33

nmol/l

0.41

395

Ulcerative proctitis

575

1.01

0.00

1.4

1.5

0.38

0.42

nmol/l

0.19

463

L04AC Interleukin inhibitors

599

1.00

0.00

1.5

0.31

0.39

nmol/l

0.73

464

Degeneration of macula and posterior pole

127

979

1.00

0.00

1.5

1.4

0.27

0.22

nmol/l

0.28

635

Ankyloglossia

174

1.03

0.00

1.8

1.6

0.30

0.34

nmol/l

0.20

147

Polymyalgia rheumatica

254

0.98

0.00

1.2

1.5

0.19

0.18

nmol/l

0.07

180

Other and unspecified disease of Bartholin gland

174

0.98

0.00

1.4

1.5

0.37

0.39

nmol/l

—

141

Alcohol-induced chronic pancreatitis

194

0.98

0.00

1.6

1.5

0.16

0.21

nmol/l

—

140

Atrial fibrillation and flutter

182

1172

1.00

0.00

1.5

1.4

0.20

0.30

nmol/l

2.80

132

838

COPD-related respiratory insufficiency

236

1.02

0.00

1.0

1.4

0.19

0.22

nmol/l

0.24

169

Postprocedural musculoskeletal disorders, not elsewhere classified

254

0.98

0.00

1.3

1.4

0.21

0.30

nmol/l

0.86

177

Other assisted single delivery

353

0.99

0.00

1.5

1.4

1.08

0.43

nmol/l

0.46

285

ILD, hospital admissions 1, main diag only

367

1.01

0.00

1.9

1.4

0.19

0.27

nmol/l

1.10

269

Fall on and from ladder

242

0.99

0.00

1.6

1.5

0.24

0.25

nmol/l

0.05

190

Personal history of certain other diseases

262

0.99

0.00

1.5

0.26

0.45

nmol/l

2.27

224

Vitamin deficiency

318

1.01

0.00

1.4

0.24

0.33

nmol/l

0.98

249

Vitamin deficiency, wide

318

1.01

0.00

1.4

0.24

0.33

nmol/l

0.98

249

Acute pharyngitis

194

1923

1.00

0.00

1.6

0.29

0.43

nmol/l

3.38

146

1587

Pleural plaque

111

0.99

0.00

1.2

1.4

0.07

0.13

nmol/l

—

Golimumab

362

0.99

0.00

1.7

1.5

0.29

0.37

nmol/l

0.59

292

Congenital malformations of cardiac septa

565

0.99

0.00

1.6

1.5

0.49

0.34

nmol/l

0.38

441

Crowding of teeth, including avohilmo

144

1193

1.00

0.00

1.6

0.30

0.38

nmol/l

1.06

115

980

Other and unspecified nonorganic psychotic disorders

212

2118

1.00

0.00

1.5

0.29

0.41

nmol/l

2.97

164

1666

Postpartum haemorrhage due to anatomy

240

2403

1.00

0.00

1.4

1.5

0.61

0.54

nmol/l

0.29

207

2003

Benign neoplasm of middle ear and respiratory system

334

0.99

0.00

1.2

1.5

0.38

0.31

nmol/l

0.17

252

Atrial septal defect

307

1.00

0.00

1.8

1.5

0.54

0.36

nmol/l

0.25

243

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

311

1.00

0.00

1.3

1.5

0.30

0.41

nmol/l

0.86

255

Psoriatic and enteropathic arthropathies

861

1.00

0.00

1.3

1.4

0.41

0.39

nmol/l

0.10

644

Malignant neoplasm of head and neck

169

1.01

0.00

1.4

1.5

0.12

0.23

nmol/l

3.55

129

Early onset COPD, excluding more controls

765

1.01

0.00

1.3

1.4

0.21

0.24

nmol/l

0.47

543

Chondropathies

137

1371

1.00

0.00

1.6

1.5

0.31

0.40

nmol/l

1.48

116

1067

Epiphora

103

0.97

0.00

1.3

1.4

0.23

0.36

nmol/l

—

Atrial fibrillation and flutter with reimbursement

623

1.00

0.00

1.5

1.4

0.18

0.22

nmol/l

0.91

425

Pneumonia due to Streptococcus pneumoniae

203

0.99

0.00

1.6

1.5

0.32

0.30

nmol/l

0.10

164

Myeloproliferative diseases (CML excluded)

263

0.99

0.00

1.7

1.5

0.22

0.29

nmol/l

0.69

199

Scissor bite

312

0.98

0.00

1.7

1.6

0.30

0.26

nmol/l

0.13

248

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

103

0.97

0.00

1.4

1.5

0.32

0.35

nmol/l

—

Benign neoplasm: Long bones of lower limb

275

1.02

0.00

1.6

1.5

0.24

0.36

nmol/l

1.16

228

Dialysis

165

1.03

0.00

1.6

1.5

0.16

0.29

nmol/l

1.90

115

Congenital malformations of great arteries

162

0.97

0.00

1.6

0.16

0.33

nmol/l

2.21

128

Crushing injury of neck

0.00

-0.00

0.0

1.6

—

0.41

—

Motor- or nonmotor-vehicle accident in traffic area

0.98

-0.00

1.5

0.24

0.39

nmol/l

—

Complications of genitourinary prosthetic devices, implants and grafts

170

1.00

-0.00

1.2

1.5

0.32

0.41

nmol/l

—

133

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

-0.00

0.0

1.6

—

0.18

—

Amyloidosis, other/unspecified

1.02

-0.00

1.2

1.5

0.27

0.20

nmol/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.4

—

0.54

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.2

—

0.21

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.88

-0.00

1.1

1.5

0.34

0.37

nmol/l

—

Beningn neoplasm: Meninges, unspecified

0.96

-0.00

1.0

1.4

0.19

0.20

nmol/l

—

Tympanosclerosis

0.00

-0.00

0.0

1.4

—

0.30

—

Thoracic root disorders

0.00

-0.00

0.0

1.7

—

0.32

—

Benign neoplasm: Oesophagus

0.88

-0.00

1.4

1.3

0.55

0.35

nmol/l

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

-0.00

0.0

1.7

—

0.14

—

Iliac crest spur

0.00

-0.00

0.0

1.6

—

0.25

—

Complex cardiac defects

0.94

-0.00

2.4

1.4

0.18

0.32

nmol/l

—

Acute mastoiditis

1.00

-0.00

1.0

1.4

0.38

0.40

nmol/l

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.4

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Estradiol (E2) [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS